id	sid	tid	token	lemma	pos
aiua-6390	1	1	archivio	archivio	PROPN
aiua-6390	1	2	italiano	italiano	X
aiua-6390	1	3	di	di	X
aiua-6390	1	4	urologia	urologia	PROPN
aiua-6390	1	5	e	e	PROPN
aiua-6390	1	6	andrologia	andrologia	NOUN
aiua-6390	1	7	2017	2017	NUM
aiua-6390	1	8	;	;	PUNCT
aiua-6390	1	9	89	89	NUM
aiua-6390	1	10	,	,	PUNCT
aiua-6390	1	11	4272	4272	NUM
aiua-6390	1	12	original	original	ADJ
aiua-6390	1	13	paper	paper	NOUN
aiua-6390	1	14	can	can	AUX
aiua-6390	1	15	re	re	VERB
aiua-6390	1	16	-	-	NOUN
aiua-6390	1	17	cturbt	cturbt	NOUN
aiua-6390	1	18	be	be	AUX
aiua-6390	1	19	useful	useful	ADJ
aiua-6390	1	20	in	in	ADP
aiua-6390	1	21	pt1hg	pt1hg	PROPN
aiua-6390	1	22	disease	disease	NOUN
aiua-6390	1	23	as	as	ADP
aiua-6390	1	24	a	a	DET
aiua-6390	1	25	risk	risk	NOUN
aiua-6390	1	26	indicator	indicator	NOUN
aiua-6390	1	27	of	of	ADP
aiua-6390	1	28	recurrence	recurrence	NOUN
aiua-6390	1	29	and	and	CCONJ
aiua-6390	1	30	progression	progression	NOUN
aiua-6390	1	31	?	?	PUNCT
aiua-6390	2	1	a	a	DET
aiua-6390	2	2	single	single	ADJ
aiua-6390	2	3	centre	centre	NOUN
aiua-6390	2	4	experience	experience	NOUN
aiua-6390	2	5	roberto	roberto	PROPN
aiua-6390	2	6	giulianelli	giulianelli	NOUN
aiua-6390	2	7	1	1	NUM
aiua-6390	2	8	,	,	PUNCT
aiua-6390	2	9	barbara	barbara	PROPN
aiua-6390	2	10	cristina	cristina	PROPN
aiua-6390	2	11	gentile	gentile	PROPN
aiua-6390	2	12	1	1	NUM
aiua-6390	2	13	,	,	PUNCT
aiua-6390	2	14	gabriella	gabriella	PROPN
aiua-6390	2	15	mirabile	mirabile	NOUN
aiua-6390	2	16	1	1	NUM
aiua-6390	2	17	,	,	PUNCT
aiua-6390	2	18	luca	luca	PROPN
aiua-6390	2	19	albanesi	albanesi	PROPN
aiua-6390	2	20	1	1	NUM
aiua-6390	2	21	,	,	PUNCT
aiua-6390	2	22	paola	paola	PROPN
aiua-6390	2	23	tariciotti	tariciotti	NOUN
aiua-6390	2	24	1	1	NUM
aiua-6390	2	25	,	,	PUNCT
aiua-6390	2	26	giorgio	giorgio	PROPN
aiua-6390	2	27	rizzo	rizzo	PROPN
aiua-6390	2	28	1	1	NUM
aiua-6390	2	29	,	,	PUNCT
aiua-6390	2	30	maurizio	maurizio	PROPN
aiua-6390	2	31	buscarini	buscarini	PROPN
aiua-6390	2	32	2	2	NUM
aiua-6390	2	33	,	,	PUNCT
aiua-6390	2	34	mauro	mauro	PROPN
aiua-6390	2	35	vermiglio	vermiglio	NOUN
aiua-6390	2	36	3	3	NUM
aiua-6390	2	37	1	1	NUM
aiua-6390	2	38	cura	cura	NOUN
aiua-6390	2	39	,	,	PUNCT
aiua-6390	2	40	nuova	nuova	PROPN
aiua-6390	2	41	villa	villa	PROPN
aiua-6390	2	42	claudia	claudia	PROPN
aiua-6390	2	43	clinic	clinic	PROPN
aiua-6390	2	44	,	,	PUNCT
aiua-6390	2	45	rome	rome	PROPN
aiua-6390	2	46	,	,	PUNCT
aiua-6390	2	47	italy	italy	PROPN
aiua-6390	2	48	;	;	PUNCT
aiua-6390	2	49	2	2	NUM
aiua-6390	2	50	campus	campus	NOUN
aiua-6390	2	51	biomedico	biomedico	NOUN
aiua-6390	2	52	,	,	PUNCT
aiua-6390	2	53	rome	rome	PROPN
aiua-6390	2	54	,	,	PUNCT
aiua-6390	2	55	italy	italy	PROPN
aiua-6390	2	56	;	;	PUNCT
aiua-6390	2	57	3	3	NUM
aiua-6390	2	58	villa	villa	PROPN
aiua-6390	2	59	gioia	gioia	PROPN
aiua-6390	2	60	clinic	clinic	PROPN
aiua-6390	2	61	,	,	PUNCT
aiua-6390	2	62	sora	sora	PROPN
aiua-6390	2	63	(	(	PUNCT
aiua-6390	2	64	fr	fr	PROPN
aiua-6390	2	65	)	)	PUNCT
aiua-6390	2	66	,	,	PUNCT
aiua-6390	2	67	italy	italy	PROPN
aiua-6390	2	68	.	.	PUNCT
aiua-6390	3	1	introduction	introduction	NOUN
aiua-6390	3	2	:	:	PUNCT
aiua-6390	3	3	understaging	understage	VERB
aiua-6390	3	4	after	after	ADP
aiua-6390	3	5	initial	initial	ADJ
aiua-6390	3	6	transurethral	transurethral	ADJ
aiua-6390	3	7	resection	resection	NOUN
aiua-6390	3	8	is	be	AUX
aiua-6390	3	9	common	common	ADJ
aiua-6390	3	10	in	in	ADP
aiua-6390	3	11	patients	patient	NOUN
aiua-6390	3	12	with	with	ADP
aiua-6390	3	13	high	high	ADJ
aiua-6390	3	14	-	-	PUNCT
aiua-6390	3	15	risk	risk	NOUN
aiua-6390	3	16	non	non	ADJ
aiua-6390	3	17	muscle	muscle	NOUN
aiua-6390	3	18	infiltrating	infiltrate	VERB
aiua-6390	3	19	bladder	bladder	NOUN
aiua-6390	3	20	cancer	cancer	NOUN
aiua-6390	3	21	(	(	PUNCT
aiua-6390	3	22	nmibc	nmibc	ADJ
aiua-6390	3	23	)	)	PUNCT
aiua-6390	3	24	and	and	CCONJ
aiua-6390	3	25	can	can	AUX
aiua-6390	3	26	delay	delay	VERB
aiua-6390	3	27	accurate	accurate	ADJ
aiua-6390	3	28	diagnosis	diagnosis	NOUN
aiua-6390	3	29	and	and	CCONJ
aiua-6390	3	30	definitive	definitive	ADJ
aiua-6390	3	31	treatment	treatment	NOUN
aiua-6390	3	32	.	.	PUNCT
aiua-6390	4	1	the	the	DET
aiua-6390	4	2	rate	rate	NOUN
aiua-6390	4	3	of	of	ADP
aiua-6390	4	4	upstaging	upstage	VERB
aiua-6390	4	5	from	from	ADP
aiua-6390	4	6	t1	t1	NOUN
aiua-6390	4	7	to	to	ADP
aiua-6390	4	8	t2	t2	NOUN
aiua-6390	4	9	disease	disease	NOUN
aiua-6390	4	10	after	after	ADP
aiua-6390	4	11	repeated	repeat	VERB
aiua-6390	4	12	transurethral	transurethral	ADJ
aiua-6390	4	13	resection	resection	NOUN
aiua-6390	4	14	ranges	range	VERB
aiua-6390	4	15	from	from	ADP
aiua-6390	4	16	0	0	NUM
aiua-6390	4	17	to	to	PART
aiua-6390	4	18	28	28	NUM
aiua-6390	4	19	%	%	NOUN
aiua-6390	4	20	,	,	PUNCT
aiua-6390	4	21	although	although	SCONJ
aiua-6390	4	22	the	the	DET
aiua-6390	4	23	rate	rate	NOUN
aiua-6390	4	24	of	of	ADP
aiua-6390	4	25	upstaging	upstaging	ADJ
aiua-6390	4	26	may	may	AUX
aiua-6390	4	27	be	be	AUX
aiua-6390	4	28	even	even	ADV
aiua-6390	4	29	higher	high	ADJ
aiua-6390	4	30	up	up	ADP
aiua-6390	4	31	to	to	ADP
aiua-6390	4	32	49	49	NUM
aiua-6390	4	33	%	%	NOUN
aiua-6390	4	34	when	when	SCONJ
aiua-6390	4	35	muscularis	muscularis	PROPN
aiua-6390	4	36	propria	propria	PROPN
aiua-6390	4	37	is	be	AUX
aiua-6390	4	38	absent	absent	ADJ
aiua-6390	4	39	in	in	ADP
aiua-6390	4	40	the	the	DET
aiua-6390	4	41	first	first	ADJ
aiua-6390	4	42	specimen	speciman	NOUN
aiua-6390	4	43	.	.	PUNCT
aiua-6390	5	1	a	a	DET
aiua-6390	5	2	restaging	restage	VERB
aiua-6390	5	3	classic	classic	ADJ
aiua-6390	5	4	transurethral	transurethral	ADJ
aiua-6390	5	5	resection	resection	NOUN
aiua-6390	5	6	of	of	ADP
aiua-6390	5	7	bladder	bladder	NOUN
aiua-6390	5	8	tumour	tumour	NOUN
aiua-6390	5	9	(	(	PUNCT
aiua-6390	5	10	re	re	NOUN
aiua-6390	5	11	-	-	NOUN
aiua-6390	5	12	cturbt	cturbt	NOUN
aiua-6390	5	13	)	)	PUNCT
aiua-6390	5	14	is	be	AUX
aiua-6390	5	15	the	the	DET
aiua-6390	5	16	better	well	ADJ
aiua-6390	5	17	predictor	predictor	NOUN
aiua-6390	5	18	of	of	ADP
aiua-6390	5	19	early	early	ADJ
aiua-6390	5	20	stage	stage	NOUN
aiua-6390	5	21	progression	progression	NOUN
aiua-6390	5	22	.	.	PUNCT
aiua-6390	6	1	according	accord	VERB
aiua-6390	6	2	to	to	ADP
aiua-6390	6	3	some	some	DET
aiua-6390	6	4	reports	report	NOUN
aiua-6390	6	5	,	,	PUNCT
aiua-6390	6	6	the	the	DET
aiua-6390	6	7	rate	rate	NOUN
aiua-6390	6	8	of	of	ADP
aiua-6390	6	9	positivity	positivity	NOUN
aiua-6390	6	10	for	for	ADP
aiua-6390	6	11	tumor	tumor	NOUN
aiua-6390	6	12	in	in	ADP
aiua-6390	6	13	re	re	NOUN
aiua-6390	6	14	-	-	NOUN
aiua-6390	6	15	cturbt	cturbt	NOUN
aiua-6390	6	16	performed	perform	VERB
aiua-6390	6	17	within	within	ADP
aiua-6390	6	18	eight	eight	NUM
aiua-6390	6	19	weeks	week	NOUN
aiua-6390	6	20	after	after	SCONJ
aiua-6390	6	21	initial	initial	ADJ
aiua-6390	6	22	cturbt	cturbt	NOUN
aiua-6390	6	23	was	be	AUX
aiua-6390	6	24	as	as	ADV
aiua-6390	6	25	high	high	ADJ
aiua-6390	6	26	as	as	ADP
aiua-6390	6	27	18	18	NUM
aiua-6390	6	28	-	-	SYM
aiua-6390	6	29	77	77	NUM
aiua-6390	6	30	%	%	NOUN
aiua-6390	6	31	,	,	PUNCT
aiua-6390	6	32	and	and	CCONJ
aiua-6390	6	33	in	in	ADP
aiua-6390	6	34	about	about	ADV
aiua-6390	6	35	40	40	NUM
aiua-6390	6	36	%	%	NOUN
aiua-6390	6	37	of	of	ADP
aiua-6390	6	38	the	the	DET
aiua-6390	6	39	patients	patient	NOUN
aiua-6390	6	40	a	a	DET
aiua-6390	6	41	change	change	NOUN
aiua-6390	6	42	in	in	ADP
aiua-6390	6	43	tumor	tumor	NOUN
aiua-6390	6	44	stage	stage	NOUN
aiua-6390	6	45	was	be	AUX
aiua-6390	6	46	reported	report	VERB
aiua-6390	6	47	.	.	PUNCT
aiua-6390	7	1	we	we	PRON
aiua-6390	7	2	aimed	aim	VERB
aiua-6390	7	3	to	to	PART
aiua-6390	7	4	investigate	investigate	VERB
aiua-6390	7	5	,	,	PUNCT
aiua-6390	7	6	in	in	ADP
aiua-6390	7	7	high	high	ADJ
aiua-6390	7	8	risk	risk	NOUN
aiua-6390	7	9	group	group	NOUN
aiua-6390	7	10	,	,	PUNCT
aiua-6390	7	11	the	the	DET
aiua-6390	7	12	presence	presence	NOUN
aiua-6390	7	13	of	of	ADP
aiua-6390	7	14	residual	residual	ADJ
aiua-6390	7	15	tumor	tumor	NOUN
aiua-6390	7	16	following	follow	VERB
aiua-6390	7	17	white	white	ADJ
aiua-6390	7	18	light	light	ADJ
aiua-6390	7	19	classical	classical	ADJ
aiua-6390	7	20	transurethral	transurethral	ADJ
aiua-6390	7	21	resection	resection	NOUN
aiua-6390	7	22	of	of	ADP
aiua-6390	7	23	bladder	bladder	NOUN
aiua-6390	7	24	tumor	tumor	NOUN
aiua-6390	7	25	(	(	PUNCT
aiua-6390	7	26	wlre	wlre	ADJ
aiua-6390	7	27	-	-	PUNCT
aiua-6390	7	28	cturbt	cturbt	NOUN
aiua-6390	7	29	)	)	PUNCT
aiua-6390	7	30	and	and	CCONJ
aiua-6390	7	31	the	the	DET
aiua-6390	7	32	different	different	ADJ
aiua-6390	7	33	recurrence	recurrence	NOUN
aiua-6390	7	34	and	and	CCONJ
aiua-6390	7	35	progression	progression	NOUN
aiua-6390	7	36	rate	rate	NOUN
aiua-6390	7	37	between	between	ADP
aiua-6390	7	38	patients	patient	NOUN
aiua-6390	7	39	with	with	ADP
aiua-6390	7	40	persistent	persistent	ADJ
aiua-6390	7	41	or	or	CCONJ
aiua-6390	7	42	negative	negative	ADJ
aiua-6390	7	43	(	(	PUNCT
aiua-6390	7	44	pt0	pt0	NOUN
aiua-6390	7	45	)	)	PUNCT
aiua-6390	7	46	oncological	oncological	ADJ
aiua-6390	7	47	disease	disease	NOUN
aiua-6390	7	48	after	after	ADP
aiua-6390	7	49	wlre	wlre	ADJ
aiua-6390	7	50	-	-	PUNCT
aiua-6390	7	51	cturbt	cturbt	NOUN
aiua-6390	7	52	.	.	PUNCT
aiua-6390	8	1	materials	material	NOUN
aiua-6390	8	2	and	and	CCONJ
aiua-6390	8	3	methods	method	NOUN
aiua-6390	8	4	:	:	PUNCT
aiua-6390	8	5	a	a	DET
aiua-6390	8	6	cohort	cohort	NOUN
aiua-6390	8	7	of	of	ADP
aiua-6390	8	8	285	285	NUM
aiua-6390	8	9	patients	patient	NOUN
aiua-6390	8	10	presenting	present	VERB
aiua-6390	8	11	with	with	ADP
aiua-6390	8	12	primitive	primitive	ADJ
aiua-6390	8	13	bladder	bladder	NOUN
aiua-6390	8	14	cancer	cancer	NOUN
aiua-6390	8	15	underwent	underwent	NOUN
aiua-6390	8	16	to	to	PART
aiua-6390	8	17	wlcturbt	wlcturbt	VERB
aiua-6390	8	18	from	from	ADP
aiua-6390	8	19	january	january	PROPN
aiua-6390	8	20	2011	2011	NUM
aiua-6390	8	21	to	to	ADP
aiua-6390	8	22	december	december	PROPN
aiua-6390	8	23	2015	2015	NUM
aiua-6390	8	24	;	;	PUNCT
aiua-6390	8	25	out	out	ADP
aiua-6390	8	26	of	of	ADP
aiua-6390	8	27	them	they	PRON
aiua-6390	8	28	92	92	NUM
aiua-6390	8	29	(	(	PUNCT
aiua-6390	8	30	32.28	32.28	NUM
aiua-6390	8	31	%	%	NOUN
aiua-6390	8	32	)	)	PUNCT
aiua-6390	8	33	were	be	AUX
aiua-6390	8	34	t1hg	t1hg	PROPN
aiua-6390	8	35	.	.	PUNCT
aiua-6390	9	1	in	in	ADP
aiua-6390	9	2	according	accord	VERB
aiua-6390	9	3	to	to	ADP
aiua-6390	9	4	eau	eau	PROPN
aiua-6390	9	5	guidelines	guideline	NOUN
aiua-6390	9	6	2011	2011	NUM
aiua-6390	9	7	,	,	PUNCT
aiua-6390	9	8	after	after	SCONJ
aiua-6390	9	9	4	4	NUM
aiua-6390	9	10	-	-	SYM
aiua-6390	9	11	6	6	NUM
aiua-6390	9	12	weeks	week	NOUN
aiua-6390	9	13	all	all	DET
aiua-6390	9	14	hg	hg	NOUN
aiua-6390	9	15	bladder	bladder	NOUN
aiua-6390	9	16	cancer	cancer	NOUN
aiua-6390	9	17	patients	patient	NOUN
aiua-6390	9	18	underwent	undergo	VERB
aiua-6390	9	19	a	a	DET
aiua-6390	9	20	wl	wl	X
aiua-6390	9	21	recturbt	recturbt	ADJ
aiua-6390	9	22	.	.	PUNCT
aiua-6390	10	1	all	all	DET
aiua-6390	10	2	patients	patient	NOUN
aiua-6390	10	3	were	be	AUX
aiua-6390	10	4	submitted	submit	VERB
aiua-6390	10	5	to	to	ADP
aiua-6390	10	6	a	a	DET
aiua-6390	10	7	subsequent	subsequent	ADJ
aiua-6390	10	8	followup	followup	NOUN
aiua-6390	10	9	including	include	VERB
aiua-6390	10	10	cystoscopy	cystoscopy	NOUN
aiua-6390	10	11	every	every	DET
aiua-6390	10	12	3	3	NUM
aiua-6390	10	13	months	month	NOUN
aiua-6390	10	14	with	with	ADP
aiua-6390	10	15	multiple	multiple	ADJ
aiua-6390	10	16	biopsies	biopsy	NOUN
aiua-6390	10	17	,	,	PUNCT
aiua-6390	10	18	randomly	randomly	ADV
aiua-6390	10	19	and	and	CCONJ
aiua-6390	10	20	in	in	ADP
aiua-6390	10	21	the	the	DET
aiua-6390	10	22	previous	previous	ADJ
aiua-6390	10	23	zone	zone	NOUN
aiua-6390	10	24	of	of	ADP
aiua-6390	10	25	resection	resection	NOUN
aiua-6390	10	26	;	;	PUNCT
aiua-6390	10	27	urinary	urinary	ADJ
aiua-6390	10	28	citology	citology	NOUN
aiua-6390	10	29	on	on	ADP
aiua-6390	10	30	3	3	NUM
aiua-6390	10	31	specimens	specimen	NOUN
aiua-6390	10	32	and	and	CCONJ
aiua-6390	10	33	kidney	kidney	NOUN
aiua-6390	10	34	/	/	SYM
aiua-6390	10	35	bladder	bladder	NOUN
aiua-6390	10	36	ultrasound	ultrasound	NOUN
aiua-6390	10	37	every	every	DET
aiua-6390	10	38	6	6	NUM
aiua-6390	10	39	months	month	NOUN
aiua-6390	10	40	.	.	PUNCT
aiua-6390	11	1	the	the	DET
aiua-6390	11	2	average	average	ADJ
aiua-6390	11	3	follow	follow	NOUN
aiua-6390	11	4	-	-	PUNCT
aiua-6390	11	5	up	up	NOUN
aiua-6390	11	6	was	be	AUX
aiua-6390	11	7	48	48	NUM
aiua-6390	11	8	months	month	NOUN
aiua-6390	11	9	.	.	PUNCT
aiua-6390	12	1	results	result	NOUN
aiua-6390	12	2	:	:	PUNCT
aiua-6390	12	3	following	follow	VERB
aiua-6390	12	4	wlre	wlre	ADJ
aiua-6390	12	5	-	-	PUNCT
aiua-6390	12	6	cturbt	cturbt	NOUN
aiua-6390	12	7	we	we	PRON
aiua-6390	12	8	observed	observe	VERB
aiua-6390	12	9	a	a	DET
aiua-6390	12	10	persistent	persistent	ADJ
aiua-6390	12	11	disease	disease	NOUN
aiua-6390	12	12	in	in	ADP
aiua-6390	12	13	18	18	NUM
aiua-6390	12	14	(	(	PUNCT
aiua-6390	12	15	15.2	15.2	NUM
aiua-6390	12	16	%	%	NOUN
aiua-6390	12	17	)	)	PUNCT
aiua-6390	12	18	patients	patient	NOUN
aiua-6390	12	19	:	:	PUNCT
aiua-6390	12	20	14	14	NUM
aiua-6390	12	21	(	(	PUNCT
aiua-6390	12	22	77.7	77.7	NUM
aiua-6390	12	23	%	%	NOUN
aiua-6390	12	24	)	)	PUNCT
aiua-6390	12	25	with	with	ADP
aiua-6390	12	26	a	a	DET
aiua-6390	12	27	hg	hg	NOUN
aiua-6390	12	28	-	-	PUNCT
aiua-6390	12	29	nmibc	nmibc	PROPN
aiua-6390	12	30	and	and	CCONJ
aiua-6390	12	31	4	4	NUM
aiua-6390	12	32	(	(	PUNCT
aiua-6390	12	33	22.2	22.2	NUM
aiua-6390	12	34	%	%	NOUN
aiua-6390	12	35	)	)	PUNCT
aiua-6390	12	36	with	with	ADP
aiua-6390	12	37	a	a	DET
aiua-6390	12	38	high	high	ADJ
aiua-6390	12	39	grade	grade	NOUN
aiua-6390	12	40	(	(	PUNCT
aiua-6390	12	41	hg	hg	NOUN
aiua-6390	12	42	)	)	PUNCT
aiua-6390	12	43	muscle	muscle	NOUN
aiua-6390	12	44	invasive	invasive	ADJ
aiua-6390	12	45	bladder	bladder	NOUN
aiua-6390	12	46	cancer	cancer	NOUN
aiua-6390	12	47	(	(	PUNCT
aiua-6390	12	48	pt2hg	pt2hg	NUM
aiua-6390	12	49	)	)	PUNCT
aiua-6390	12	50	.	.	PUNCT
aiua-6390	13	1	after	after	SCONJ
aiua-6390	13	2	follow	follow	VERB
aiua-6390	13	3	up	up	ADP
aiua-6390	13	4	of	of	ADP
aiua-6390	13	5	all	all	DET
aiua-6390	13	6	92	92	NUM
aiua-6390	13	7	patients	patient	NOUN
aiua-6390	13	8	according	accord	VERB
aiua-6390	13	9	to	to	ADP
aiua-6390	13	10	the	the	DET
aiua-6390	13	11	guidelines	guideline	NOUN
aiua-6390	13	12	eau	eau	PROPN
aiua-6390	13	13	,	,	PUNCT
aiua-6390	13	14	we	we	PRON
aiua-6390	13	15	observed	observe	VERB
aiua-6390	13	16	recurrence	recurrence	NOUN
aiua-6390	13	17	in	in	ADP
aiua-6390	13	18	36/92	36/92	NUM
aiua-6390	13	19	(	(	PUNCT
aiua-6390	13	20	39.1	39.1	NUM
aiua-6390	13	21	%	%	NOUN
aiua-6390	13	22	)	)	PUNCT
aiua-6390	13	23	and	and	CCONJ
aiua-6390	13	24	progression	progression	NOUN
aiua-6390	13	25	in	in	ADP
aiua-6390	13	26	14/92	14/92	NUM
aiua-6390	13	27	(	(	PUNCT
aiua-6390	13	28	15.2	15.2	NUM
aiua-6390	13	29	%	%	NOUN
aiua-6390	13	30	)	)	PUNCT
aiua-6390	13	31	.	.	PUNCT
aiua-6390	14	1	of	of	ADP
aiua-6390	14	2	14	14	NUM
aiua-6390	14	3	nmibc	nmibc	ADJ
aiua-6390	14	4	with	with	ADP
aiua-6390	14	5	persistent	persistent	ADJ
aiua-6390	14	6	disease	disease	NOUN
aiua-6390	14	7	,	,	PUNCT
aiua-6390	14	8	10	10	NUM
aiua-6390	14	9	patients	patient	NOUN
aiua-6390	14	10	(	(	PUNCT
aiua-6390	14	11	71.4	71.4	NUM
aiua-6390	14	12	%	%	NOUN
aiua-6390	14	13	)	)	PUNCT
aiua-6390	14	14	showed	show	VERB
aiua-6390	14	15	recurrence	recurrence	NOUN
aiua-6390	14	16	:	:	PUNCT
aiua-6390	14	17	4	4	NUM
aiua-6390	14	18	patients	patient	NOUN
aiua-6390	14	19	(	(	PUNCT
aiua-6390	14	20	40	40	NUM
aiua-6390	14	21	%	%	NOUN
aiua-6390	14	22	)	)	PUNCT
aiua-6390	14	23	were	be	AUX
aiua-6390	14	24	pt1hg	pt1hg	NUM
aiua-6390	14	25	with	with	ADP
aiua-6390	14	26	concomitant	concomitant	ADJ
aiua-6390	14	27	carcinoma	carcinoma	NOUN
aiua-6390	14	28	in	in	ADP
aiua-6390	14	29	situ	situ	NOUN
aiua-6390	14	30	(	(	PUNCT
aiua-6390	14	31	cis	cis	NOUN
aiua-6390	14	32	)	)	PUNCT
aiua-6390	14	33	,	,	PUNCT
aiua-6390	14	34	3	3	NUM
aiua-6390	14	35	patients	patient	NOUN
aiua-6390	14	36	(	(	PUNCT
aiua-6390	14	37	30	30	NUM
aiua-6390	14	38	%	%	NOUN
aiua-6390	14	39	)	)	PUNCT
aiua-6390	14	40	multifocal	multifocal	ADJ
aiua-6390	14	41	ptahg	ptahg	NOUN
aiua-6390	14	42	,	,	PUNCT
aiua-6390	14	43	2	2	NUM
aiua-6390	14	44	(	(	PUNCT
aiua-6390	14	45	20	20	NUM
aiua-6390	14	46	%	%	NOUN
aiua-6390	14	47	)	)	PUNCT
aiua-6390	14	48	patients	patient	NOUN
aiua-6390	14	49	cis	cis	NOUN
aiua-6390	14	50	and	and	CCONJ
aiua-6390	14	51	one	one	NUM
aiua-6390	14	52	patient	patient	NOUN
aiua-6390	14	53	(	(	PUNCT
aiua-6390	14	54	10	10	NUM
aiua-6390	14	55	%	%	NOUN
aiua-6390	14	56	)	)	PUNCT
aiua-6390	14	57	a	a	DET
aiua-6390	14	58	muscle	muscle	NOUN
aiua-6390	14	59	invasive	invasive	ADJ
aiua-6390	14	60	neoplasm	neoplasm	NOUN
aiua-6390	14	61	(	(	PUNCT
aiua-6390	14	62	pt2hg	pt2hg	NUM
aiua-6390	14	63	)	)	PUNCT
aiua-6390	14	64	.	.	PUNCT
aiua-6390	15	1	instead	instead	ADV
aiua-6390	15	2	of	of	ADP
aiua-6390	15	3	the	the	DET
aiua-6390	15	4	group	group	NOUN
aiua-6390	15	5	of	of	ADP
aiua-6390	15	6	48	48	NUM
aiua-6390	15	7	patients	patient	NOUN
aiua-6390	15	8	pt0	pt0	NOUN
aiua-6390	15	9	following	follow	VERB
aiua-6390	15	10	wl	wl	PROPN
aiua-6390	15	11	recturbt	recturbt	PROPN
aiua-6390	15	12	,	,	PUNCT
aiua-6390	15	13	we	we	PRON
aiua-6390	15	14	observed	observe	VERB
aiua-6390	15	15	recurrence	recurrence	NOUN
aiua-6390	15	16	in	in	ADP
aiua-6390	15	17	26	26	NUM
aiua-6390	15	18	patients	patient	NOUN
aiua-6390	15	19	(	(	PUNCT
aiua-6390	15	20	54.1	54.1	NUM
aiua-6390	15	21	%	%	NOUN
aiua-6390	15	22	)	)	PUNCT
aiua-6390	15	23	and	and	CCONJ
aiua-6390	15	24	in	in	ADP
aiua-6390	15	25	two	two	NUM
aiua-6390	15	26	patients	patient	NOUN
aiua-6390	15	27	(	(	PUNCT
aiua-6390	15	28	4.1	4.1	NUM
aiua-6390	15	29	%	%	NOUN
aiua-6390	15	30	)	)	PUNCT
aiua-6390	15	31	progressions	progression	NOUN
aiua-6390	15	32	,	,	PUNCT
aiua-6390	15	33	who	who	PRON
aiua-6390	15	34	presented	present	VERB
aiua-6390	15	35	after	after	ADP
aiua-6390	15	36	3	3	NUM
aiua-6390	15	37	months	month	NOUN
aiua-6390	15	38	in	in	ADP
aiua-6390	15	39	association	association	NOUN
aiua-6390	15	40	with	with	ADP
aiua-6390	15	41	cis	cis	NOUN
aiua-6390	15	42	.	.	PUNCT
aiua-6390	16	1	the	the	DET
aiua-6390	16	2	remaining	remain	VERB
aiua-6390	16	3	22	22	NUM
aiua-6390	16	4	patients	patient	NOUN
aiua-6390	16	5	(	(	PUNCT
aiua-6390	16	6	45.9	45.9	NUM
aiua-6390	16	7	%	%	NOUN
aiua-6390	16	8	)	)	PUNCT
aiua-6390	16	9	with	with	ADP
aiua-6390	16	10	initial	initial	ADJ
aiua-6390	16	11	pt1hg	pt1hg	PROPN
aiua-6390	16	12	are	be	AUX
aiua-6390	16	13	still	still	ADV
aiua-6390	16	14	progression	progression	NOUN
aiua-6390	16	15	free	free	ADJ
aiua-6390	16	16	.	.	PUNCT
aiua-6390	17	1	multivariate	multivariate	NOUN
aiua-6390	17	2	analysis	analysis	NOUN
aiua-6390	17	3	showed	show	VERB
aiua-6390	17	4	that	that	SCONJ
aiua-6390	17	5	the	the	DET
aiua-6390	17	6	most	most	ADV
aiua-6390	17	7	important	important	ADJ
aiua-6390	17	8	variable	variable	NOUN
aiua-6390	17	9	of	of	ADP
aiua-6390	17	10	early	early	ADJ
aiua-6390	17	11	progression	progression	NOUN
aiua-6390	17	12	were	be	AUX
aiua-6390	17	13	persistent	persistent	ADJ
aiua-6390	17	14	neoplasm	neoplasm	NOUN
aiua-6390	17	15	and	and	CCONJ
aiua-6390	17	16	histopathological	histopathological	ADJ
aiua-6390	17	17	findings	finding	NOUN
aiua-6390	17	18	at	at	ADP
aiua-6390	17	19	wlre	wlre	ADJ
aiua-6390	17	20	-	-	PUNCT
aiua-6390	17	21	cturbt	cturbt	NOUN
aiua-6390	17	22	(	(	PUNCT
aiua-6390	17	23	p	p	X
aiua-6390	17	24	=	=	NOUN
aiua-6390	17	25	0.01	0.01	NUM
aiua-6390	17	26	)	)	PUNCT
aiua-6390	17	27	,	,	PUNCT
aiua-6390	17	28	followed	follow	VERB
aiua-6390	17	29	by	by	ADP
aiua-6390	17	30	the	the	DET
aiua-6390	17	31	summary	summary	NOUN
aiua-6390	17	32	no	no	DET
aiua-6390	17	33	conflict	conflict	NOUN
aiua-6390	17	34	of	of	ADP
aiua-6390	17	35	interest	interest	NOUN
aiua-6390	17	36	declared	declare	VERB
aiua-6390	17	37	.	.	PUNCT
aiua-6390	18	1	introduction	introduction	NOUN
aiua-6390	18	2	bladder	bladder	NOUN
aiua-6390	18	3	cancer	cancer	NOUN
aiua-6390	18	4	is	be	AUX
aiua-6390	18	5	a	a	DET
aiua-6390	18	6	common	common	ADJ
aiua-6390	18	7	genito	genito	ADJ
aiua-6390	18	8	-	-	PUNCT
aiua-6390	18	9	urinary	urinary	ADJ
aiua-6390	18	10	malignancy	malignancy	NOUN
aiua-6390	18	11	,	,	PUNCT
aiua-6390	18	12	with	with	ADP
aiua-6390	18	13	transitional	transitional	ADJ
aiua-6390	18	14	cell	cell	NOUN
aiua-6390	18	15	carcinoma	carcinoma	NOUN
aiua-6390	18	16	comprising	comprise	VERB
aiua-6390	18	17	nearly	nearly	ADV
aiua-6390	18	18	90	90	NUM
aiua-6390	18	19	%	%	NOUN
aiua-6390	18	20	of	of	ADP
aiua-6390	18	21	all	all	DET
aiua-6390	18	22	primary	primary	ADJ
aiua-6390	18	23	bladder	bladder	NOUN
aiua-6390	18	24	tumours	tumour	VERB
aiua-6390	18	25	.	.	PUNCT
aiua-6390	19	1	at	at	ADP
aiua-6390	19	2	the	the	DET
aiua-6390	19	3	first	first	ADJ
aiua-6390	19	4	diagnosis	diagnosis	NOUN
aiua-6390	19	5	70	70	NUM
aiua-6390	19	6	%	%	NOUN
aiua-6390	19	7	to	to	PART
aiua-6390	19	8	80	80	NUM
aiua-6390	19	9	%	%	NOUN
aiua-6390	19	10	of	of	ADP
aiua-6390	19	11	urothelial	urothelial	ADJ
aiua-6390	19	12	tumours	tumour	NOUN
aiua-6390	19	13	are	be	AUX
aiua-6390	19	14	confined	confine	VERB
aiua-6390	19	15	to	to	ADP
aiua-6390	19	16	the	the	DET
aiua-6390	19	17	epithelium	epithelium	NOUN
aiua-6390	19	18	,	,	PUNCT
aiua-6390	19	19	the	the	DET
aiua-6390	19	20	remainder	remainder	NOUN
aiua-6390	19	21	is	be	AUX
aiua-6390	19	22	characterized	characterize	VERB
aiua-6390	19	23	by	by	ADP
aiua-6390	19	24	muscle	muscle	NOUN
aiua-6390	19	25	invasion	invasion	NOUN
aiua-6390	19	26	.	.	PUNCT
aiua-6390	20	1	a	a	DET
aiua-6390	20	2	significant	significant	ADJ
aiua-6390	20	3	number	number	NOUN
aiua-6390	20	4	of	of	ADP
aiua-6390	20	5	patients	patient	NOUN
aiua-6390	20	6	with	with	ADP
aiua-6390	20	7	high	high	ADJ
aiua-6390	20	8	risk	risk	NOUN
aiua-6390	20	9	non	non	ADJ
aiua-6390	20	10	-	-	ADJ
aiua-6390	20	11	muscle	muscle	ADJ
aiua-6390	20	12	invasive	invasive	ADJ
aiua-6390	20	13	bladder	bladder	NOUN
aiua-6390	20	14	tumours	tumour	NOUN
aiua-6390	20	15	(	(	PUNCT
aiua-6390	20	16	hg	hg	NOUN
aiua-6390	20	17	-	-	NOUN
aiua-6390	20	18	nmibt	nmibt	ADJ
aiua-6390	20	19	)	)	PUNCT
aiua-6390	20	20	treated	treat	VERB
aiua-6390	20	21	with	with	ADP
aiua-6390	20	22	white	white	ADJ
aiua-6390	20	23	light	light	ADJ
aiua-6390	20	24	classic	classic	ADJ
aiua-6390	20	25	transurethral	transurethral	ADJ
aiua-6390	20	26	resection	resection	NOUN
aiua-6390	20	27	of	of	ADP
aiua-6390	20	28	bladder	bladder	NOUN
aiua-6390	20	29	tumours	tumour	NOUN
aiua-6390	20	30	(	(	PUNCT
aiua-6390	20	31	wlcturbt	wlcturbt	PROPN
aiua-6390	20	32	)	)	PUNCT
aiua-6390	20	33	and	and	CCONJ
aiua-6390	20	34	intravesical	intravesical	ADJ
aiua-6390	20	35	bcg	bcg	PROPN
aiua-6390	20	36	will	will	AUX
aiua-6390	20	37	progress	progress	VERB
aiua-6390	20	38	to	to	ADP
aiua-6390	20	39	invasive	invasive	ADJ
aiua-6390	20	40	disease	disease	NOUN
aiua-6390	20	41	(	(	PUNCT
aiua-6390	20	42	1	1	NUM
aiua-6390	20	43	-	-	SYM
aiua-6390	20	44	3	3	NUM
aiua-6390	20	45	)	)	PUNCT
aiua-6390	20	46	.	.	PUNCT
aiua-6390	21	1	progression	progression	NOUN
aiua-6390	21	2	to	to	PART
aiua-6390	21	3	muscle	muscle	NOUN
aiua-6390	21	4	invasion	invasion	NOUN
aiua-6390	21	5	(	(	PUNCT
aiua-6390	21	6	pt2	pt2	NOUN
aiua-6390	21	7	)	)	PUNCT
aiua-6390	21	8	mandates	mandate	VERB
aiua-6390	21	9	immediate	immediate	ADJ
aiua-6390	21	10	radical	radical	ADJ
aiua-6390	21	11	cystectomy	cystectomy	NOUN
aiua-6390	21	12	(	(	PUNCT
aiua-6390	21	13	4	4	NUM
aiua-6390	21	14	)	)	PUNCT
aiua-6390	21	15	.	.	PUNCT
aiua-6390	22	1	wlcturbt	wlcturbt	PROPN
aiua-6390	22	2	is	be	AUX
aiua-6390	22	3	the	the	DET
aiua-6390	22	4	standard	standard	ADJ
aiua-6390	22	5	initial	initial	ADJ
aiua-6390	22	6	therapy	therapy	NOUN
aiua-6390	22	7	for	for	ADP
aiua-6390	22	8	nmibt	nmibt	ADJ
aiua-6390	22	9	,	,	PUNCT
aiua-6390	22	10	but	but	CCONJ
aiua-6390	22	11	the	the	DET
aiua-6390	22	12	high	high	ADJ
aiua-6390	22	13	percentage	percentage	NOUN
aiua-6390	22	14	of	of	ADP
aiua-6390	22	15	recurrence	recurrence	NOUN
aiua-6390	22	16	after	after	ADP
aiua-6390	22	17	surgery	surgery	NOUN
aiua-6390	22	18	is	be	AUX
aiua-6390	22	19	still	still	ADV
aiua-6390	22	20	an	an	DET
aiua-6390	22	21	unresolved	unresolved	ADJ
aiua-6390	22	22	problem	problem	NOUN
aiua-6390	22	23	(	(	PUNCT
aiua-6390	22	24	5	5	NUM
aiua-6390	22	25	)	)	PUNCT
aiua-6390	22	26	.	.	PUNCT
aiua-6390	23	1	high	high	ADJ
aiua-6390	23	2	grade	grade	NOUN
aiua-6390	23	3	pt1	pt1	NOUN
aiua-6390	23	4	bladder	bladder	NOUN
aiua-6390	23	5	neoplasm	neoplasm	NOUN
aiua-6390	23	6	(	(	PUNCT
aiua-6390	23	7	pt1hg	pt1hg	X
aiua-6390	23	8	)	)	PUNCT
aiua-6390	23	9	really	really	ADV
aiua-6390	23	10	represents	represent	VERB
aiua-6390	23	11	a	a	DET
aiua-6390	23	12	therapeutic	therapeutic	ADJ
aiua-6390	23	13	challenge	challenge	NOUN
aiua-6390	23	14	due	due	ADP
aiua-6390	23	15	to	to	ADP
aiua-6390	23	16	the	the	DET
aiua-6390	23	17	high	high	ADJ
aiua-6390	23	18	risk	risk	NOUN
aiua-6390	23	19	of	of	ADP
aiua-6390	23	20	progression	progression	NOUN
aiua-6390	23	21	(	(	PUNCT
aiua-6390	23	22	about	about	ADV
aiua-6390	23	23	15	15	NUM
aiua-6390	23	24	-	-	SYM
aiua-6390	23	25	30	30	NUM
aiua-6390	23	26	%	%	NOUN
aiua-6390	23	27	)	)	PUNCT
aiua-6390	23	28	to	to	ADP
aiua-6390	23	29	muscle	muscle	NOUN
aiua-6390	23	30	-	-	PUNCT
aiua-6390	23	31	invasive	invasive	ADJ
aiua-6390	23	32	disease	disease	NOUN
aiua-6390	23	33	,	,	PUNCT
aiua-6390	23	34	usually	usually	ADV
aiua-6390	23	35	within	within	ADP
aiua-6390	23	36	5	5	NUM
aiua-6390	23	37	years	year	NOUN
aiua-6390	23	38	(	(	PUNCT
aiua-6390	23	39	6	6	NUM
aiua-6390	23	40	)	)	PUNCT
aiua-6390	23	41	.	.	PUNCT
aiua-6390	24	1	however	however	ADV
aiua-6390	24	2	,	,	PUNCT
aiua-6390	24	3	no	no	DET
aiua-6390	24	4	consensus	consensus	NOUN
aiua-6390	24	5	exists	exist	VERB
aiua-6390	24	6	regarding	regard	VERB
aiua-6390	24	7	the	the	DET
aiua-6390	24	8	treatment	treatment	NOUN
aiua-6390	24	9	of	of	ADP
aiua-6390	24	10	patients	patient	NOUN
aiua-6390	24	11	with	with	ADP
aiua-6390	24	12	recurrent	recurrent	ADJ
aiua-6390	24	13	bladder	bladder	NOUN
aiua-6390	24	14	tumours	tumour	NOUN
aiua-6390	24	15	that	that	PRON
aiua-6390	24	16	invade	invade	VERB
aiua-6390	24	17	the	the	DET
aiua-6390	24	18	lamina	lamina	ADJ
aiua-6390	24	19	propria	propria	PROPN
aiua-6390	24	20	(	(	PUNCT
aiua-6390	24	21	pt1	pt1	PROPN
aiua-6390	24	22	)	)	PUNCT
aiua-6390	24	23	(	(	PUNCT
aiua-6390	24	24	7	7	NUM
aiua-6390	24	25	-	-	SYM
aiua-6390	24	26	9	9	NUM
aiua-6390	24	27	)	)	PUNCT
aiua-6390	24	28	.	.	PUNCT
aiua-6390	25	1	recent	recent	ADJ
aiua-6390	25	2	studies	study	NOUN
aiua-6390	25	3	suggested	suggest	VERB
aiua-6390	25	4	that	that	SCONJ
aiua-6390	25	5	the	the	DET
aiua-6390	25	6	first	first	ADJ
aiua-6390	25	7	cturbt	cturbt	NOUN
aiua-6390	25	8	may	may	AUX
aiua-6390	25	9	be	be	AUX
aiua-6390	25	10	incomplete	incomplete	ADJ
aiua-6390	25	11	in	in	ADP
aiua-6390	25	12	a	a	DET
aiua-6390	25	13	significant	significant	ADJ
aiua-6390	25	14	number	number	NOUN
aiua-6390	25	15	of	of	ADP
aiua-6390	25	16	cases	case	NOUN
aiua-6390	25	17	(	(	PUNCT
aiua-6390	25	18	10	10	NUM
aiua-6390	25	19	)	)	PUNCT
aiua-6390	25	20	.	.	PUNCT
aiua-6390	26	1	understaging	understage	VERB
aiua-6390	26	2	at	at	ADP
aiua-6390	26	3	the	the	DET
aiua-6390	26	4	time	time	NOUN
aiua-6390	26	5	of	of	ADP
aiua-6390	26	6	the	the	DET
aiua-6390	26	7	initial	initial	ADJ
aiua-6390	26	8	transurethral	transurethral	ADJ
aiua-6390	26	9	resection	resection	NOUN
aiua-6390	26	10	is	be	AUX
aiua-6390	26	11	common	common	ADJ
aiua-6390	26	12	for	for	ADP
aiua-6390	26	13	patients	patient	NOUN
aiua-6390	26	14	with	with	ADP
aiua-6390	26	15	high	high	ADJ
aiua-6390	26	16	-	-	PUNCT
aiua-6390	26	17	risk	risk	NOUN
aiua-6390	26	18	nmibc	nmibc	NOUN
aiua-6390	26	19	and	and	CCONJ
aiua-6390	26	20	can	can	AUX
aiua-6390	26	21	delay	delay	VERB
aiua-6390	26	22	accurate	accurate	ADJ
aiua-6390	26	23	diagnosis	diagnosis	NOUN
aiua-6390	26	24	and	and	CCONJ
aiua-6390	26	25	definitive	definitive	ADJ
aiua-6390	26	26	treatment	treatment	NOUN
aiua-6390	26	27	.	.	PUNCT
aiua-6390	27	1	it	it	PRON
aiua-6390	27	2	is	be	AUX
aiua-6390	27	3	therefore	therefore	ADV
aiua-6390	27	4	recommended	recommend	VERB
aiua-6390	27	5	for	for	ADP
aiua-6390	27	6	patients	patient	NOUN
aiua-6390	27	7	with	with	ADP
aiua-6390	27	8	high	high	ADJ
aiua-6390	27	9	-	-	PUNCT
aiua-6390	27	10	risk	risk	NOUN
aiua-6390	27	11	disease	disease	NOUN
aiua-6390	27	12	and	and	CCONJ
aiua-6390	27	13	in	in	ADP
aiua-6390	27	14	those	those	PRON
aiua-6390	27	15	with	with	ADP
aiua-6390	27	16	large	large	ADJ
aiua-6390	27	17	or	or	CCONJ
aiua-6390	27	18	multiple	multiple	ADJ
aiua-6390	27	19	tumors	tumor	NOUN
aiua-6390	27	20	or	or	CCONJ
aiua-6390	27	21	when	when	SCONJ
aiua-6390	27	22	the	the	DET
aiua-6390	27	23	initial	initial	ADJ
aiua-6390	27	24	transurethral	transurethral	ADJ
aiua-6390	27	25	resection	resection	NOUN
aiua-6390	27	26	is	be	AUX
aiua-6390	27	27	incomplete	incomplete	ADJ
aiua-6390	27	28	,	,	PUNCT
aiua-6390	27	29	to	to	PART
aiua-6390	27	30	repeat	repeat	VERB
aiua-6390	27	31	wlre	wlre	ADJ
aiua-6390	27	32	-	-	PUNCT
aiua-6390	27	33	cturbt	cturbt	NOUN
aiua-6390	27	34	within	within	ADP
aiua-6390	27	35	2	2	NUM
aiua-6390	27	36	-	-	SYM
aiua-6390	27	37	6	6	NUM
aiua-6390	27	38	doi	doi	NOUN
aiua-6390	27	39	:	:	PUNCT
aiua-6390	27	40	10.4081	10.4081	NUM
aiua-6390	27	41	/	/	SYM
aiua-6390	27	42	aiua.2017.4.272	aiua.2017.4.272	NOUN
aiua-6390	27	43	result	result	NOUN
aiua-6390	27	44	of	of	ADP
aiua-6390	27	45	the	the	DET
aiua-6390	27	46	first	first	ADJ
aiua-6390	27	47	cystoscopy	cystoscopy	NOUN
aiua-6390	27	48	(	(	PUNCT
aiua-6390	27	49	p	p	NOUN
aiua-6390	27	50	=	=	NOUN
aiua-6390	27	51	0.002	0.002	NUM
aiua-6390	27	52	)	)	PUNCT
aiua-6390	27	53	and	and	CCONJ
aiua-6390	27	54	presence	presence	NOUN
aiua-6390	27	55	of	of	ADP
aiua-6390	27	56	cis	cis	NOUN
aiua-6390	27	57	(	(	PUNCT
aiua-6390	27	58	p	p	NOUN
aiua-6390	27	59	=	=	NOUN
aiua-6390	27	60	0.02	0.02	NUM
aiua-6390	27	61	)	)	PUNCT
aiua-6390	27	62	.	.	PUNCT
aiua-6390	28	1	discussion	discussion	NOUN
aiua-6390	28	2	:	:	PUNCT
aiua-6390	28	3	following	follow	VERB
aiua-6390	28	4	wlre	wlre	ADJ
aiua-6390	28	5	-	-	PUNCT
aiua-6390	28	6	cturbt	cturbt	NOUN
aiua-6390	28	7	in	in	ADP
aiua-6390	28	8	hg	hg	NOUN
aiua-6390	28	9	-	-	PUNCT
aiua-6390	28	10	nmibc	nmibc	ADJ
aiua-6390	28	11	patients	patient	NOUN
aiua-6390	28	12	we	we	PRON
aiua-6390	28	13	identified	identify	VERB
aiua-6390	28	14	in	in	ADP
aiua-6390	28	15	15	15	NUM
aiua-6390	28	16	%	%	NOUN
aiua-6390	28	17	of	of	ADP
aiua-6390	28	18	cases	case	NOUN
aiua-6390	28	19	a	a	DET
aiua-6390	28	20	persistent	persistent	ADJ
aiua-6390	28	21	disease	disease	NOUN
aiua-6390	28	22	with	with	ADP
aiua-6390	28	23	a	a	DET
aiua-6390	28	24	4.3	4.3	NUM
aiua-6390	28	25	%	%	NOUN
aiua-6390	28	26	of	of	ADP
aiua-6390	28	27	mibc	mibc	PROPN
aiua-6390	28	28	.	.	PUNCT
aiua-6390	29	1	in	in	ADP
aiua-6390	29	2	the	the	DET
aiua-6390	29	3	high	high	ADJ
aiua-6390	29	4	risk	risk	NOUN
aiua-6390	29	5	persistent	persistent	ADJ
aiua-6390	29	6	bladder	bladder	NOUN
aiua-6390	29	7	neoplasms	neoplasm	NOUN
aiua-6390	29	8	group	group	NOUN
aiua-6390	29	9	we	we	PRON
aiua-6390	29	10	observed	observe	VERB
aiua-6390	29	11	recurrent	recurrent	ADJ
aiua-6390	29	12	and	and	CCONJ
aiua-6390	29	13	progression	progression	NOUN
aiua-6390	29	14	rate	rate	NOUN
aiua-6390	29	15	higher	high	ADJ
aiua-6390	29	16	than	than	ADP
aiua-6390	29	17	in	in	ADP
aiua-6390	29	18	t0	t0	PROPN
aiua-6390	29	19	bladder	bladder	NOUN
aiua-6390	29	20	tumours	tumours	PROPN
aiua-6390	29	21	group	group	NOUN
aiua-6390	29	22	(	(	PUNCT
aiua-6390	29	23	∆	∆	PROPN
aiua-6390	29	24	=	=	PUNCT
aiua-6390	30	1	+	+	CCONJ
aiua-6390	30	2	17.3	17.3	NUM
aiua-6390	30	3	%	%	NOUN
aiua-6390	30	4	and	and	CCONJ
aiua-6390	30	5	∆	∆	PROPN
aiua-6390	30	6	=	=	NOUN
aiua-6390	31	1	+	+	CCONJ
aiua-6390	31	2	62.5	62.5	NUM
aiua-6390	31	3	%	%	NOUN
aiua-6390	31	4	,	,	PUNCT
aiua-6390	31	5	p	p	X
aiua-6390	31	6	<	<	X
aiua-6390	31	7	0.05	0.05	NUM
aiua-6390	31	8	)	)	PUNCT
aiua-6390	31	9	.	.	PUNCT
aiua-6390	32	1	key	key	ADJ
aiua-6390	32	2	words	word	NOUN
aiua-6390	32	3	:	:	PUNCT
aiua-6390	32	4	pt1hg	pt1hg	NUM
aiua-6390	32	5	;	;	PUNCT
aiua-6390	32	6	wlre	wlre	ADJ
aiua-6390	32	7	-	-	PUNCT
aiua-6390	32	8	cturbt	cturbt	NOUN
aiua-6390	32	9	;	;	PUNCT
aiua-6390	32	10	bcg	bcg	NOUN
aiua-6390	32	11	schedule	schedule	NOUN
aiua-6390	32	12	;	;	PUNCT
aiua-6390	32	13	pcishg	pcishg	NOUN
aiua-6390	32	14	recurrence	recurrence	NOUN
aiua-6390	32	15	and	and	CCONJ
aiua-6390	32	16	progression	progression	NOUN
aiua-6390	32	17	rate	rate	NOUN
aiua-6390	32	18	.	.	PUNCT
aiua-6390	32	19	submitted	submit	VERB
aiua-6390	32	20	14	14	NUM
aiua-6390	32	21	november	november	PROPN
aiua-6390	32	22	2016	2016	NUM
aiua-6390	32	23	;	;	PUNCT
aiua-6390	32	24	accepted	accept	VERB
aiua-6390	32	25	11	11	NUM
aiua-6390	32	26	january	january	PROPN
aiua-6390	32	27	2017	2017	NUM
aiua-6390	32	28	giulianelli_stesura	giulianelli_stesura	NOUN
aiua-6390	32	29	seveso	seveso	NOUN
aiua-6390	32	30	03/01/18	03/01/18	PROPN
aiua-6390	32	31	11:58	11:58	NUM
aiua-6390	32	32	pagina	pagina	NOUN
aiua-6390	32	33	272	272	NUM
aiua-6390	32	34	273archivio	273archivio	PROPN
aiua-6390	32	35	italiano	italiano	NOUN
aiua-6390	32	36	di	di	X
aiua-6390	32	37	urologia	urologia	PROPN
aiua-6390	32	38	e	e	PROPN
aiua-6390	32	39	andrologia	andrologia	NOUN
aiua-6390	32	40	2017	2017	NUM
aiua-6390	32	41	;	;	PUNCT
aiua-6390	32	42	89	89	NUM
aiua-6390	32	43	,	,	PUNCT
aiua-6390	32	44	4	4	NUM
aiua-6390	32	45	can	can	AUX
aiua-6390	32	46	re	re	VERB
aiua-6390	32	47	-	-	NOUN
aiua-6390	32	48	cturbt	cturbt	NOUN
aiua-6390	32	49	be	be	AUX
aiua-6390	32	50	useful	useful	ADJ
aiua-6390	32	51	in	in	ADP
aiua-6390	32	52	pt1hg	pt1hg	PROPN
aiua-6390	32	53	disease	disease	NOUN
aiua-6390	32	54	as	as	ADP
aiua-6390	32	55	a	a	DET
aiua-6390	32	56	risk	risk	NOUN
aiua-6390	32	57	indicator	indicator	NOUN
aiua-6390	32	58	of	of	ADP
aiua-6390	32	59	recurrence	recurrence	NOUN
aiua-6390	32	60	and	and	CCONJ
aiua-6390	32	61	progression	progression	NOUN
aiua-6390	32	62	?	?	PUNCT
aiua-6390	33	1	a	a	DET
aiua-6390	33	2	single	single	ADJ
aiua-6390	33	3	centre	centre	NOUN
aiua-6390	33	4	experience	experience	NOUN
aiua-6390	33	5	weeks	week	NOUN
aiua-6390	33	6	in	in	ADP
aiua-6390	33	7	order	order	NOUN
aiua-6390	33	8	to	to	PART
aiua-6390	33	9	guide	guide	VERB
aiua-6390	33	10	appropriate	appropriate	ADJ
aiua-6390	33	11	management	management	NOUN
aiua-6390	33	12	(	(	PUNCT
aiua-6390	33	13	11	11	NUM
aiua-6390	33	14	)	)	PUNCT
aiua-6390	33	15	.	.	PUNCT
aiua-6390	34	1	we	we	PRON
aiua-6390	34	2	aimed	aim	VERB
aiua-6390	34	3	to	to	PART
aiua-6390	34	4	investigate	investigate	VERB
aiua-6390	34	5	,	,	PUNCT
aiua-6390	34	6	in	in	ADP
aiua-6390	34	7	high	high	ADJ
aiua-6390	34	8	risk	risk	NOUN
aiua-6390	34	9	group	group	NOUN
aiua-6390	34	10	,	,	PUNCT
aiua-6390	34	11	the	the	DET
aiua-6390	34	12	presence	presence	NOUN
aiua-6390	34	13	of	of	ADP
aiua-6390	34	14	residual	residual	ADJ
aiua-6390	34	15	tumor	tumor	NOUN
aiua-6390	34	16	following	follow	VERB
aiua-6390	34	17	wlcturbt	wlcturbt	NOUN
aiua-6390	34	18	and	and	CCONJ
aiua-6390	34	19	the	the	DET
aiua-6390	34	20	different	different	ADJ
aiua-6390	34	21	recurrence	recurrence	NOUN
aiua-6390	34	22	and	and	CCONJ
aiua-6390	34	23	progression	progression	NOUN
aiua-6390	34	24	rate	rate	NOUN
aiua-6390	34	25	between	between	ADP
aiua-6390	34	26	patients	patient	NOUN
aiua-6390	34	27	with	with	ADP
aiua-6390	34	28	persistent	persistent	ADJ
aiua-6390	34	29	or	or	CCONJ
aiua-6390	34	30	negative	negative	ADJ
aiua-6390	34	31	(	(	PUNCT
aiua-6390	34	32	pt0	pt0	NOUN
aiua-6390	34	33	)	)	PUNCT
aiua-6390	34	34	oncological	oncological	ADJ
aiua-6390	34	35	disease	disease	NOUN
aiua-6390	34	36	after	after	ADP
aiua-6390	34	37	wlre	wlre	ADJ
aiua-6390	34	38	-	-	PUNCT
aiua-6390	34	39	cturbt	cturbt	NOUN
aiua-6390	34	40	.	.	PUNCT
aiua-6390	35	1	materials	material	NOUN
aiua-6390	35	2	and	and	CCONJ
aiua-6390	35	3	methods	method	NOUN
aiua-6390	35	4	in	in	ADP
aiua-6390	35	5	our	our	PRON
aiua-6390	35	6	department	department	NOUN
aiua-6390	35	7	from	from	ADP
aiua-6390	35	8	january	january	PROPN
aiua-6390	35	9	2011	2011	NUM
aiua-6390	35	10	to	to	ADP
aiua-6390	35	11	june	june	PROPN
aiua-6390	35	12	2015	2015	NUM
aiua-6390	35	13	,	,	PUNCT
aiua-6390	35	14	285	285	NUM
aiua-6390	35	15	consecutive	consecutive	ADJ
aiua-6390	35	16	patients	patient	NOUN
aiua-6390	35	17	with	with	ADP
aiua-6390	35	18	a	a	DET
aiua-6390	35	19	first	first	ADJ
aiua-6390	35	20	diagnosis	diagnosis	NOUN
aiua-6390	35	21	of	of	ADP
aiua-6390	35	22	clinical	clinical	ADJ
aiua-6390	35	23	bladder	bladder	NOUN
aiua-6390	35	24	tumor	tumor	NOUN
aiua-6390	35	25	underwent	underwent	NOUN
aiua-6390	35	26	wlcturbt	wlcturbt	NOUN
aiua-6390	35	27	.	.	PUNCT
aiua-6390	36	1	histopathological	histopathological	ADJ
aiua-6390	36	2	findings	finding	NOUN
aiua-6390	36	3	showed	show	VERB
aiua-6390	36	4	95	95	NUM
aiua-6390	36	5	high	high	ADJ
aiua-6390	36	6	grade	grade	NOUN
aiua-6390	36	7	(	(	PUNCT
aiua-6390	36	8	hg	hg	NOUN
aiua-6390	36	9	)	)	PUNCT
aiua-6390	36	10	bladder	bladder	NOUN
aiua-6390	36	11	tumours	tumour	NOUN
aiua-6390	36	12	invading	invade	VERB
aiua-6390	36	13	the	the	DET
aiua-6390	36	14	lamina	lamina	ADJ
aiua-6390	36	15	propria	propria	PROPN
aiua-6390	36	16	(	(	PUNCT
aiua-6390	36	17	pt1	pt1	PROPN
aiua-6390	36	18	)	)	PUNCT
aiua-6390	36	19	but	but	CCONJ
aiua-6390	36	20	only	only	ADV
aiua-6390	36	21	92	92	NUM
aiua-6390	36	22	(	(	PUNCT
aiua-6390	36	23	32.28	32.28	NUM
aiua-6390	36	24	%	%	NOUN
aiua-6390	36	25	)	)	PUNCT
aiua-6390	36	26	cases	case	NOUN
aiua-6390	36	27	were	be	AUX
aiua-6390	36	28	eligible	eligible	ADJ
aiua-6390	36	29	for	for	ADP
aiua-6390	36	30	our	our	PRON
aiua-6390	36	31	study	study	NOUN
aiua-6390	36	32	.	.	PUNCT
aiua-6390	37	1	patients	patient	NOUN
aiua-6390	37	2	mean	mean	VERB
aiua-6390	37	3	age	age	NOUN
aiua-6390	37	4	was	be	AUX
aiua-6390	37	5	68	68	NUM
aiua-6390	37	6	years	year	NOUN
aiua-6390	37	7	(	(	PUNCT
aiua-6390	37	8	range	range	NOUN
aiua-6390	37	9	42	42	NUM
aiua-6390	37	10	to	to	PART
aiua-6390	37	11	78	78	NUM
aiua-6390	37	12	yrs	yr	NOUN
aiua-6390	37	13	,	,	PUNCT
aiua-6390	37	14	sd	sd	ADP
aiua-6390	37	15	10.4	10.4	NUM
aiua-6390	37	16	)	)	PUNCT
aiua-6390	37	17	;	;	PUNCT
aiua-6390	37	18	22	22	NUM
aiua-6390	37	19	patients	patient	NOUN
aiua-6390	37	20	were	be	AUX
aiua-6390	37	21	women	woman	NOUN
aiua-6390	37	22	;	;	PUNCT
aiua-6390	37	23	mean	mean	VERB
aiua-6390	37	24	follow	follow	VERB
aiua-6390	37	25	-	-	PUNCT
aiua-6390	37	26	up	up	NOUN
aiua-6390	37	27	28	28	NUM
aiua-6390	37	28	months	month	NOUN
aiua-6390	37	29	(	(	PUNCT
aiua-6390	37	30	range	range	NOUN
aiua-6390	37	31	16	16	NUM
aiua-6390	37	32	-	-	SYM
aiua-6390	37	33	5	5	NUM
aiua-6390	37	34	months	month	NOUN
aiua-6390	37	35	)	)	PUNCT
aiua-6390	37	36	.	.	PUNCT
aiua-6390	38	1	focality	focality	NOUN
aiua-6390	38	2	and	and	CCONJ
aiua-6390	38	3	dimensions	dimension	NOUN
aiua-6390	38	4	are	be	AUX
aiua-6390	38	5	reported	report	VERB
aiua-6390	38	6	table	table	NOUN
aiua-6390	38	7	1	1	NUM
aiua-6390	38	8	.	.	PUNCT
aiua-6390	39	1	we	we	PRON
aiua-6390	39	2	performed	perform	VERB
aiua-6390	39	3	wlcturbt	wlcturbt	NOUN
aiua-6390	39	4	with	with	ADP
aiua-6390	39	5	complete	complete	ADJ
aiua-6390	39	6	resection	resection	NOUN
aiua-6390	39	7	of	of	ADP
aiua-6390	39	8	all	all	DET
aiua-6390	39	9	visible	visible	ADJ
aiua-6390	39	10	lesions	lesion	NOUN
aiua-6390	39	11	and	and	CCONJ
aiua-6390	39	12	tumor	tumor	NOUN
aiua-6390	39	13	bed	bed	NOUN
aiua-6390	39	14	and	and	CCONJ
aiua-6390	39	15	margins	margin	NOUN
aiua-6390	39	16	were	be	AUX
aiua-6390	39	17	taken	take	VERB
aiua-6390	39	18	separately	separately	ADV
aiua-6390	39	19	.	.	PUNCT
aiua-6390	40	1	all	all	DET
aiua-6390	40	2	resections	resection	NOUN
aiua-6390	40	3	were	be	AUX
aiua-6390	40	4	performed	perform	VERB
aiua-6390	40	5	in	in	ADP
aiua-6390	40	6	our	our	PRON
aiua-6390	40	7	institution	institution	NOUN
aiua-6390	40	8	by	by	ADP
aiua-6390	40	9	the	the	DET
aiua-6390	40	10	same	same	ADJ
aiua-6390	40	11	experienced	experienced	ADJ
aiua-6390	40	12	surgeon	surgeon	NOUN
aiua-6390	40	13	,	,	PUNCT
aiua-6390	40	14	r.g	r.g	PROPN
aiua-6390	40	15	.	.	PROPN
aiua-6390	40	16	our	our	PRON
aiua-6390	40	17	exclusion	exclusion	NOUN
aiua-6390	40	18	criteria	criterion	NOUN
aiua-6390	40	19	included	include	VERB
aiua-6390	40	20	patients	patient	NOUN
aiua-6390	40	21	that	that	PRON
aiua-6390	40	22	underwent	undergo	VERB
aiua-6390	40	23	an	an	DET
aiua-6390	40	24	incomplete	incomplete	ADJ
aiua-6390	40	25	resection	resection	NOUN
aiua-6390	40	26	or	or	CCONJ
aiua-6390	40	27	cases	case	NOUN
aiua-6390	40	28	whose	whose	DET
aiua-6390	40	29	specimens	specimen	NOUN
aiua-6390	40	30	were	be	AUX
aiua-6390	40	31	without	without	ADP
aiua-6390	40	32	muscle	muscle	NOUN
aiua-6390	40	33	tissue	tissue	NOUN
aiua-6390	40	34	in	in	ADP
aiua-6390	40	35	order	order	NOUN
aiua-6390	40	36	to	to	PART
aiua-6390	40	37	evaluate	evaluate	VERB
aiua-6390	40	38	tumour	tumour	NOUN
aiua-6390	40	39	invasion	invasion	NOUN
aiua-6390	40	40	.	.	PUNCT
aiua-6390	41	1	we	we	PRON
aiua-6390	41	2	excluded	exclude	VERB
aiua-6390	41	3	three	three	NUM
aiua-6390	41	4	patients	patient	NOUN
aiua-6390	41	5	:	:	PUNCT
aiua-6390	41	6	two	two	NUM
aiua-6390	41	7	because	because	SCONJ
aiua-6390	41	8	of	of	ADP
aiua-6390	41	9	the	the	DET
aiua-6390	41	10	lack	lack	NOUN
aiua-6390	41	11	of	of	ADP
aiua-6390	41	12	muscle	muscle	NOUN
aiua-6390	41	13	tissue	tissue	NOUN
aiua-6390	41	14	in	in	ADP
aiua-6390	41	15	the	the	DET
aiua-6390	41	16	specimen	speciman	NOUN
aiua-6390	41	17	and	and	CCONJ
aiua-6390	41	18	one	one	NUM
aiua-6390	41	19	because	because	SCONJ
aiua-6390	41	20	of	of	ADP
aiua-6390	41	21	the	the	DET
aiua-6390	41	22	incomplete	incomplete	ADJ
aiua-6390	41	23	resection	resection	NOUN
aiua-6390	41	24	.	.	PUNCT
aiua-6390	42	1	a	a	DET
aiua-6390	42	2	wlre	wlre	ADJ
aiua-6390	42	3	-	-	PUNCT
aiua-6390	42	4	cturbt	cturbt	NOUN
aiua-6390	42	5	,	,	PUNCT
aiua-6390	42	6	according	accord	VERB
aiua-6390	42	7	to	to	ADP
aiua-6390	42	8	eau	eau	PROPN
aiua-6390	42	9	guidelines	guideline	NOUN
aiua-6390	42	10	(	(	PUNCT
aiua-6390	42	11	11	11	NUM
aiua-6390	42	12	)	)	PUNCT
aiua-6390	42	13	,	,	PUNCT
aiua-6390	42	14	was	be	AUX
aiua-6390	42	15	routinely	routinely	ADV
aiua-6390	42	16	performed	perform	VERB
aiua-6390	42	17	within	within	ADP
aiua-6390	42	18	4	4	NUM
aiua-6390	42	19	to	to	PART
aiua-6390	42	20	6	6	NUM
aiua-6390	42	21	weeks	week	NOUN
aiua-6390	42	22	following	follow	VERB
aiua-6390	42	23	the	the	DET
aiua-6390	42	24	first	first	ADJ
aiua-6390	42	25	resection	resection	NOUN
aiua-6390	42	26	if	if	SCONJ
aiua-6390	42	27	the	the	DET
aiua-6390	42	28	histopathological	histopathological	ADJ
aiua-6390	42	29	findings	finding	NOUN
aiua-6390	42	30	revealed	reveal	VERB
aiua-6390	42	31	t1	t1	PROPN
aiua-6390	42	32	tumour	tumour	NOUN
aiua-6390	42	33	.	.	PUNCT
aiua-6390	43	1	the	the	DET
aiua-6390	43	2	surgeon	surgeon	NOUN
aiua-6390	43	3	performed	perform	VERB
aiua-6390	43	4	the	the	DET
aiua-6390	43	5	procedure	procedure	NOUN
aiua-6390	43	6	with	with	ADP
aiua-6390	43	7	the	the	DET
aiua-6390	43	8	same	same	ADJ
aiua-6390	43	9	technique	technique	NOUN
aiua-6390	43	10	of	of	ADP
aiua-6390	43	11	the	the	DET
aiua-6390	43	12	initial	initial	ADJ
aiua-6390	43	13	wlcturbt	wlcturbt	NOUN
aiua-6390	43	14	:	:	PUNCT
aiua-6390	43	15	complete	complete	ADJ
aiua-6390	43	16	resection	resection	NOUN
aiua-6390	43	17	of	of	ADP
aiua-6390	43	18	all	all	DET
aiua-6390	43	19	suspect	suspect	ADJ
aiua-6390	43	20	residual	residual	ADJ
aiua-6390	43	21	tumour	tumour	NOUN
aiua-6390	43	22	,	,	PUNCT
aiua-6390	43	23	separate	separate	ADJ
aiua-6390	43	24	resection	resection	NOUN
aiua-6390	43	25	of	of	ADP
aiua-6390	43	26	the	the	DET
aiua-6390	43	27	underlying	underlie	VERB
aiua-6390	43	28	bladder	bladder	NOUN
aiua-6390	43	29	wall	wall	NOUN
aiua-6390	43	30	with	with	ADP
aiua-6390	43	31	an	an	DET
aiua-6390	43	32	adequate	adequate	ADJ
aiua-6390	43	33	amount	amount	NOUN
aiua-6390	43	34	of	of	ADP
aiua-6390	43	35	detrusor	detrusor	NOUN
aiua-6390	43	36	muscle	muscle	NOUN
aiua-6390	43	37	,	,	PUNCT
aiua-6390	43	38	wide	wide	ADJ
aiua-6390	43	39	resection	resection	NOUN
aiua-6390	43	40	of	of	ADP
aiua-6390	43	41	the	the	DET
aiua-6390	43	42	margins	margin	NOUN
aiua-6390	43	43	to	to	PART
aiua-6390	43	44	exclude	exclude	VERB
aiua-6390	43	45	the	the	DET
aiua-6390	43	46	presence	presence	NOUN
aiua-6390	43	47	of	of	ADP
aiua-6390	43	48	carcinoma	carcinoma	NOUN
aiua-6390	43	49	in	in	ADP
aiua-6390	43	50	situ	situ	NOUN
aiua-6390	43	51	(	(	PUNCT
aiua-6390	43	52	cis	cis	NOUN
aiua-6390	43	53	)	)	PUNCT
aiua-6390	43	54	and	and	CCONJ
aiua-6390	43	55	associated	associate	VERB
aiua-6390	43	56	biopsies	biopsy	NOUN
aiua-6390	43	57	with	with	ADP
aiua-6390	43	58	a	a	DET
aiua-6390	43	59	loop	loop	NOUN
aiua-6390	43	60	resection	resection	NOUN
aiua-6390	43	61	(	(	PUNCT
aiua-6390	43	62	‘	'	PUNCT
aiua-6390	43	63	selected	select	VERB
aiua-6390	43	64	biopsies	biopsy	NOUN
aiua-6390	43	65	’	'	PUNCT
aiua-6390	43	66	)	)	PUNCT
aiua-6390	43	67	of	of	ADP
aiua-6390	43	68	the	the	DET
aiua-6390	43	69	abnormal	abnormal	ADJ
aiua-6390	43	70	areas	area	NOUN
aiua-6390	43	71	of	of	ADP
aiua-6390	43	72	urothelium	urothelium	NOUN
aiua-6390	43	73	.	.	PUNCT
aiua-6390	44	1	if	if	SCONJ
aiua-6390	44	2	there	there	PRON
aiua-6390	44	3	was	be	VERB
aiua-6390	44	4	not	not	PART
aiua-6390	44	5	residual	residual	ADJ
aiua-6390	44	6	tumour	tumour	NOUN
aiua-6390	44	7	or	or	CCONJ
aiua-6390	44	8	if	if	SCONJ
aiua-6390	44	9	it	it	PRON
aiua-6390	44	10	was	be	AUX
aiua-6390	44	11	superficial	superficial	ADJ
aiua-6390	44	12	,	,	PUNCT
aiua-6390	44	13	intravesical	intravesical	ADJ
aiua-6390	44	14	immunotherapy	immunotherapy	NOUN
aiua-6390	44	15	conforming	conforming	NOUN
aiua-6390	44	16	to	to	ADP
aiua-6390	44	17	lamm	lamm	PROPN
aiua-6390	44	18	’s	’s	PART
aiua-6390	44	19	schedule	schedule	NOUN
aiua-6390	44	20	was	be	AUX
aiua-6390	44	21	planned	plan	VERB
aiua-6390	44	22	(	(	PUNCT
aiua-6390	44	23	12	12	NUM
aiua-6390	44	24	)	)	PUNCT
aiua-6390	44	25	.	.	PUNCT
aiua-6390	45	1	in	in	ADP
aiua-6390	45	2	according	accord	VERB
aiua-6390	45	3	to	to	ADP
aiua-6390	45	4	eau	eau	PROPN
aiua-6390	45	5	guidelines	guideline	NOUN
aiua-6390	45	6	(	(	PUNCT
aiua-6390	45	7	11	11	NUM
aiua-6390	45	8	)	)	PUNCT
aiua-6390	45	9	,	,	PUNCT
aiua-6390	45	10	urine	urine	NOUN
aiua-6390	45	11	cytology	cytology	NOUN
aiua-6390	45	12	and	and	CCONJ
aiua-6390	45	13	follow	follow	VERB
aiua-6390	45	14	-	-	PUNCT
aiua-6390	45	15	up	up	ADP
aiua-6390	45	16	cystoscopy	cystoscopy	NOUN
aiua-6390	45	17	were	be	AUX
aiua-6390	45	18	performed	perform	VERB
aiua-6390	45	19	every	every	DET
aiua-6390	45	20	3	3	NUM
aiua-6390	45	21	-	-	PUNCT
aiua-6390	45	22	month	month	NOUN
aiua-6390	45	23	for	for	ADP
aiua-6390	45	24	the	the	DET
aiua-6390	45	25	first	first	ADJ
aiua-6390	45	26	year	year	NOUN
aiua-6390	45	27	,	,	PUNCT
aiua-6390	45	28	biannually	biannually	ADV
aiua-6390	45	29	for	for	ADP
aiua-6390	45	30	the	the	DET
aiua-6390	45	31	second	second	ADJ
aiua-6390	45	32	year	year	NOUN
aiua-6390	45	33	and	and	CCONJ
aiua-6390	45	34	annually	annually	ADV
aiua-6390	45	35	thereafter	thereafter	ADV
aiua-6390	45	36	.	.	PUNCT
aiua-6390	46	1	ultrasonography	ultrasonography	NOUN
aiua-6390	46	2	of	of	ADP
aiua-6390	46	3	the	the	DET
aiua-6390	46	4	urinary	urinary	ADJ
aiua-6390	46	5	upper	upper	ADJ
aiua-6390	46	6	tract	tract	NOUN
aiua-6390	46	7	was	be	AUX
aiua-6390	46	8	performed	perform	VERB
aiua-6390	46	9	every	every	DET
aiua-6390	46	10	six	six	NUM
aiua-6390	46	11	months	month	NOUN
aiua-6390	46	12	.	.	PUNCT
aiua-6390	47	1	however	however	ADV
aiua-6390	47	2	,	,	PUNCT
aiua-6390	47	3	if	if	SCONJ
aiua-6390	47	4	muscle	muscle	NOUN
aiua-6390	47	5	invasive	invasive	VERB
aiua-6390	47	6	residual	residual	ADJ
aiua-6390	47	7	tumour	tumour	NOUN
aiua-6390	47	8	or	or	CCONJ
aiua-6390	47	9	cis	cis	NOUN
aiua-6390	47	10	were	be	AUX
aiua-6390	47	11	detected	detect	VERB
aiua-6390	47	12	,	,	PUNCT
aiua-6390	47	13	subsequent	subsequent	ADJ
aiua-6390	47	14	treatment	treatment	NOUN
aiua-6390	47	15	strategy	strategy	NOUN
aiua-6390	47	16	was	be	AUX
aiua-6390	47	17	radical	radical	ADJ
aiua-6390	47	18	cystoprostatectomy	cystoprostatectomy	NOUN
aiua-6390	47	19	.	.	PUNCT
aiua-6390	48	1	recurrence	recurrence	NOUN
aiua-6390	48	2	free	free	ADJ
aiua-6390	48	3	survival	survival	NOUN
aiua-6390	48	4	,	,	PUNCT
aiua-6390	48	5	progression	progression	NOUN
aiua-6390	48	6	free	free	ADJ
aiua-6390	48	7	survival	survival	NOUN
aiua-6390	48	8	and	and	CCONJ
aiua-6390	48	9	overall	overall	ADJ
aiua-6390	48	10	survival	survival	NOUN
aiua-6390	48	11	curves	curve	NOUN
aiua-6390	48	12	were	be	AUX
aiua-6390	48	13	calculated	calculate	VERB
aiua-6390	48	14	by	by	ADP
aiua-6390	48	15	the	the	DET
aiua-6390	48	16	kaplanmeier	kaplanmei	ADJ
aiua-6390	48	17	method	method	NOUN
aiua-6390	48	18	(	(	PUNCT
aiua-6390	48	19	13	13	NUM
aiua-6390	48	20	)	)	PUNCT
aiua-6390	48	21	and	and	CCONJ
aiua-6390	48	22	compared	compare	VERB
aiua-6390	48	23	by	by	ADP
aiua-6390	48	24	the	the	DET
aiua-6390	48	25	log	log	NOUN
aiua-6390	48	26	rank	rank	NOUN
aiua-6390	48	27	test	test	NOUN
aiua-6390	48	28	(	(	PUNCT
aiua-6390	48	29	14	14	NUM
aiua-6390	48	30	)	)	PUNCT
aiua-6390	48	31	.	.	PUNCT
aiua-6390	49	1	statistical	statistical	ADJ
aiua-6390	49	2	analysis	analysis	NOUN
aiua-6390	49	3	was	be	AUX
aiua-6390	49	4	performed	perform	VERB
aiua-6390	49	5	using	use	VERB
aiua-6390	49	6	the	the	DET
aiua-6390	49	7	pearson	pearson	PROPN
aiua-6390	49	8	chi	chi	PROPN
aiua-6390	49	9	-	-	PUNCT
aiua-6390	49	10	square	square	ADJ
aiua-6390	49	11	test	test	NOUN
aiua-6390	49	12	(	(	PUNCT
aiua-6390	49	13	15	15	NUM
aiua-6390	49	14	)	)	PUNCT
aiua-6390	49	15	.	.	PUNCT
aiua-6390	50	1	tumors	tumor	NOUN
aiua-6390	50	2	were	be	AUX
aiua-6390	50	3	classified	classify	VERB
aiua-6390	50	4	according	accord	VERB
aiua-6390	50	5	to	to	ADP
aiua-6390	50	6	the	the	DET
aiua-6390	50	7	tnm	tnm	NOUN
aiua-6390	50	8	system	system	NOUN
aiua-6390	50	9	of	of	ADP
aiua-6390	50	10	the	the	DET
aiua-6390	50	11	uicc	uicc	NOUN
aiua-6390	50	12	(	(	PUNCT
aiua-6390	50	13	16	16	NUM
aiua-6390	50	14	)	)	PUNCT
aiua-6390	50	15	and	and	CCONJ
aiua-6390	50	16	grading	grade	VERB
aiua-6390	50	17	according	accord	VERB
aiua-6390	50	18	to	to	ADP
aiua-6390	50	19	who	who	PRON
aiua-6390	50	20	classification	classification	VERB
aiua-6390	50	21	.	.	PUNCT
aiua-6390	51	1	patients	patient	NOUN
aiua-6390	51	2	were	be	AUX
aiua-6390	51	3	fully	fully	ADV
aiua-6390	51	4	informed	inform	VERB
aiua-6390	51	5	and	and	CCONJ
aiua-6390	51	6	consented	consent	VERB
aiua-6390	51	7	the	the	DET
aiua-6390	51	8	procedure	procedure	NOUN
aiua-6390	51	9	.	.	PUNCT
aiua-6390	52	1	results	result	NOUN
aiua-6390	52	2	of	of	ADP
aiua-6390	52	3	the	the	DET
aiua-6390	52	4	95	95	NUM
aiua-6390	52	5	enrolled	enrol	VERB
aiua-6390	52	6	patients	patient	NOUN
aiua-6390	52	7	,	,	PUNCT
aiua-6390	52	8	92	92	NUM
aiua-6390	52	9	were	be	AUX
aiua-6390	52	10	considered	consider	VERB
aiua-6390	52	11	evaluable	evaluable	ADJ
aiua-6390	52	12	for	for	ADP
aiua-6390	52	13	the	the	DET
aiua-6390	52	14	actual	actual	ADJ
aiua-6390	52	15	analysis	analysis	NOUN
aiua-6390	52	16	.	.	PUNCT
aiua-6390	53	1	after	after	SCONJ
aiua-6390	53	2	wlre	wlre	ADJ
aiua-6390	53	3	-	-	PUNCT
aiua-6390	53	4	cturbt	cturbt	NOUN
aiua-6390	53	5	performed	perform	VERB
aiua-6390	53	6	within	within	ADP
aiua-6390	53	7	4	4	NUM
aiua-6390	53	8	to	to	PART
aiua-6390	53	9	6	6	NUM
aiua-6390	53	10	weeks	week	NOUN
aiua-6390	53	11	following	follow	VERB
aiua-6390	53	12	the	the	DET
aiua-6390	53	13	first	first	ADJ
aiua-6390	53	14	resection	resection	NOUN
aiua-6390	53	15	,	,	PUNCT
aiua-6390	53	16	we	we	PRON
aiua-6390	53	17	observed	observe	VERB
aiua-6390	53	18	18	18	NUM
aiua-6390	53	19	(	(	PUNCT
aiua-6390	53	20	19.5	19.5	NUM
aiua-6390	53	21	%	%	NOUN
aiua-6390	53	22	)	)	PUNCT
aiua-6390	53	23	patients	patient	NOUN
aiua-6390	53	24	with	with	ADP
aiua-6390	53	25	recurrence	recurrence	NOUN
aiua-6390	53	26	:	:	PUNCT
aiua-6390	53	27	4	4	NUM
aiua-6390	53	28	(	(	PUNCT
aiua-6390	53	29	4.34	4.34	NUM
aiua-6390	53	30	%	%	NOUN
aiua-6390	53	31	)	)	PUNCT
aiua-6390	53	32	with	with	ADP
aiua-6390	53	33	muscle	muscle	NOUN
aiua-6390	53	34	invasive	invasive	ADJ
aiua-6390	53	35	bladder	bladder	NOUN
aiua-6390	53	36	cancer	cancer	NOUN
aiua-6390	53	37	(	(	PUNCT
aiua-6390	53	38	mibc	mibc	PROPN
aiua-6390	53	39	)	)	PUNCT
aiua-6390	53	40	and	and	CCONJ
aiua-6390	53	41	14	14	NUM
aiua-6390	53	42	(	(	PUNCT
aiua-6390	53	43	15.2	15.2	NUM
aiua-6390	53	44	%	%	NOUN
aiua-6390	53	45	)	)	PUNCT
aiua-6390	53	46	with	with	ADP
aiua-6390	53	47	nmibc	nmibc	PROPN
aiua-6390	53	48	(	(	PUNCT
aiua-6390	53	49	table	table	NOUN
aiua-6390	53	50	2	2	NUM
aiua-6390	53	51	)	)	PUNCT
aiua-6390	53	52	.	.	PUNCT
aiua-6390	54	1	regarding	regard	VERB
aiua-6390	54	2	focality	focality	NOUN
aiua-6390	54	3	,	,	PUNCT
aiua-6390	54	4	dimension	dimension	NOUN
aiua-6390	54	5	and	and	CCONJ
aiua-6390	54	6	concomitant	concomitant	ADJ
aiua-6390	54	7	cis	cis	NOUN
aiua-6390	54	8	,	,	PUNCT
aiua-6390	54	9	all	all	DET
aiua-6390	54	10	patients	patient	NOUN
aiua-6390	54	11	with	with	ADP
aiua-6390	54	12	invasive	invasive	ADJ
aiua-6390	54	13	neoplasms	neoplasm	NOUN
aiua-6390	54	14	were	be	AUX
aiua-6390	54	15	multifocal	multifocal	ADJ
aiua-6390	54	16	(	(	PUNCT
aiua-6390	54	17	p	p	X
aiua-6390	54	18	<	<	X
aiua-6390	54	19	0.01	0.01	NUM
aiua-6390	54	20	)	)	PUNCT
aiua-6390	54	21	,	,	PUNCT
aiua-6390	54	22	>	>	X
aiua-6390	54	23	3	3	NUM
aiua-6390	54	24	cm	cm	NOUN
aiua-6390	54	25	(	(	PUNCT
aiua-6390	54	26	p	p	X
aiua-6390	54	27	<	<	X
aiua-6390	54	28	0.01	0.01	NUM
aiua-6390	54	29	)	)	PUNCT
aiua-6390	54	30	or	or	CCONJ
aiua-6390	54	31	with	with	ADP
aiua-6390	54	32	concomitant	concomitant	ADJ
aiua-6390	54	33	cis	cis	NOUN
aiua-6390	54	34	(	(	PUNCT
aiua-6390	54	35	p	p	X
aiua-6390	54	36	<	<	X
aiua-6390	54	37	0.001	0.001	NUM
aiua-6390	54	38	)	)	PUNCT
aiua-6390	54	39	to	to	ADP
aiua-6390	54	40	the	the	DET
aiua-6390	54	41	first	first	ADJ
aiua-6390	54	42	wlcturbt	wlcturbt	NOUN
aiua-6390	54	43	.	.	PUNCT
aiua-6390	55	1	all	all	DET
aiua-6390	55	2	mibc	mibc	PROPN
aiua-6390	55	3	patients	patient	NOUN
aiua-6390	55	4	underwent	undergo	VERB
aiua-6390	55	5	radical	radical	ADJ
aiua-6390	55	6	cystoprostatectomy	cystoprostatectomy	NOUN
aiua-6390	55	7	with	with	ADP
aiua-6390	55	8	staging	stage	VERB
aiua-6390	55	9	lymphadenectomy	lymphadenectomy	NOUN
aiua-6390	55	10	and	and	CCONJ
aiua-6390	55	11	the	the	DET
aiua-6390	55	12	histopathological	histopathological	ADJ
aiua-6390	55	13	evaluation	evaluation	NOUN
aiua-6390	55	14	revealed	reveal	VERB
aiua-6390	55	15	one	one	NUM
aiua-6390	55	16	patient	patient	NOUN
aiua-6390	55	17	with	with	ADP
aiua-6390	55	18	no	no	DET
aiua-6390	55	19	evidence	evidence	NOUN
aiua-6390	55	20	of	of	ADP
aiua-6390	55	21	tcc	tcc	PROPN
aiua-6390	55	22	in	in	ADP
aiua-6390	55	23	the	the	DET
aiua-6390	55	24	cystectomy	cystectomy	NOUN
aiua-6390	55	25	specimen	speciman	NOUN
aiua-6390	55	26	(	(	PUNCT
aiua-6390	55	27	pt0	pt0	NOUN
aiua-6390	55	28	)	)	PUNCT
aiua-6390	55	29	and	and	CCONJ
aiua-6390	55	30	three	three	NUM
aiua-6390	55	31	patients	patient	NOUN
aiua-6390	55	32	with	with	ADP
aiua-6390	55	33	muscle	muscle	NOUN
aiua-6390	55	34	invasion	invasion	NOUN
aiua-6390	55	35	(	(	PUNCT
aiua-6390	55	36	pt2b	pt2b	PROPN
aiua-6390	55	37	)	)	PUNCT
aiua-6390	55	38	but	but	CCONJ
aiua-6390	55	39	no	no	DET
aiua-6390	55	40	evidence	evidence	NOUN
aiua-6390	55	41	of	of	ADP
aiua-6390	55	42	positive	positive	ADJ
aiua-6390	55	43	lymphnodes	lymphnode	NOUN
aiua-6390	55	44	(	(	PUNCT
aiua-6390	55	45	pn0	pn0	NOUN
aiua-6390	55	46	)	)	PUNCT
aiua-6390	55	47	.	.	PUNCT
aiua-6390	56	1	we	we	PRON
aiua-6390	56	2	carried	carry	VERB
aiua-6390	56	3	out	out	ADP
aiua-6390	56	4	the	the	DET
aiua-6390	56	5	follow	follow	NOUN
aiua-6390	56	6	up	up	ADP
aiua-6390	56	7	of	of	ADP
aiua-6390	56	8	all	all	DET
aiua-6390	56	9	92	92	NUM
aiua-6390	56	10	patients	patient	NOUN
aiua-6390	56	11	according	accord	VERB
aiua-6390	56	12	to	to	ADP
aiua-6390	56	13	the	the	DET
aiua-6390	56	14	eau	eau	PROPN
aiua-6390	56	15	guidelines	guideline	NOUN
aiua-6390	56	16	,	,	PUNCT
aiua-6390	56	17	and	and	CCONJ
aiua-6390	56	18	we	we	PRON
aiua-6390	56	19	found	find	VERB
aiua-6390	56	20	out	out	ADP
aiua-6390	56	21	recurrence	recurrence	NOUN
aiua-6390	56	22	in	in	ADP
aiua-6390	56	23	36/92	36/92	NUM
aiua-6390	56	24	(	(	PUNCT
aiua-6390	56	25	39.1	39.1	NUM
aiua-6390	56	26	%	%	NOUN
aiua-6390	56	27	)	)	PUNCT
aiua-6390	56	28	and	and	CCONJ
aiua-6390	56	29	progression	progression	NOUN
aiua-6390	56	30	in	in	ADP
aiua-6390	56	31	14/92	14/92	NUM
aiua-6390	56	32	(	(	PUNCT
aiua-6390	56	33	15.2	15.2	NUM
aiua-6390	56	34	%	%	NOUN
aiua-6390	56	35	)	)	PUNCT
aiua-6390	56	36	.	.	PUNCT
aiua-6390	57	1	all	all	DET
aiua-6390	57	2	the	the	DET
aiua-6390	57	3	14	14	NUM
aiua-6390	57	4	patients	patient	NOUN
aiua-6390	57	5	(	(	PUNCT
aiua-6390	57	6	15.2	15.2	NUM
aiua-6390	57	7	%	%	NOUN
aiua-6390	57	8	)	)	PUNCT
aiua-6390	57	9	with	with	ADP
aiua-6390	57	10	nmibc	nmibc	ADJ
aiua-6390	57	11	underwent	underwent	ADJ
aiua-6390	57	12	intravesical	intravesical	ADJ
aiua-6390	57	13	immunotherapy	immunotherapy	NOUN
aiua-6390	57	14	conforming	conform	VERB
aiua-6390	57	15	to	to	ADP
aiua-6390	57	16	lamm	lamm	PROPN
aiua-6390	57	17	’s	’s	PART
aiua-6390	57	18	schedule	schedule	NOUN
aiua-6390	57	19	(	(	PUNCT
aiua-6390	57	20	12	12	NUM
aiua-6390	57	21	)	)	PUNCT
aiua-6390	57	22	and	and	CCONJ
aiua-6390	57	23	10	10	NUM
aiua-6390	57	24	(	(	PUNCT
aiua-6390	57	25	71.4	71.4	NUM
aiua-6390	57	26	%	%	NOUN
aiua-6390	57	27	)	)	PUNCT
aiua-6390	57	28	of	of	ADP
aiua-6390	57	29	them	they	PRON
aiua-6390	57	30	showed	show	VERB
aiua-6390	57	31	recurrences	recurrence	NOUN
aiua-6390	57	32	respectively	respectively	ADV
aiua-6390	57	33	after	after	ADP
aiua-6390	57	34	4	4	NUM
aiua-6390	57	35	,	,	PUNCT
aiua-6390	57	36	6	6	NUM
aiua-6390	57	37	,	,	PUNCT
aiua-6390	57	38	7	7	NUM
aiua-6390	57	39	,	,	PUNCT
aiua-6390	57	40	10	10	NUM
aiua-6390	57	41	and	and	CCONJ
aiua-6390	57	42	12	12	NUM
aiua-6390	57	43	months	month	NOUN
aiua-6390	57	44	(	(	PUNCT
aiua-6390	57	45	see	see	VERB
aiua-6390	57	46	table	table	NOUN
aiua-6390	57	47	3	3	NUM
aiua-6390	57	48	)	)	PUNCT
aiua-6390	57	49	.	.	PUNCT
aiua-6390	58	1	of	of	ADP
aiua-6390	58	2	these	these	DET
aiua-6390	58	3	10	10	NUM
aiua-6390	58	4	patients	patient	NOUN
aiua-6390	58	5	,	,	PUNCT
aiua-6390	58	6	4	4	NUM
aiua-6390	58	7	patients	patient	NOUN
aiua-6390	58	8	(	(	PUNCT
aiua-6390	58	9	40	40	NUM
aiua-6390	58	10	%	%	NOUN
aiua-6390	58	11	)	)	PUNCT
aiua-6390	58	12	showed	show	VERB
aiua-6390	58	13	recurrences	recurrence	NOUN
aiua-6390	58	14	pt1hg	pt1hg	PRON
aiua-6390	58	15	with	with	ADP
aiua-6390	58	16	concomitant	concomitant	ADJ
aiua-6390	58	17	cis	cis	NOUN
aiua-6390	58	18	,	,	PUNCT
aiua-6390	58	19	3	3	NUM
aiua-6390	58	20	patients	patient	NOUN
aiua-6390	58	21	(	(	PUNCT
aiua-6390	58	22	30.0	30.0	NUM
aiua-6390	58	23	%	%	NOUN
aiua-6390	58	24	)	)	PUNCT
aiua-6390	58	25	multifocal	multifocal	ADJ
aiua-6390	58	26	ptahg	ptahg	NOUN
aiua-6390	58	27	,	,	PUNCT
aiua-6390	58	28	two	two	NUM
aiua-6390	58	29	(	(	PUNCT
aiua-6390	58	30	20.0	20.0	NUM
aiua-6390	58	31	%	%	NOUN
aiua-6390	58	32	)	)	PUNCT
aiua-6390	58	33	cis	cis	NOUN
aiua-6390	58	34	and	and	CCONJ
aiua-6390	58	35	one	one	NUM
aiua-6390	58	36	(	(	PUNCT
aiua-6390	58	37	10.0	10.0	NUM
aiua-6390	58	38	%	%	NOUN
aiua-6390	58	39	)	)	PUNCT
aiua-6390	58	40	a	a	DET
aiua-6390	58	41	muscle	muscle	NOUN
aiua-6390	58	42	invasive	invasive	ADJ
aiua-6390	58	43	neoplasm	neoplasm	NOUN
aiua-6390	58	44	(	(	PUNCT
aiua-6390	58	45	pt2hg	pt2hg	NUM
aiua-6390	58	46	)	)	PUNCT
aiua-6390	58	47	.	.	PUNCT
aiua-6390	59	1	all	all	DET
aiua-6390	59	2	these	these	DET
aiua-6390	59	3	patients	patient	NOUN
aiua-6390	59	4	with	with	ADP
aiua-6390	59	5	high	high	ADJ
aiua-6390	59	6	grade	grade	NOUN
aiua-6390	59	7	persistent	persistent	ADJ
aiua-6390	59	8	disease	disease	NOUN
aiua-6390	59	9	following	follow	VERB
aiua-6390	59	10	bcg	bcg	NOUN
aiua-6390	59	11	-	-	PUNCT
aiua-6390	59	12	schedule	schedule	NOUN
aiua-6390	59	13	were	be	AUX
aiua-6390	59	14	regarded	regard	VERB
aiua-6390	59	15	as	as	ADP
aiua-6390	59	16	"	"	PUNCT
aiua-6390	59	17	patients	patient	NOUN
aiua-6390	59	18	progressing	progress	VERB
aiua-6390	59	19	"	"	PUNCT
aiua-6390	59	20	and	and	CCONJ
aiua-6390	59	21	after	after	SCONJ
aiua-6390	59	22	pelvis	pelvis	NOUN
aiua-6390	59	23	-	-	PUNCT
aiua-6390	59	24	abdomen	abdomen	NOUN
aiua-6390	59	25	ct	ct	NOUN
aiua-6390	59	26	and	and	CCONJ
aiua-6390	59	27	scintigraphy	scintigraphy	NOUN
aiua-6390	59	28	,	,	PUNCT
aiua-6390	59	29	radical	radical	ADJ
aiua-6390	59	30	cystoprostatectomy	cystoprostatectomy	NOUN
aiua-6390	59	31	with	with	ADP
aiua-6390	59	32	staging	staging	NOUN
aiua-6390	59	33	lymphadenectomy	lymphadenectomy	NOUN
aiua-6390	59	34	was	be	AUX
aiua-6390	59	35	suggested	suggest	VERB
aiua-6390	59	36	.	.	PUNCT
aiua-6390	60	1	the	the	DET
aiua-6390	60	2	histopathological	histopathological	ADJ
aiua-6390	60	3	evaluation	evaluation	NOUN
aiua-6390	60	4	revealed	reveal	VERB
aiua-6390	60	5	two	two	NUM
aiua-6390	60	6	patients	patient	NOUN
aiua-6390	60	7	(	(	PUNCT
aiua-6390	60	8	2.17	2.17	NUM
aiua-6390	60	9	%	%	NOUN
aiua-6390	60	10	)	)	PUNCT
aiua-6390	60	11	with	with	ADP
aiua-6390	60	12	no	no	DET
aiua-6390	60	13	evidence	evidence	NOUN
aiua-6390	60	14	of	of	ADP
aiua-6390	60	15	tcc	tcc	PROPN
aiua-6390	60	16	in	in	ADP
aiua-6390	60	17	the	the	DET
aiua-6390	60	18	cystectomy	cystectomy	NOUN
aiua-6390	60	19	specimen	speciman	NOUN
aiua-6390	60	20	(	(	PUNCT
aiua-6390	60	21	pt0	pt0	PROPN
aiua-6390	60	22	)	)	PUNCT
aiua-6390	60	23	,	,	PUNCT
aiua-6390	60	24	six	six	NUM
aiua-6390	60	25	patients	patient	NOUN
aiua-6390	60	26	(	(	PUNCT
aiua-6390	60	27	6.52	6.52	NUM
aiua-6390	60	28	%	%	NOUN
aiua-6390	60	29	)	)	PUNCT
aiua-6390	60	30	with	with	ADP
aiua-6390	60	31	muscle	muscle	NOUN
aiua-6390	60	32	invasive	invasive	ADJ
aiua-6390	60	33	tumor	tumor	NOUN
aiua-6390	60	34	pt2a	pt2a	PROPN
aiua-6390	60	35	and	and	CCONJ
aiua-6390	60	36	two	two	NUM
aiua-6390	60	37	(	(	PUNCT
aiua-6390	60	38	2.17	2.17	NUM
aiua-6390	60	39	%	%	NOUN
aiua-6390	60	40	)	)	PUNCT
aiua-6390	60	41	pt2b	pt2b	NOUN
aiua-6390	60	42	,	,	PUNCT
aiua-6390	60	43	with	with	ADP
aiua-6390	60	44	no	no	DET
aiua-6390	60	45	evidence	evidence	NOUN
aiua-6390	60	46	of	of	ADP
aiua-6390	60	47	positive	positive	ADJ
aiua-6390	60	48	lynphnodes	lynphnode	NOUN
aiua-6390	60	49	(	(	PUNCT
aiua-6390	60	50	pn0	pn0	NOUN
aiua-6390	60	51	)	)	PUNCT
aiua-6390	60	52	.	.	PUNCT
aiua-6390	61	1	all	all	PRON
aiua-6390	61	2	of	of	ADP
aiua-6390	61	3	the	the	DET
aiua-6390	61	4	patients	patient	NOUN
aiua-6390	61	5	are	be	AUX
aiua-6390	61	6	actually	actually	ADV
aiua-6390	61	7	living	live	VERB
aiua-6390	61	8	and	and	CCONJ
aiua-6390	61	9	disease	disease	NOUN
aiua-6390	61	10	-	-	PUNCT
aiua-6390	61	11	free	free	ADJ
aiua-6390	61	12	but	but	CCONJ
aiua-6390	61	13	one	one	NUM
aiua-6390	61	14	(	(	PUNCT
aiua-6390	61	15	1.08	1.08	NUM
aiua-6390	61	16	)	)	PUNCT
aiua-6390	61	17	with	with	ADP
aiua-6390	61	18	muscle	muscle	NOUN
aiua-6390	61	19	invasive	invasive	ADJ
aiua-6390	61	20	tumor	tumor	NOUN
aiua-6390	61	21	(	(	PUNCT
aiua-6390	61	22	pt2an0	pt2an0	NOUN
aiua-6390	61	23	)	)	PUNCT
aiua-6390	61	24	who	who	PRON
aiua-6390	61	25	died	die	VERB
aiua-6390	61	26	for	for	ADP
aiua-6390	61	27	another	another	DET
aiua-6390	61	28	cause	cause	NOUN
aiua-6390	61	29	without	without	ADP
aiua-6390	61	30	evidence	evidence	NOUN
aiua-6390	61	31	of	of	ADP
aiua-6390	61	32	disease	disease	NOUN
aiua-6390	61	33	progression	progression	NOUN
aiua-6390	61	34	.	.	PUNCT
aiua-6390	62	1	in	in	ADP
aiua-6390	62	2	the	the	DET
aiua-6390	62	3	group	group	NOUN
aiua-6390	62	4	of	of	ADP
aiua-6390	62	5	patients	patient	NOUN
aiua-6390	62	6	with	with	ADP
aiua-6390	62	7	table	table	NOUN
aiua-6390	62	8	1	1	NUM
aiua-6390	62	9	.	.	PUNCT
aiua-6390	63	1	t1hg	t1hg	NOUN
aiua-6390	63	2	patients	patient	NOUN
aiua-6390	63	3	:	:	PUNCT
aiua-6390	63	4	focality	focality	NOUN
aiua-6390	63	5	and	and	CCONJ
aiua-6390	63	6	dimensions	dimension	NOUN
aiua-6390	63	7	.	.	PUNCT
aiua-6390	64	1	focality	focality	NOUN
aiua-6390	64	2	pts	pts	ADP
aiua-6390	64	3	dimensions	dimensions	PROPN
aiua-6390	64	4	pts	pt	NOUN
aiua-6390	64	5	unifocal	unifocal	ADJ
aiua-6390	64	6	14	14	NUM
aiua-6390	64	7	<	<	SYM
aiua-6390	64	8	1	1	NUM
aiua-6390	64	9	cm	cm	NUM
aiua-6390	64	10	12	12	NUM
aiua-6390	64	11	multifocal	multifocal	ADJ
aiua-6390	64	12	78	78	NUM
aiua-6390	64	13	>	>	SYM
aiua-6390	64	14	1	1	NUM
aiua-6390	64	15	<	<	X
aiua-6390	64	16	3	3	NUM
aiua-6390	64	17	cm	cm	NUM
aiua-6390	64	18	54	54	NUM
aiua-6390	64	19	>	>	SYM
aiua-6390	64	20	3	3	NUM
aiua-6390	64	21	cm	cm	NUM
aiua-6390	64	22	26	26	NUM
aiua-6390	64	23	92	92	NUM
aiua-6390	64	24	92	92	NUM
aiua-6390	64	25	table	table	NOUN
aiua-6390	64	26	2	2	NUM
aiua-6390	64	27	.	.	PUNCT
aiua-6390	65	1	t1hg	t1hg	PROPN
aiua-6390	65	2	patients	patient	NOUN
aiua-6390	65	3	returb	returb	VERB
aiua-6390	65	4	:	:	PUNCT
aiua-6390	65	5	recurrence	recurrence	NOUN
aiua-6390	65	6	and	and	CCONJ
aiua-6390	65	7	progression	progression	NOUN
aiua-6390	65	8	.	.	PUNCT
aiua-6390	66	1	re	re	NOUN
aiua-6390	66	2	-	-	NOUN
aiua-6390	66	3	turb	turb	NOUN
aiua-6390	66	4	pts	pts	ADP
aiua-6390	66	5	pt1	pt1	PROPN
aiua-6390	66	6	pt2	pt2	PROPN
aiua-6390	66	7	progression	progression	NOUN
aiua-6390	66	8	recurrences	recurrence	VERB
aiua-6390	66	9	18	18	NUM
aiua-6390	66	10	14	14	NUM
aiua-6390	66	11	4	4	NUM
aiua-6390	66	12	%	%	NOUN
aiua-6390	66	13	19.50	19.50	NUM
aiua-6390	66	14	%	%	NOUN
aiua-6390	66	15	15.10	15.10	NUM
aiua-6390	66	16	%	%	NOUN
aiua-6390	66	17	4.40	4.40	NUM
aiua-6390	66	18	%	%	NOUN
aiua-6390	66	19	table	table	NOUN
aiua-6390	66	20	3	3	NUM
aiua-6390	66	21	.	.	PUNCT
aiua-6390	67	1	tahg	tahg	PROPN
aiua-6390	67	2	patients	patient	NOUN
aiua-6390	67	3	follow	follow	VERB
aiua-6390	67	4	-	-	PUNCT
aiua-6390	67	5	up	up	NOUN
aiua-6390	67	6	:	:	PUNCT
aiua-6390	67	7	bcg	bcg	NOUN
aiua-6390	67	8	,	,	PUNCT
aiua-6390	67	9	recurrence	recurrence	NOUN
aiua-6390	67	10	and	and	CCONJ
aiua-6390	67	11	progression	progression	NOUN
aiua-6390	67	12	.	.	PUNCT
aiua-6390	68	1	bcg	bcg	PROPN
aiua-6390	68	2	rec	rec	PROPN
aiua-6390	68	3	4	4	NUM
aiua-6390	68	4	mo	mo	PROPN
aiua-6390	68	5	6	6	NUM
aiua-6390	68	6	mo	mo	PROPN
aiua-6390	68	7	7	7	NUM
aiua-6390	68	8	mo	mo	PROPN
aiua-6390	68	9	10	10	NUM
aiua-6390	68	10	mo	mo	PROPN
aiua-6390	68	11	12	12	NUM
aiua-6390	68	12	mo	mo	PROPN
aiua-6390	68	13	14	14	NUM
aiua-6390	68	14	pt1hg	pt1hg	NUM
aiua-6390	68	15	/	/	SYM
aiua-6390	68	16	cis	cis	NOUN
aiua-6390	68	17	ptahg	ptahg	NOUN
aiua-6390	68	18	cis	cis	NOUN
aiua-6390	68	19	pt2hg	pt2hg	PRON
aiua-6390	68	20	pt1hg	pt1hg	NOUN
aiua-6390	68	21	/	/	SYM
aiua-6390	68	22	cis	cis	NOUN
aiua-6390	68	23	pts	pts	ADP
aiua-6390	68	24	10	10	NUM
aiua-6390	68	25	3	3	NUM
aiua-6390	68	26	3	3	NUM
aiua-6390	68	27	2	2	NUM
aiua-6390	68	28	1	1	NUM
aiua-6390	68	29	1	1	NUM
aiua-6390	68	30	15.20	15.20	NUM
aiua-6390	68	31	%	%	NOUN
aiua-6390	68	32	10.87	10.87	NUM
aiua-6390	68	33	%	%	NOUN
aiua-6390	68	34	3.27	3.27	NUM
aiua-6390	68	35	%	%	NOUN
aiua-6390	68	36	3.27	3.27	NUM
aiua-6390	68	37	%	%	NOUN
aiua-6390	68	38	2.17	2.17	NUM
aiua-6390	68	39	%	%	NOUN
aiua-6390	68	40	1.08	1.08	NUM
aiua-6390	68	41	%	%	NOUN
aiua-6390	68	42	1.08	1.08	NUM
aiua-6390	68	43	%	%	NOUN
aiua-6390	68	44	giulianelli_stesura	giulianelli_stesura	NOUN
aiua-6390	68	45	seveso	seveso	NOUN
aiua-6390	68	46	03/01/18	03/01/18	PROPN
aiua-6390	68	47	11:58	11:58	NUM
aiua-6390	68	48	pagina	pagina	NOUN
aiua-6390	68	49	273	273	NUM
aiua-6390	68	50	archivio	archivio	NOUN
aiua-6390	68	51	italiano	italiano	X
aiua-6390	68	52	di	di	X
aiua-6390	68	53	urologia	urologia	PROPN
aiua-6390	68	54	e	e	PROPN
aiua-6390	68	55	andrologia	andrologia	NOUN
aiua-6390	68	56	2017	2017	NUM
aiua-6390	68	57	;	;	PUNCT
aiua-6390	68	58	89	89	NUM
aiua-6390	68	59	,	,	PUNCT
aiua-6390	68	60	4	4	NUM
aiua-6390	68	61	r.	r.	PROPN
aiua-6390	68	62	giulianelli	giulianelli	PROPN
aiua-6390	68	63	,	,	PUNCT
aiua-6390	68	64	b.c	b.c	PROPN
aiua-6390	68	65	.	.	PROPN
aiua-6390	68	66	gentile	gentile	NOUN
aiua-6390	68	67	,	,	PUNCT
aiua-6390	68	68	g.	g.	PROPN
aiua-6390	68	69	mirabile	mirabile	PROPN
aiua-6390	68	70	,	,	PUNCT
aiua-6390	68	71	l.	l.	PROPN
aiua-6390	68	72	albanesi	albanesi	PROPN
aiua-6390	68	73	,	,	PUNCT
aiua-6390	68	74	p.	p.	NOUN
aiua-6390	68	75	tariciotti	tariciotti	PROPN
aiua-6390	68	76	,	,	PUNCT
aiua-6390	68	77	g.	g.	PROPN
aiua-6390	68	78	rizzo	rizzo	PROPN
aiua-6390	68	79	,	,	PUNCT
aiua-6390	68	80	m.	m.	NOUN
aiua-6390	68	81	buscarini	buscarini	PROPN
aiua-6390	68	82	,	,	PUNCT
aiua-6390	68	83	m.	m.	NOUN
aiua-6390	68	84	vermiglio	vermiglio	NOUN
aiua-6390	68	85	274	274	NUM
aiua-6390	68	86	persistent	persistent	ADJ
aiua-6390	68	87	disease	disease	NOUN
aiua-6390	68	88	following	follow	VERB
aiua-6390	68	89	wlrecturbt	wlrecturbt	NOUN
aiua-6390	68	90	we	we	PRON
aiua-6390	68	91	observed	observe	VERB
aiua-6390	68	92	a	a	DET
aiua-6390	68	93	overall	overall	ADJ
aiua-6390	68	94	mibc	mibc	ADJ
aiua-6390	68	95	rate	rate	NOUN
aiua-6390	68	96	of	of	ADP
aiua-6390	68	97	66.6	66.6	NUM
aiua-6390	68	98	%	%	NOUN
aiua-6390	68	99	(	(	PUNCT
aiua-6390	68	100	12	12	NUM
aiua-6390	68	101	pts	pt	NOUN
aiua-6390	68	102	)	)	PUNCT
aiua-6390	68	103	.	.	PUNCT
aiua-6390	69	1	instead	instead	ADV
aiua-6390	69	2	of	of	ADP
aiua-6390	69	3	the	the	DET
aiua-6390	69	4	group	group	NOUN
aiua-6390	69	5	of	of	ADP
aiua-6390	69	6	48	48	NUM
aiua-6390	69	7	patients	patient	NOUN
aiua-6390	69	8	who	who	PRON
aiua-6390	69	9	were	be	AUX
aiua-6390	69	10	t0	t0	PROPN
aiua-6390	69	11	following	follow	VERB
aiua-6390	69	12	wlre	wlre	ADJ
aiua-6390	69	13	-	-	PUNCT
aiua-6390	69	14	cturbt	cturbt	NOUN
aiua-6390	69	15	and	and	CCONJ
aiua-6390	69	16	had	have	VERB
aiua-6390	69	17	intravesical	intravesical	ADJ
aiua-6390	69	18	immunotherapy	immunotherapy	NOUN
aiua-6390	69	19	(	(	PUNCT
aiua-6390	69	20	bcg	bcg	PROPN
aiua-6390	69	21	)	)	PUNCT
aiua-6390	69	22	conforming	conform	VERB
aiua-6390	69	23	to	to	ADP
aiua-6390	69	24	lamm	lamm	PROPN
aiua-6390	69	25	’s	’s	PART
aiua-6390	69	26	schedule	schedule	NOUN
aiua-6390	69	27	(	(	PUNCT
aiua-6390	69	28	12	12	NUM
aiua-6390	69	29	)	)	PUNCT
aiua-6390	69	30	,	,	PUNCT
aiua-6390	69	31	we	we	PRON
aiua-6390	69	32	observed	observe	VERB
aiua-6390	69	33	recurrence	recurrence	NOUN
aiua-6390	69	34	in	in	ADP
aiua-6390	69	35	26	26	NUM
aiua-6390	69	36	pts	pt	NOUN
aiua-6390	69	37	(	(	PUNCT
aiua-6390	69	38	54.1	54.1	NUM
aiua-6390	69	39	%	%	NOUN
aiua-6390	69	40	)	)	PUNCT
aiua-6390	69	41	and	and	CCONJ
aiua-6390	69	42	in	in	ADP
aiua-6390	69	43	only	only	ADV
aiua-6390	69	44	two	two	NUM
aiua-6390	69	45	patients	patient	NOUN
aiua-6390	69	46	(	(	PUNCT
aiua-6390	69	47	4.1	4.1	NUM
aiua-6390	69	48	%	%	NOUN
aiua-6390	69	49	)	)	PUNCT
aiua-6390	69	50	progression	progression	NOUN
aiua-6390	69	51	,	,	PUNCT
aiua-6390	69	52	who	who	PRON
aiua-6390	69	53	presented	present	VERB
aiua-6390	69	54	after	after	ADP
aiua-6390	69	55	3	3	NUM
aiua-6390	69	56	months	month	NOUN
aiua-6390	69	57	,	,	PUNCT
aiua-6390	69	58	associated	associate	VERB
aiua-6390	69	59	with	with	ADP
aiua-6390	69	60	cis	cis	NOUN
aiua-6390	69	61	.	.	PUNCT
aiua-6390	70	1	the	the	DET
aiua-6390	70	2	remaining	remain	VERB
aiua-6390	70	3	22	22	NUM
aiua-6390	70	4	patients	patient	NOUN
aiua-6390	70	5	(	(	PUNCT
aiua-6390	70	6	45.9	45.9	NUM
aiua-6390	70	7	%	%	NOUN
aiua-6390	70	8	)	)	PUNCT
aiua-6390	70	9	with	with	ADP
aiua-6390	70	10	initial	initial	ADJ
aiua-6390	70	11	t1hg	t1hg	NOUN
aiua-6390	70	12	are	be	AUX
aiua-6390	70	13	still	still	ADV
aiua-6390	70	14	progression	progression	NOUN
aiua-6390	70	15	free	free	ADJ
aiua-6390	70	16	.	.	PUNCT
aiua-6390	71	1	figures	figure	NOUN
aiua-6390	71	2	1	1	NUM
aiua-6390	71	3	and	and	CCONJ
aiua-6390	71	4	2	2	NUM
aiua-6390	71	5	show	show	VERB
aiua-6390	71	6	kaplan	kaplan	PROPN
aiua-6390	71	7	-	-	PUNCT
aiua-6390	71	8	meier	meier	PROPN
aiua-6390	71	9	overall	overall	ADJ
aiua-6390	71	10	recurrencefree	recurrencefree	ADJ
aiua-6390	71	11	and	and	CCONJ
aiua-6390	71	12	progression	progression	NOUN
aiua-6390	71	13	-	-	PUNCT
aiua-6390	71	14	free	free	ADJ
aiua-6390	71	15	curves	curve	NOUN
aiua-6390	71	16	,	,	PUNCT
aiua-6390	71	17	respectively	respectively	ADV
aiua-6390	71	18	.	.	PUNCT
aiua-6390	72	1	discussion	discussion	NOUN
aiua-6390	72	2	wlcturbt	wlcturbt	NOUN
aiua-6390	72	3	is	be	AUX
aiua-6390	72	4	the	the	DET
aiua-6390	72	5	main	main	ADJ
aiua-6390	72	6	-	-	PUNCT
aiua-6390	72	7	stay	stay	NOUN
aiua-6390	72	8	approach	approach	NOUN
aiua-6390	72	9	in	in	ADP
aiua-6390	72	10	the	the	DET
aiua-6390	72	11	diagnosis	diagnosis	NOUN
aiua-6390	72	12	and	and	CCONJ
aiua-6390	72	13	treatment	treatment	NOUN
aiua-6390	72	14	of	of	ADP
aiua-6390	72	15	bladder	bladder	NOUN
aiua-6390	72	16	cancer	cancer	NOUN
aiua-6390	72	17	.	.	PUNCT
aiua-6390	73	1	on	on	ADP
aiua-6390	73	2	the	the	DET
aiua-6390	73	3	basis	basis	NOUN
aiua-6390	73	4	of	of	ADP
aiua-6390	73	5	the	the	DET
aiua-6390	73	6	eortc	eortc	ADJ
aiua-6390	73	7	risk	risk	NOUN
aiua-6390	73	8	tables	table	NOUN
aiua-6390	73	9	and	and	CCONJ
aiua-6390	73	10	prognostic	prognostic	ADJ
aiua-6390	73	11	factors	factor	NOUN
aiua-6390	73	12	for	for	ADP
aiua-6390	73	13	t1hg	t1hg	DET
aiua-6390	73	14	bladder	bladder	NOUN
aiua-6390	73	15	tumours	tumour	VERB
aiua-6390	73	16	,	,	PUNCT
aiua-6390	73	17	the	the	DET
aiua-6390	73	18	probability	probability	NOUN
aiua-6390	73	19	of	of	ADP
aiua-6390	73	20	recurrence	recurrence	NOUN
aiua-6390	73	21	at	at	ADP
aiua-6390	73	22	1	1	NUM
aiua-6390	73	23	and	and	CCONJ
aiua-6390	73	24	5	5	NUM
aiua-6390	73	25	year	year	NOUN
aiua-6390	73	26	,	,	PUNCT
aiua-6390	73	27	respectively	respectively	ADV
aiua-6390	73	28	,	,	PUNCT
aiua-6390	73	29	is	be	AUX
aiua-6390	73	30	24	24	NUM
aiua-6390	73	31	-	-	SYM
aiua-6390	73	32	61	61	NUM
aiua-6390	73	33	%	%	NOUN
aiua-6390	73	34	and	and	CCONJ
aiua-6390	73	35	46	46	NUM
aiua-6390	73	36	-	-	SYM
aiua-6390	73	37	78	78	NUM
aiua-6390	73	38	%	%	NOUN
aiua-6390	73	39	,	,	PUNCT
aiua-6390	73	40	and	and	CCONJ
aiua-6390	73	41	the	the	DET
aiua-6390	73	42	probability	probability	NOUN
aiua-6390	73	43	of	of	ADP
aiua-6390	73	44	progression	progression	NOUN
aiua-6390	73	45	,	,	PUNCT
aiua-6390	73	46	respectively	respectively	ADV
aiua-6390	73	47	,	,	PUNCT
aiua-6390	73	48	is	be	AUX
aiua-6390	73	49	1	1	NUM
aiua-6390	73	50	-	-	SYM
aiua-6390	73	51	17	17	NUM
aiua-6390	73	52	%	%	NOUN
aiua-6390	73	53	and	and	CCONJ
aiua-6390	73	54	6	6	NUM
aiua-6390	73	55	-	-	SYM
aiua-6390	73	56	45	45	NUM
aiua-6390	73	57	%	%	NOUN
aiua-6390	73	58	(	(	PUNCT
aiua-6390	73	59	3	3	NUM
aiua-6390	73	60	)	)	PUNCT
aiua-6390	73	61	.	.	PUNCT
aiua-6390	74	1	if	if	SCONJ
aiua-6390	74	2	patients	patient	NOUN
aiua-6390	74	3	are	be	AUX
aiua-6390	74	4	diagnosed	diagnose	VERB
aiua-6390	74	5	with	with	ADP
aiua-6390	74	6	high	high	ADJ
aiua-6390	74	7	-	-	PUNCT
aiua-6390	74	8	grade	grade	NOUN
aiua-6390	74	9	t1	t1	NOUN
aiua-6390	74	10	,	,	PUNCT
aiua-6390	74	11	a	a	DET
aiua-6390	74	12	recturbt	recturbt	NOUN
aiua-6390	74	13	is	be	AUX
aiua-6390	74	14	strongly	strongly	ADV
aiua-6390	74	15	recommended	recommend	VERB
aiua-6390	74	16	regardless	regardless	ADV
aiua-6390	74	17	of	of	ADP
aiua-6390	74	18	the	the	DET
aiua-6390	74	19	presence	presence	NOUN
aiua-6390	74	20	of	of	ADP
aiua-6390	74	21	muscle	muscle	NOUN
aiua-6390	74	22	in	in	ADP
aiua-6390	74	23	specimens	specimen	NOUN
aiua-6390	74	24	because	because	SCONJ
aiua-6390	74	25	of	of	ADP
aiua-6390	74	26	the	the	DET
aiua-6390	74	27	possibility	possibility	NOUN
aiua-6390	74	28	of	of	ADP
aiua-6390	74	29	understating	understate	VERB
aiua-6390	74	30	due	due	ADP
aiua-6390	74	31	to	to	ADP
aiua-6390	74	32	incomplete	incomplete	ADJ
aiua-6390	74	33	resection	resection	NOUN
aiua-6390	74	34	(	(	PUNCT
aiua-6390	74	35	17	17	NUM
aiua-6390	74	36	,	,	PUNCT
aiua-6390	74	37	18	18	NUM
aiua-6390	74	38	)	)	PUNCT
aiua-6390	74	39	.	.	PUNCT
aiua-6390	75	1	it	it	PRON
aiua-6390	75	2	provides	provide	VERB
aiua-6390	75	3	more	more	ADV
aiua-6390	75	4	accurate	accurate	ADJ
aiua-6390	75	5	pathological	pathological	ADJ
aiua-6390	75	6	staging	staging	NOUN
aiua-6390	75	7	information	information	NOUN
aiua-6390	75	8	,	,	PUNCT
aiua-6390	75	9	since	since	SCONJ
aiua-6390	75	10	persistent	persistent	ADJ
aiua-6390	75	11	tumor	tumor	NOUN
aiua-6390	75	12	in	in	ADP
aiua-6390	75	13	second	second	ADJ
aiua-6390	75	14	cturbt	cturbt	NOUN
aiua-6390	75	15	specimens	specimen	NOUN
aiua-6390	75	16	can	can	AUX
aiua-6390	75	17	be	be	AUX
aiua-6390	75	18	detected	detect	VERB
aiua-6390	75	19	in	in	ADP
aiua-6390	75	20	33%-55	33%-55	NUM
aiua-6390	75	21	%	%	NOUN
aiua-6390	75	22	of	of	ADP
aiua-6390	75	23	patients	patient	NOUN
aiua-6390	75	24	(	(	PUNCT
aiua-6390	75	25	19	19	NUM
aiua-6390	75	26	,	,	PUNCT
aiua-6390	75	27	20	20	NUM
aiua-6390	75	28	)	)	PUNCT
aiua-6390	75	29	.	.	PUNCT
aiua-6390	76	1	in	in	ADP
aiua-6390	76	2	our	our	PRON
aiua-6390	76	3	experience	experience	NOUN
aiua-6390	76	4	we	we	PRON
aiua-6390	76	5	observed	observe	VERB
aiua-6390	76	6	persistent	persistent	ADJ
aiua-6390	76	7	bladder	bladder	NOUN
aiua-6390	76	8	lesions	lesion	NOUN
aiua-6390	76	9	after	after	ADP
aiua-6390	76	10	wlre	wlre	ADJ
aiua-6390	76	11	-	-	PUNCT
aiua-6390	76	12	cturbt	cturbt	NOUN
aiua-6390	76	13	in	in	ADP
aiua-6390	76	14	19.5	19.5	NUM
aiua-6390	76	15	%	%	NOUN
aiua-6390	76	16	of	of	ADP
aiua-6390	76	17	patients	patient	NOUN
aiua-6390	76	18	.	.	PUNCT
aiua-6390	77	1	in	in	ADP
aiua-6390	77	2	addition	addition	NOUN
aiua-6390	77	3	,	,	PUNCT
aiua-6390	77	4	a	a	DET
aiua-6390	77	5	wlre	wlre	ADJ
aiua-6390	77	6	-	-	PUNCT
aiua-6390	77	7	cturbt	cturbt	NOUN
aiua-6390	77	8	promotes	promote	VERB
aiua-6390	77	9	cancer	cancer	NOUN
aiua-6390	77	10	control	control	NOUN
aiua-6390	77	11	.	.	PUNCT
aiua-6390	78	1	in	in	ADP
aiua-6390	78	2	a	a	DET
aiua-6390	78	3	randomized	randomized	ADJ
aiua-6390	78	4	controlled	control	VERB
aiua-6390	78	5	study	study	NOUN
aiua-6390	78	6	,	,	PUNCT
aiua-6390	78	7	re	re	NOUN
aiua-6390	78	8	-	-	NOUN
aiua-6390	78	9	cturbt	cturbt	NOUN
aiua-6390	78	10	decreased	decrease	VERB
aiua-6390	78	11	the	the	DET
aiua-6390	78	12	recurrence	recurrence	NOUN
aiua-6390	78	13	rate	rate	NOUN
aiua-6390	78	14	compared	compare	VERB
aiua-6390	78	15	to	to	ADP
aiua-6390	78	16	a	a	DET
aiua-6390	78	17	single	single	ADJ
aiua-6390	78	18	cturbt	cturbt	NOUN
aiua-6390	78	19	(	(	PUNCT
aiua-6390	78	20	21	21	NUM
aiua-6390	78	21	)	)	PUNCT
aiua-6390	78	22	.	.	PUNCT
aiua-6390	79	1	in	in	ADP
aiua-6390	79	2	our	our	PRON
aiua-6390	79	3	expeience	expeience	NOUN
aiua-6390	79	4	,	,	PUNCT
aiua-6390	79	5	in	in	ADP
aiua-6390	79	6	the	the	DET
aiua-6390	79	7	persistent	persistent	ADJ
aiua-6390	79	8	group	group	NOUN
aiua-6390	79	9	,	,	PUNCT
aiua-6390	79	10	recurrences	recurrence	NOUN
aiua-6390	79	11	and	and	CCONJ
aiua-6390	79	12	progressions	progression	NOUN
aiua-6390	79	13	were	be	AUX
aiua-6390	79	14	more	more	ADV
aiua-6390	79	15	elevated	elevated	ADJ
aiua-6390	79	16	than	than	ADP
aiua-6390	79	17	in	in	ADP
aiua-6390	79	18	t0	t0	PROPN
aiua-6390	79	19	group	group	NOUN
aiua-6390	79	20	.	.	PUNCT
aiua-6390	80	1	persistent	persistent	ADJ
aiua-6390	80	2	disease	disease	NOUN
aiua-6390	80	3	after	after	ADP
aiua-6390	80	4	wlre	wlre	ADJ
aiua-6390	80	5	-	-	PUNCT
aiua-6390	80	6	cturbt	cturbt	NOUN
aiua-6390	80	7	is	be	AUX
aiua-6390	80	8	a	a	DET
aiua-6390	80	9	poor	poor	ADJ
aiua-6390	80	10	prognostic	prognostic	ADJ
aiua-6390	80	11	indicator	indicator	NOUN
aiua-6390	80	12	of	of	ADP
aiua-6390	80	13	recurrence	recurrence	NOUN
aiua-6390	80	14	and	and	CCONJ
aiua-6390	80	15	progression	progression	NOUN
aiua-6390	80	16	.	.	PUNCT
aiua-6390	81	1	dutta	dutta	NOUN
aiua-6390	81	2	et	et	PROPN
aiua-6390	81	3	al	al	PROPN
aiua-6390	81	4	.	.	PROPN
aiua-6390	82	1	(	(	PUNCT
aiua-6390	82	2	22	22	NUM
aiua-6390	82	3	)	)	PUNCT
aiua-6390	82	4	demonstrated	demonstrate	VERB
aiua-6390	82	5	that	that	SCONJ
aiua-6390	82	6	,	,	PUNCT
aiua-6390	82	7	if	if	SCONJ
aiua-6390	82	8	a	a	DET
aiua-6390	82	9	wlrecturbt	wlrecturbt	NOUN
aiua-6390	82	10	is	be	AUX
aiua-6390	82	11	performed	perform	VERB
aiua-6390	82	12	,	,	PUNCT
aiua-6390	82	13	the	the	DET
aiua-6390	82	14	risk	risk	NOUN
aiua-6390	82	15	of	of	ADP
aiua-6390	82	16	upstaging	upstaging	ADJ
aiua-6390	82	17	is	be	AUX
aiua-6390	82	18	near	near	ADP
aiua-6390	82	19	30	30	NUM
aiua-6390	82	20	%	%	NOUN
aiua-6390	82	21	,	,	PUNCT
aiua-6390	82	22	but	but	CCONJ
aiua-6390	82	23	the	the	DET
aiua-6390	82	24	risk	risk	NOUN
aiua-6390	82	25	of	of	ADP
aiua-6390	82	26	residual	residual	ADJ
aiua-6390	82	27	tumour	tumour	NOUN
aiua-6390	82	28	is	be	AUX
aiua-6390	82	29	still	still	ADV
aiua-6390	82	30	significant	significant	ADJ
aiua-6390	82	31	.	.	PUNCT
aiua-6390	83	1	we	we	PRON
aiua-6390	83	2	already	already	ADV
aiua-6390	83	3	reported	report	VERB
aiua-6390	83	4	our	our	PRON
aiua-6390	83	5	experience	experience	NOUN
aiua-6390	83	6	concerning	concern	VERB
aiua-6390	83	7	the	the	DET
aiua-6390	83	8	need	need	NOUN
aiua-6390	83	9	of	of	ADP
aiua-6390	83	10	wlrecturbt	wlrecturbt	NOUN
aiua-6390	83	11	in	in	ADP
aiua-6390	83	12	patients	patient	NOUN
aiua-6390	83	13	with	with	ADP
aiua-6390	83	14	primary	primary	ADJ
aiua-6390	83	15	pt1	pt1	PROPN
aiua-6390	83	16	tcc	tcc	PROPN
aiua-6390	83	17	of	of	ADP
aiua-6390	83	18	the	the	DET
aiua-6390	83	19	bladder	bladder	NOUN
aiua-6390	83	20	.	.	PUNCT
aiua-6390	84	1	residual	residual	ADJ
aiua-6390	84	2	tumour	tumour	NOUN
aiua-6390	84	3	rate	rate	NOUN
aiua-6390	84	4	was	be	AUX
aiua-6390	84	5	19.5	19.5	NUM
aiua-6390	84	6	%	%	NOUN
aiua-6390	84	7	in	in	ADP
aiua-6390	84	8	18	18	NUM
aiua-6390	84	9	patients	patient	NOUN
aiua-6390	84	10	who	who	PRON
aiua-6390	84	11	underwent	undergo	VERB
aiua-6390	84	12	wlre	wlre	ADJ
aiua-6390	84	13	-	-	PUNCT
aiua-6390	84	14	cturbt	cturbt	NOUN
aiua-6390	84	15	following	follow	VERB
aiua-6390	84	16	primary	primary	ADJ
aiua-6390	84	17	diagnosis	diagnosis	NOUN
aiua-6390	84	18	of	of	ADP
aiua-6390	84	19	t1	t1	NOUN
aiua-6390	84	20	disease	disease	NOUN
aiua-6390	84	21	and	and	CCONJ
aiua-6390	84	22	overall	overall	ADJ
aiua-6390	84	23	recurrence	recurrence	NOUN
aiua-6390	84	24	was	be	AUX
aiua-6390	84	25	39.1	39.1	NUM
aiua-6390	84	26	%	%	NOUN
aiua-6390	84	27	.	.	PUNCT
aiua-6390	85	1	residual	residual	ADJ
aiua-6390	85	2	neoplasms	neoplasm	NOUN
aiua-6390	85	3	were	be	AUX
aiua-6390	85	4	detected	detect	VERB
aiua-6390	85	5	only	only	ADV
aiua-6390	85	6	in	in	ADP
aiua-6390	85	7	multifocal	multifocal	ADJ
aiua-6390	85	8	tumor	tumor	NOUN
aiua-6390	85	9	,	,	PUNCT
aiua-6390	85	10	concomitant	concomitant	ADJ
aiua-6390	85	11	cis	cis	NOUN
aiua-6390	85	12	and	and	CCONJ
aiua-6390	85	13	>	>	X
aiua-6390	85	14	3	3	NUM
aiua-6390	85	15	cm	cm	NOUN
aiua-6390	85	16	at	at	ADP
aiua-6390	85	17	first	first	ADJ
aiua-6390	85	18	pt1hg	pt1hg	NUM
aiua-6390	85	19	bladder	bladder	NOUN
aiua-6390	85	20	tumours	tumour	VERB
aiua-6390	85	21	.	.	PUNCT
aiua-6390	86	1	our	our	PRON
aiua-6390	86	2	opinion	opinion	NOUN
aiua-6390	86	3	is	be	AUX
aiua-6390	86	4	that	that	SCONJ
aiua-6390	86	5	the	the	DET
aiua-6390	86	6	main	main	ADJ
aiua-6390	86	7	and	and	CCONJ
aiua-6390	86	8	most	most	ADV
aiua-6390	86	9	important	important	ADJ
aiua-6390	86	10	rule	rule	NOUN
aiua-6390	86	11	is	be	AUX
aiua-6390	86	12	a	a	DET
aiua-6390	86	13	complete	complete	ADJ
aiua-6390	86	14	resection	resection	NOUN
aiua-6390	86	15	of	of	ADP
aiua-6390	86	16	the	the	DET
aiua-6390	86	17	nmibc	nmibc	NOUN
aiua-6390	86	18	.	.	PUNCT
aiua-6390	87	1	this	this	DET
aiua-6390	87	2	procedure	procedure	NOUN
aiua-6390	87	3	is	be	AUX
aiua-6390	87	4	not	not	PART
aiua-6390	87	5	only	only	ADV
aiua-6390	87	6	mandatory	mandatory	ADJ
aiua-6390	87	7	for	for	ADP
aiua-6390	87	8	an	an	DET
aiua-6390	87	9	adequate	adequate	ADJ
aiua-6390	87	10	staging	staging	NOUN
aiua-6390	87	11	but	but	CCONJ
aiua-6390	87	12	also	also	ADV
aiua-6390	87	13	useful	useful	ADJ
aiua-6390	87	14	to	to	ADP
aiua-6390	87	15	the	the	DET
aiua-6390	87	16	completion	completion	NOUN
aiua-6390	87	17	of	of	ADP
aiua-6390	87	18	wlcturbt	wlcturbt	NOUN
aiua-6390	87	19	for	for	ADP
aiua-6390	87	20	most	most	ADJ
aiua-6390	87	21	of	of	ADP
aiua-6390	87	22	the	the	DET
aiua-6390	87	23	non	non	ADJ
aiua-6390	87	24	muscle	muscle	NOUN
aiua-6390	87	25	invasion	invasion	NOUN
aiua-6390	87	26	tumours	tumour	VERB
aiua-6390	87	27	.	.	PUNCT
aiua-6390	88	1	an	an	DET
aiua-6390	88	2	inadequate	inadequate	ADJ
aiua-6390	88	3	and	and	CCONJ
aiua-6390	88	4	incomplete	incomplete	ADJ
aiua-6390	88	5	resection	resection	NOUN
aiua-6390	88	6	increases	increase	VERB
aiua-6390	88	7	recurrence	recurrence	NOUN
aiua-6390	88	8	rate	rate	NOUN
aiua-6390	88	9	as	as	ADP
aiua-6390	88	10	brausi	brausi	PROPN
aiua-6390	88	11	et	et	PROPN
aiua-6390	88	12	al	al	PROPN
aiua-6390	88	13	.	.	PROPN
aiua-6390	89	1	(	(	PUNCT
aiua-6390	89	2	10	10	NUM
aiua-6390	89	3	)	)	PUNCT
aiua-6390	89	4	already	already	ADV
aiua-6390	89	5	showed	show	VERB
aiua-6390	89	6	:	:	PUNCT
aiua-6390	89	7	in	in	ADP
aiua-6390	89	8	fact	fact	NOUN
aiua-6390	89	9	the	the	DET
aiua-6390	89	10	curative	curative	ADJ
aiua-6390	89	11	effect	effect	NOUN
aiua-6390	89	12	of	of	ADP
aiua-6390	89	13	an	an	DET
aiua-6390	89	14	excellent	excellent	ADJ
aiua-6390	89	15	resection	resection	NOUN
aiua-6390	89	16	is	be	AUX
aiua-6390	89	17	especially	especially	ADV
aiua-6390	89	18	showed	show	VERB
aiua-6390	89	19	in	in	ADP
aiua-6390	89	20	superficial	superficial	ADJ
aiua-6390	89	21	disease	disease	NOUN
aiua-6390	89	22	.	.	PUNCT
aiua-6390	90	1	grimm	grimm	NOUN
aiua-6390	90	2	et	et	PROPN
aiua-6390	90	3	al	al	PROPN
aiua-6390	90	4	.	.	PUNCT
aiua-6390	91	1	(	(	PUNCT
aiua-6390	91	2	23	23	NUM
aiua-6390	91	3	)	)	PUNCT
aiua-6390	91	4	investigated	investigate	VERB
aiua-6390	91	5	the	the	DET
aiua-6390	91	6	role	role	NOUN
aiua-6390	91	7	of	of	ADP
aiua-6390	91	8	wlre	wlre	ADJ
aiua-6390	91	9	-	-	PUNCT
aiua-6390	91	10	cturbt	cturbt	NOUN
aiua-6390	91	11	in	in	ADP
aiua-6390	91	12	an	an	DET
aiua-6390	91	13	heterogeneous	heterogeneous	ADJ
aiua-6390	91	14	group	group	NOUN
aiua-6390	91	15	of	of	ADP
aiua-6390	91	16	patients	patient	NOUN
aiua-6390	91	17	with	with	ADP
aiua-6390	91	18	superficial	superficial	ADJ
aiua-6390	91	19	bladder	bladder	NOUN
aiua-6390	91	20	cancer	cancer	NOUN
aiua-6390	91	21	.	.	PUNCT
aiua-6390	92	1	they	they	PRON
aiua-6390	92	2	found	find	VERB
aiua-6390	92	3	that	that	SCONJ
aiua-6390	92	4	the	the	DET
aiua-6390	92	5	estimated	estimate	VERB
aiua-6390	92	6	risk	risk	NOUN
aiua-6390	92	7	of	of	ADP
aiua-6390	92	8	recurrence	recurrence	NOUN
aiua-6390	92	9	after	after	ADP
aiua-6390	92	10	1	1	NUM
aiua-6390	92	11	,	,	PUNCT
aiua-6390	92	12	2	2	NUM
aiua-6390	92	13	and	and	CCONJ
aiua-6390	92	14	3	3	NUM
aiua-6390	92	15	years	year	NOUN
aiua-6390	92	16	was	be	AUX
aiua-6390	92	17	18	18	NUM
aiua-6390	92	18	%	%	NOUN
aiua-6390	92	19	,	,	PUNCT
aiua-6390	92	20	29	29	NUM
aiua-6390	92	21	%	%	NOUN
aiua-6390	92	22	and	and	CCONJ
aiua-6390	92	23	32	32	NUM
aiua-6390	92	24	%	%	NOUN
aiua-6390	92	25	respectively	respectively	ADV
aiua-6390	92	26	and	and	CCONJ
aiua-6390	92	27	recurrence	recurrence	NOUN
aiua-6390	92	28	was	be	AUX
aiua-6390	92	29	observed	observe	VERB
aiua-6390	92	30	in	in	ADP
aiua-6390	92	31	38	38	NUM
aiua-6390	92	32	%	%	NOUN
aiua-6390	92	33	pts	pt	NOUN
aiua-6390	92	34	treated	treat	VERB
aiua-6390	92	35	with	with	ADP
aiua-6390	92	36	re	re	NOUN
aiua-6390	92	37	-	-	NOUN
aiua-6390	92	38	turbt	turbt	ADJ
aiua-6390	92	39	.	.	PUNCT
aiua-6390	93	1	divrik	divrik	NOUN
aiua-6390	93	2	et	et	PROPN
aiua-6390	93	3	al	al	PROPN
aiua-6390	93	4	.	.	PROPN
aiua-6390	94	1	(	(	PUNCT
aiua-6390	94	2	24	24	NUM
aiua-6390	94	3	)	)	PUNCT
aiua-6390	94	4	found	find	VERB
aiua-6390	94	5	the	the	DET
aiua-6390	94	6	recurrence	recurrence	NOUN
aiua-6390	94	7	rate	rate	NOUN
aiua-6390	94	8	was	be	AUX
aiua-6390	94	9	13.6	13.6	NUM
aiua-6390	94	10	%	%	NOUN
aiua-6390	94	11	,	,	PUNCT
aiua-6390	94	12	22.3	22.3	NUM
aiua-6390	94	13	%	%	NOUN
aiua-6390	94	14	and	and	CCONJ
aiua-6390	94	15	31.2	31.2	NUM
aiua-6390	94	16	%	%	NOUN
aiua-6390	94	17	in	in	ADP
aiua-6390	94	18	the	the	DET
aiua-6390	94	19	first	first	ADJ
aiua-6390	94	20	,	,	PUNCT
aiua-6390	94	21	the	the	DET
aiua-6390	94	22	second	second	ADJ
aiua-6390	94	23	and	and	CCONJ
aiua-6390	94	24	the	the	DET
aiua-6390	94	25	third	third	ADJ
aiua-6390	94	26	year	year	NOUN
aiua-6390	94	27	respectively	respectively	ADV
aiua-6390	94	28	and	and	CCONJ
aiua-6390	94	29	that	that	SCONJ
aiua-6390	94	30	overall	overall	ADJ
aiua-6390	94	31	recurrence	recurrence	NOUN
aiua-6390	94	32	was	be	AUX
aiua-6390	94	33	25.6	25.6	NUM
aiua-6390	94	34	%	%	NOUN
aiua-6390	94	35	.	.	PUNCT
aiua-6390	95	1	klan	klan	PROPN
aiua-6390	95	2	et	et	PROPN
aiua-6390	95	3	al	al	PROPN
aiua-6390	95	4	.	.	PROPN
aiua-6390	96	1	(	(	PUNCT
aiua-6390	96	2	25	25	NUM
aiua-6390	96	3	)	)	PUNCT
aiua-6390	96	4	reported	report	VERB
aiua-6390	96	5	a	a	DET
aiua-6390	96	6	residual	residual	ADJ
aiua-6390	96	7	tumour	tumour	NOUN
aiua-6390	96	8	rate	rate	NOUN
aiua-6390	96	9	of	of	ADP
aiua-6390	96	10	50	50	NUM
aiua-6390	96	11	%	%	NOUN
aiua-6390	96	12	in	in	ADP
aiua-6390	96	13	patients	patient	NOUN
aiua-6390	96	14	with	with	ADP
aiua-6390	96	15	pt1	pt1	PROPN
aiua-6390	96	16	hg	hg	PROPN
aiua-6390	96	17	tumours	tumours	PROPN
aiua-6390	96	18	;	;	PUNCT
aiua-6390	96	19	herr	herr	NOUN
aiua-6390	96	20	(	(	PUNCT
aiua-6390	96	21	26	26	NUM
aiua-6390	96	22	)	)	PUNCT
aiua-6390	96	23	reported	report	VERB
aiua-6390	96	24	a	a	DET
aiua-6390	96	25	rate	rate	NOUN
aiua-6390	96	26	of	of	ADP
aiua-6390	96	27	74	74	NUM
aiua-6390	96	28	%	%	NOUN
aiua-6390	96	29	residual	residual	ADJ
aiua-6390	96	30	tumours	tumour	NOUN
aiua-6390	96	31	in	in	ADP
aiua-6390	96	32	58	58	NUM
aiua-6390	96	33	patients	patient	NOUN
aiua-6390	96	34	with	with	ADP
aiua-6390	96	35	pt1	pt1	PROPN
aiua-6390	96	36	hg	hg	PROPN
aiua-6390	96	37	bladder	bladder	NOUN
aiua-6390	96	38	cancer	cancer	NOUN
aiua-6390	96	39	,	,	PUNCT
aiua-6390	96	40	while	while	SCONJ
aiua-6390	96	41	mersdorf	mersdorf	PROPN
aiua-6390	96	42	et	et	PROPN
aiua-6390	96	43	al	al	PROPN
aiua-6390	96	44	.	.	PROPN
aiua-6390	97	1	(	(	PUNCT
aiua-6390	97	2	27	27	NUM
aiua-6390	97	3	)	)	PUNCT
aiua-6390	97	4	detected	detect	VERB
aiua-6390	97	5	residual	residual	ADJ
aiua-6390	97	6	tumours	tumour	NOUN
aiua-6390	97	7	in	in	ADP
aiua-6390	97	8	58	58	NUM
aiua-6390	97	9	%	%	NOUN
aiua-6390	97	10	(	(	PUNCT
aiua-6390	97	11	26	26	NUM
aiua-6390	97	12	of	of	ADP
aiua-6390	97	13	45	45	NUM
aiua-6390	97	14	patients	patient	NOUN
aiua-6390	97	15	)	)	PUNCT
aiua-6390	97	16	pt1hg	pt1hg	NUM
aiua-6390	97	17	bladder	bladder	NOUN
aiua-6390	97	18	cancer	cancer	NOUN
aiua-6390	97	19	.	.	PUNCT
aiua-6390	98	1	wlre	wlre	ADJ
aiua-6390	98	2	-	-	PUNCT
aiua-6390	98	3	cturbt	cturbt	NOUN
aiua-6390	98	4	certainly	certainly	ADV
aiua-6390	98	5	detected	detect	VERB
aiua-6390	98	6	a	a	DET
aiua-6390	98	7	significant	significant	ADJ
aiua-6390	98	8	percentage	percentage	NOUN
aiua-6390	98	9	of	of	ADP
aiua-6390	98	10	residual	residual	ADJ
aiua-6390	98	11	tumours	tumour	NOUN
aiua-6390	98	12	and	and	CCONJ
aiua-6390	98	13	,	,	PUNCT
aiua-6390	98	14	among	among	ADP
aiua-6390	98	15	them	they	PRON
aiua-6390	98	16	,	,	PUNCT
aiua-6390	98	17	cis	cis	NOUN
aiua-6390	98	18	and	and	CCONJ
aiua-6390	98	19	muscle	muscle	NOUN
aiua-6390	98	20	invasive	invasive	ADJ
aiua-6390	98	21	disease	disease	NOUN
aiua-6390	98	22	rates	rate	NOUN
aiua-6390	98	23	were	be	AUX
aiua-6390	98	24	reported	report	VERB
aiua-6390	98	25	with	with	ADP
aiua-6390	98	26	a	a	DET
aiua-6390	98	27	range	range	NOUN
aiua-6390	98	28	of	of	ADP
aiua-6390	98	29	6	6	NUM
aiua-6390	98	30	%	%	NOUN
aiua-6390	98	31	to	to	PART
aiua-6390	98	32	24	24	NUM
aiua-6390	98	33	%	%	NOUN
aiua-6390	98	34	in	in	ADP
aiua-6390	98	35	different	different	ADJ
aiua-6390	98	36	studies	study	NOUN
aiua-6390	98	37	(	(	PUNCT
aiua-6390	98	38	28	28	NUM
aiua-6390	98	39	,	,	PUNCT
aiua-6390	98	40	29	29	NUM
aiua-6390	98	41	)	)	PUNCT
aiua-6390	98	42	.	.	PUNCT
aiua-6390	99	1	kitamura	kitamura	PROPN
aiua-6390	99	2	and	and	CCONJ
aiua-6390	99	3	kakehi	kakehi	PROPN
aiua-6390	99	4	(	(	PUNCT
aiua-6390	99	5	30	30	NUM
aiua-6390	99	6	)	)	PUNCT
aiua-6390	99	7	suggested	suggest	VERB
aiua-6390	99	8	that	that	SCONJ
aiua-6390	99	9	optimal	optimal	ADJ
aiua-6390	99	10	management	management	NOUN
aiua-6390	99	11	strategies	strategy	NOUN
aiua-6390	99	12	should	should	AUX
aiua-6390	99	13	be	be	AUX
aiua-6390	99	14	based	base	VERB
aiua-6390	99	15	on	on	ADP
aiua-6390	99	16	pathological	pathological	ADJ
aiua-6390	99	17	findfigure	findfigure	NOUN
aiua-6390	99	18	1	1	NUM
aiua-6390	99	19	.	.	PUNCT
aiua-6390	100	1	kaplan	kaplan	PROPN
aiua-6390	100	2	-	-	PUNCT
aiua-6390	100	3	meier	meier	PROPN
aiua-6390	100	4	overall	overall	ADJ
aiua-6390	100	5	recurrence	recurrence	PROPN
aiua-6390	100	6	survival	survival	NOUN
aiua-6390	100	7	analysis	analysis	NOUN
aiua-6390	100	8	.	.	PUNCT
aiua-6390	101	1	figure	figure	NOUN
aiua-6390	101	2	2	2	NUM
aiua-6390	101	3	.	.	PUNCT
aiua-6390	102	1	kaplan	kaplan	PROPN
aiua-6390	102	2	-	-	PUNCT
aiua-6390	102	3	meier	meier	PROPN
aiua-6390	102	4	overall	overall	ADJ
aiua-6390	102	5	progression	progression	NOUN
aiua-6390	102	6	survival	survival	NOUN
aiua-6390	102	7	analysis	analysis	NOUN
aiua-6390	102	8	.	.	PUNCT
aiua-6390	103	1	giulianelli_stesura	giulianelli_stesura	NOUN
aiua-6390	103	2	seveso	seveso	NOUN
aiua-6390	103	3	03/01/18	03/01/18	PROPN
aiua-6390	103	4	11:58	11:58	NUM
aiua-6390	103	5	pagina	pagina	NOUN
aiua-6390	103	6	274	274	NUM
aiua-6390	103	7	275archivio	275archivio	PROPN
aiua-6390	103	8	italiano	italiano	NOUN
aiua-6390	103	9	di	di	NOUN
aiua-6390	103	10	urologia	urologia	PROPN
aiua-6390	103	11	e	e	PROPN
aiua-6390	103	12	andrologia	andrologia	NOUN
aiua-6390	103	13	2017	2017	NUM
aiua-6390	103	14	;	;	PUNCT
aiua-6390	103	15	89	89	NUM
aiua-6390	103	16	,	,	PUNCT
aiua-6390	103	17	4	4	NUM
aiua-6390	103	18	can	can	AUX
aiua-6390	103	19	re	re	VERB
aiua-6390	103	20	-	-	NOUN
aiua-6390	103	21	cturbt	cturbt	NOUN
aiua-6390	103	22	be	be	AUX
aiua-6390	103	23	useful	useful	ADJ
aiua-6390	103	24	in	in	ADP
aiua-6390	103	25	pt1hg	pt1hg	PROPN
aiua-6390	103	26	disease	disease	NOUN
aiua-6390	103	27	as	as	ADP
aiua-6390	103	28	a	a	DET
aiua-6390	103	29	risk	risk	NOUN
aiua-6390	103	30	indicator	indicator	NOUN
aiua-6390	103	31	of	of	ADP
aiua-6390	103	32	recurrence	recurrence	NOUN
aiua-6390	103	33	and	and	CCONJ
aiua-6390	103	34	progression	progression	NOUN
aiua-6390	103	35	?	?	PUNCT
aiua-6390	104	1	a	a	DET
aiua-6390	104	2	single	single	ADJ
aiua-6390	104	3	centre	centre	NOUN
aiua-6390	104	4	experience	experience	NOUN
aiua-6390	104	5	conclusions	conclusion	NOUN
aiua-6390	104	6	wlre	wlre	ADJ
aiua-6390	104	7	-	-	PUNCT
aiua-6390	104	8	cturbt	cturbt	NOUN
aiua-6390	104	9	is	be	AUX
aiua-6390	104	10	a	a	DET
aiua-6390	104	11	useful	useful	ADJ
aiua-6390	104	12	tool	tool	NOUN
aiua-6390	104	13	because	because	SCONJ
aiua-6390	104	14	in	in	ADP
aiua-6390	104	15	a	a	DET
aiua-6390	104	16	percentage	percentage	NOUN
aiua-6390	104	17	of	of	ADP
aiua-6390	104	18	the	the	DET
aiua-6390	104	19	patients	patient	NOUN
aiua-6390	104	20	this	this	DET
aiua-6390	104	21	additional	additional	ADJ
aiua-6390	104	22	surgery	surgery	NOUN
aiua-6390	104	23	results	result	NOUN
aiua-6390	104	24	in	in	ADP
aiua-6390	104	25	an	an	DET
aiua-6390	104	26	improvement	improvement	NOUN
aiua-6390	104	27	of	of	ADP
aiua-6390	104	28	treatment	treatment	NOUN
aiua-6390	104	29	strategy	strategy	NOUN
aiua-6390	104	30	.	.	PUNCT
aiua-6390	105	1	true	true	ADJ
aiua-6390	105	2	recurrence	recurrence	NOUN
aiua-6390	105	3	rate	rate	NOUN
aiua-6390	105	4	can	can	AUX
aiua-6390	105	5	be	be	AUX
aiua-6390	105	6	better	well	ADV
aiua-6390	105	7	evaluated	evaluate	VERB
aiua-6390	105	8	by	by	ADP
aiua-6390	105	9	this	this	DET
aiua-6390	105	10	approach	approach	NOUN
aiua-6390	105	11	because	because	SCONJ
aiua-6390	105	12	residual	residual	ADJ
aiua-6390	105	13	tumors	tumor	NOUN
aiua-6390	105	14	may	may	AUX
aiua-6390	105	15	be	be	AUX
aiua-6390	105	16	erroneously	erroneously	ADV
aiua-6390	105	17	defined	define	VERB
aiua-6390	105	18	as	as	ADP
aiua-6390	105	19	recurrence	recurrence	NOUN
aiua-6390	105	20	.	.	PUNCT
aiua-6390	106	1	our	our	PRON
aiua-6390	106	2	data	datum	NOUN
aiua-6390	106	3	showed	show	VERB
aiua-6390	106	4	that	that	SCONJ
aiua-6390	106	5	it	it	PRON
aiua-6390	106	6	is	be	AUX
aiua-6390	106	7	necessary	necessary	ADJ
aiua-6390	106	8	to	to	PART
aiua-6390	106	9	perform	perform	VERB
aiua-6390	106	10	a	a	DET
aiua-6390	106	11	wlrecturbt	wlrecturbt	NOUN
aiua-6390	106	12	in	in	ADP
aiua-6390	106	13	patients	patient	NOUN
aiua-6390	106	14	with	with	ADP
aiua-6390	106	15	newly	newly	ADV
aiua-6390	106	16	diagnosed	diagnose	VERB
aiua-6390	106	17	,	,	PUNCT
aiua-6390	106	18	high	high	ADJ
aiua-6390	106	19	grade	grade	NOUN
aiua-6390	106	20	(	(	PUNCT
aiua-6390	106	21	hg	hg	NOUN
aiua-6390	106	22	)	)	PUNCT
aiua-6390	106	23	,	,	PUNCT
aiua-6390	106	24	stage	stage	NOUN
aiua-6390	106	25	pt1	pt1	PROPN
aiua-6390	106	26	bladder	bladder	NOUN
aiua-6390	106	27	cancer	cancer	NOUN
aiua-6390	106	28	for	for	ADP
aiua-6390	106	29	a	a	DET
aiua-6390	106	30	‘	'	PUNCT
aiua-6390	106	31	real	real	ADJ
aiua-6390	106	32	’	'	PUNCT
aiua-6390	106	33	staging	staging	NOUN
aiua-6390	106	34	and	and	CCONJ
aiua-6390	106	35	a	a	DET
aiua-6390	106	36	complete	complete	ADJ
aiua-6390	106	37	resection	resection	NOUN
aiua-6390	106	38	(	(	PUNCT
aiua-6390	106	39	15	15	NUM
aiua-6390	106	40	%	%	NOUN
aiua-6390	106	41	persistent	persistent	ADJ
aiua-6390	106	42	disease	disease	NOUN
aiua-6390	106	43	)	)	PUNCT
aiua-6390	106	44	.	.	PUNCT
aiua-6390	107	1	in	in	ADP
aiua-6390	107	2	our	our	PRON
aiua-6390	107	3	experience	experience	NOUN
aiua-6390	107	4	,	,	PUNCT
aiua-6390	107	5	following	follow	VERB
aiua-6390	107	6	wlre	wlre	ADJ
aiua-6390	107	7	-	-	PUNCT
aiua-6390	107	8	cturbt	cturbt	NOUN
aiua-6390	107	9	in	in	ADP
aiua-6390	107	10	hgnmibc	hgnmibc	PROPN
aiua-6390	107	11	risk	risk	NOUN
aiua-6390	107	12	group	group	NOUN
aiua-6390	107	13	patients	patient	NOUN
aiua-6390	107	14	we	we	PRON
aiua-6390	107	15	dentified	dentifie	VERB
aiua-6390	107	16	a	a	DET
aiua-6390	107	17	15	15	NUM
aiua-6390	107	18	%	%	NOUN
aiua-6390	107	19	persistent	persistent	ADJ
aiua-6390	107	20	disease	disease	NOUN
aiua-6390	107	21	with	with	ADP
aiua-6390	107	22	a	a	DET
aiua-6390	107	23	4.3	4.3	NUM
aiua-6390	107	24	%	%	NOUN
aiua-6390	107	25	of	of	ADP
aiua-6390	107	26	mibc	mibc	PROPN
aiua-6390	107	27	.	.	PUNCT
aiua-6390	108	1	in	in	ADP
aiua-6390	108	2	the	the	DET
aiua-6390	108	3	patients	patient	NOUN
aiua-6390	108	4	with	with	ADP
aiua-6390	108	5	persistent	persistent	ADJ
aiua-6390	108	6	bladder	bladder	NOUN
aiua-6390	108	7	neoplasms	neoplasm	NOUN
aiua-6390	108	8	we	we	PRON
aiua-6390	108	9	observed	observe	VERB
aiua-6390	108	10	a	a	DET
aiua-6390	108	11	overall	overall	ADJ
aiua-6390	108	12	recurrence	recurrence	NOUN
aiua-6390	108	13	and	and	CCONJ
aiua-6390	108	14	progression	progression	NOUN
aiua-6390	108	15	rate	rate	NOUN
aiua-6390	108	16	more	more	ADV
aiua-6390	108	17	elevated	elevated	ADJ
aiua-6390	108	18	than	than	ADP
aiua-6390	108	19	in	in	ADP
aiua-6390	108	20	t0	t0	PROPN
aiua-6390	108	21	bladder	bladder	NOUN
aiua-6390	108	22	tumours	tumours	PROPN
aiua-6390	108	23	group	group	NOUN
aiua-6390	108	24	(	(	PUNCT
aiua-6390	108	25	∆	∆	PROPN
aiua-6390	108	26	=	=	PUNCT
aiua-6390	109	1	+	+	CCONJ
aiua-6390	109	2	17.3	17.3	NUM
aiua-6390	109	3	%	%	NOUN
aiua-6390	109	4	and	and	CCONJ
aiua-6390	109	5	∆	∆	PROPN
aiua-6390	109	6	=	=	NOUN
aiua-6390	110	1	+	+	CCONJ
aiua-6390	110	2	62.5	62.5	NUM
aiua-6390	110	3	%	%	NOUN
aiua-6390	110	4	)	)	PUNCT
aiua-6390	110	5	.	.	PUNCT
aiua-6390	111	1	references	reference	NOUN
aiua-6390	111	2	1	1	NUM
aiua-6390	111	3	.	.	PUNCT
aiua-6390	111	4	andius	andius	PROPN
aiua-6390	111	5	p	p	PROPN
aiua-6390	111	6	,	,	PUNCT
aiua-6390	111	7	holmang	holmang	PROPN
aiua-6390	111	8	s.	s.	PROPN
aiua-6390	111	9	bacillus	bacillus	PROPN
aiua-6390	111	10	calmette	calmette	PROPN
aiua-6390	111	11	-	-	PUNCT
aiua-6390	111	12	guerin	guerin	PROPN
aiua-6390	111	13	therapy	therapy	NOUN
aiua-6390	111	14	in	in	ADP
aiua-6390	111	15	stage	stage	NOUN
aiua-6390	111	16	ta	ta	PROPN
aiua-6390	111	17	-	-	PUNCT
aiua-6390	111	18	t1	t1	NOUN
aiua-6390	111	19	bladder	bladder	NOUN
aiua-6390	111	20	cancer	cancer	NOUN
aiua-6390	111	21	:	:	PUNCT
aiua-6390	111	22	prognostic	prognostic	ADJ
aiua-6390	111	23	factors	factor	NOUN
aiua-6390	111	24	for	for	ADP
aiua-6390	111	25	time	time	NOUN
aiua-6390	111	26	to	to	PART
aiua-6390	111	27	recurrence	recurrence	VERB
aiua-6390	111	28	and	and	CCONJ
aiua-6390	111	29	progression	progression	NOUN
aiua-6390	111	30	.	.	PUNCT
aiua-6390	112	1	bju	bju	NOUN
aiua-6390	112	2	int	int	PROPN
aiua-6390	112	3	.	.	PUNCT
aiua-6390	113	1	2004	2004	NUM
aiua-6390	113	2	;	;	PUNCT
aiua-6390	113	3	93:980	93:980	NUM
aiua-6390	113	4	2	2	X
aiua-6390	113	5	.	.	PUNCT
aiua-6390	113	6	herr	herr	PROPN
aiua-6390	113	7	hw	hw	PROPN
aiua-6390	113	8	,	,	PUNCT
aiua-6390	113	9	klein	klein	PROPN
aiua-6390	113	10	ea	ea	PROPN
aiua-6390	113	11	,	,	PUNCT
aiua-6390	113	12	rogatko	rogatko	PROPN
aiua-6390	113	13	a.	a.	PROPN
aiua-6390	113	14	local	local	PROPN
aiua-6390	113	15	bcg	bcg	PROPN
aiua-6390	113	16	failures	failure	NOUN
aiua-6390	113	17	in	in	ADP
aiua-6390	113	18	superficial	superficial	ADJ
aiua-6390	113	19	bladder	bladder	NOUN
aiua-6390	113	20	cancer	cancer	NOUN
aiua-6390	113	21	.	.	PUNCT
aiua-6390	114	1	a	a	DET
aiua-6390	114	2	multivariate	multivariate	NOUN
aiua-6390	114	3	analysis	analysis	NOUN
aiua-6390	114	4	of	of	ADP
aiua-6390	114	5	risk	risk	NOUN
aiua-6390	114	6	factors	factor	NOUN
aiua-6390	114	7	influencing	influence	VERB
aiua-6390	114	8	survival	survival	NOUN
aiua-6390	114	9	.	.	PUNCT
aiua-6390	115	1	eur	eur	PROPN
aiua-6390	115	2	urol	urol	PROPN
aiua-6390	115	3	.	.	PUNCT
aiua-6390	115	4	1991	1991	NUM
aiua-6390	115	5	;	;	PUNCT
aiua-6390	115	6	19:97	19:97	NUM
aiua-6390	115	7	3	3	NUM
aiua-6390	115	8	.	.	PUNCT
aiua-6390	115	9	sylvester	sylvester	PROPN
aiua-6390	115	10	rj	rj	PROPN
aiua-6390	115	11	,	,	PUNCT
aiua-6390	115	12	van	van	PROPN
aiua-6390	115	13	der	der	PROPN
aiua-6390	115	14	meijden	meijden	PROPN
aiua-6390	115	15	ap	ap	PROPN
aiua-6390	115	16	,	,	PUNCT
aiua-6390	115	17	oosterlinck	oosterlinck	NOUN
aiua-6390	115	18	w	w	PROPN
aiua-6390	115	19	,	,	PUNCT
aiua-6390	115	20	et	et	PROPN
aiua-6390	115	21	al	al	PROPN
aiua-6390	115	22	.	.	PROPN
aiua-6390	115	23	predicting	predict	VERB
aiua-6390	115	24	recurrence	recurrence	NOUN
aiua-6390	115	25	and	and	CCONJ
aiua-6390	115	26	progression	progression	NOUN
aiua-6390	115	27	in	in	ADP
aiua-6390	115	28	individual	individual	ADJ
aiua-6390	115	29	patients	patient	NOUN
aiua-6390	115	30	with	with	ADP
aiua-6390	115	31	stage	stage	NOUN
aiua-6390	115	32	ta	ta	PROPN
aiua-6390	115	33	-	-	PUNCT
aiua-6390	115	34	t1	t1	NOUN
aiua-6390	115	35	bladder	bladder	NOUN
aiua-6390	115	36	cancer	cancer	NOUN
aiua-6390	115	37	using	use	VERB
aiua-6390	115	38	eortc	eortc	VERB
aiua-6390	115	39	risk	risk	NOUN
aiua-6390	115	40	table	table	NOUN
aiua-6390	115	41	:	:	PUNCT
aiua-6390	115	42	a	a	DET
aiua-6390	115	43	combined	combined	ADJ
aiua-6390	115	44	analysis	analysis	NOUN
aiua-6390	115	45	of	of	ADP
aiua-6390	115	46	2596	2596	NUM
aiua-6390	115	47	patients	patient	NOUN
aiua-6390	115	48	from	from	ADP
aiua-6390	115	49	seven	seven	NUM
aiua-6390	115	50	eortc	eortc	ADJ
aiua-6390	115	51	trials	trial	NOUN
aiua-6390	115	52	.	.	PUNCT
aiua-6390	116	1	eur	eur	PROPN
aiua-6390	116	2	urol	urol	PROPN
aiua-6390	116	3	.	.	PUNCT
aiua-6390	117	1	2006	2006	NUM
aiua-6390	117	2	;	;	PUNCT
aiua-6390	117	3	49:466	49:466	NUM
aiua-6390	117	4	.	.	NOUN
aiua-6390	118	1	4	4	NUM
aiua-6390	118	2	.	.	X
aiua-6390	118	3	segal	segal	PROPN
aiua-6390	118	4	r	r	PROPN
aiua-6390	118	5	,	,	PUNCT
aiua-6390	118	6	yafi	yafi	PROPN
aiua-6390	118	7	fa	fa	PROPN
aiua-6390	118	8	,	,	PUNCT
aiua-6390	118	9	brimo	brimo	PROPN
aiua-6390	118	10	f	f	PROPN
aiua-6390	118	11	,	,	PUNCT
aiua-6390	118	12	et	et	PROPN
aiua-6390	118	13	al	al	PROPN
aiua-6390	118	14	.	.	PUNCT
aiua-6390	118	15	prognostic	prognostic	ADJ
aiua-6390	118	16	factors	factor	NOUN
aiua-6390	118	17	and	and	CCONJ
aiua-6390	118	18	outcome	outcome	VERB
aiua-6390	118	19	in	in	ADP
aiua-6390	118	20	patients	patient	NOUN
aiua-6390	118	21	with	with	ADP
aiua-6390	118	22	t1	t1	PROPN
aiua-6390	118	23	high	high	ADJ
aiua-6390	118	24	-	-	PUNCT
aiua-6390	118	25	grade	grade	NOUN
aiua-6390	118	26	bladder	bladder	NOUN
aiua-6390	118	27	cancer	cancer	NOUN
aiua-6390	118	28	:	:	PUNCT
aiua-6390	118	29	can	can	AUX
aiua-6390	118	30	we	we	PRON
aiua-6390	118	31	identify	identify	VERB
aiua-6390	118	32	patients	patient	NOUN
aiua-6390	118	33	for	for	ADP
aiua-6390	118	34	early	early	ADJ
aiua-6390	118	35	cystectomy	cystectomy	NOUN
aiua-6390	118	36	?	?	PUNCT
aiua-6390	119	1	bju	bju	NOUN
aiua-6390	119	2	int	int	PROPN
aiua-6390	119	3	.	.	PUNCT
aiua-6390	120	1	2012	2012	NUM
aiua-6390	120	2	;	;	PUNCT
aiua-6390	120	3	109:1026	109:1026	NUM
aiua-6390	120	4	-	-	SYM
aiua-6390	120	5	30	30	NUM
aiua-6390	120	6	.	.	PUNCT
aiua-6390	121	1	5	5	NUM
aiua-6390	121	2	.	.	X
aiua-6390	121	3	kim	kim	PROPN
aiua-6390	121	4	hs	hs	PROPN
aiua-6390	121	5	,	,	PUNCT
aiua-6390	121	6	ku	ku	PROPN
aiua-6390	121	7	jh	jh	PROPN
aiua-6390	121	8	,	,	PUNCT
aiua-6390	121	9	kim	kim	PROPN
aiua-6390	121	10	sj	sj	PROPN
aiua-6390	121	11	,	,	PUNCT
aiua-6390	121	12	et	et	PROPN
aiua-6390	121	13	al	al	PROPN
aiua-6390	121	14	.	.	PUNCT
aiua-6390	122	1	prognostic	prognostic	ADJ
aiua-6390	122	2	factors	factor	NOUN
aiua-6390	122	3	for	for	ADP
aiua-6390	122	4	recurrence	recurrence	NOUN
aiua-6390	122	5	and	and	CCONJ
aiua-6390	122	6	progression	progression	NOUN
aiua-6390	122	7	in	in	ADP
aiua-6390	122	8	korean	korean	ADJ
aiua-6390	122	9	non	non	ADJ
aiua-6390	122	10	-	-	ADJ
aiua-6390	122	11	muscle	muscle	ADJ
aiua-6390	122	12	-	-	PUNCT
aiua-6390	122	13	invasive	invasive	ADJ
aiua-6390	122	14	bladder	bladder	NOUN
aiua-6390	122	15	cancer	cancer	NOUN
aiua-6390	122	16	patients	patient	NOUN
aiua-6390	122	17	:	:	PUNCT
aiua-6390	122	18	a	a	DET
aiua-6390	122	19	retrospective	retrospective	ADJ
aiua-6390	122	20	,	,	PUNCT
aiua-6390	122	21	multi	multi	ADJ
aiua-6390	122	22	-	-	ADJ
aiua-6390	122	23	institutional	institutional	ADJ
aiua-6390	122	24	study	study	NOUN
aiua-6390	122	25	.	.	PUNCT
aiua-6390	123	1	yonsei	yonsei	PROPN
aiua-6390	123	2	med	med	PROPN
aiua-6390	123	3	j.	j.	PROPN
aiua-6390	123	4	2016	2016	NUM
aiua-6390	123	5	;	;	PUNCT
aiua-6390	123	6	57:855	57:855	NUM
aiua-6390	123	7	-	-	SYM
aiua-6390	123	8	64	64	NUM
aiua-6390	123	9	.	.	PUNCT
aiua-6390	124	1	6	6	NUM
aiua-6390	124	2	.	.	X
aiua-6390	124	3	nepple	nepple	PROPN
aiua-6390	124	4	kg	kg	PROPN
aiua-6390	124	5	,	,	PUNCT
aiua-6390	124	6	o’donnell	o’donnell	PROPN
aiua-6390	124	7	ma	ma	PROPN
aiua-6390	124	8	.	.	PUNCT
aiua-6390	125	1	the	the	DET
aiua-6390	125	2	optimal	optimal	ADJ
aiua-6390	125	3	management	management	NOUN
aiua-6390	125	4	of	of	ADP
aiua-6390	125	5	t1	t1	NOUN
aiua-6390	125	6	highgrade	highgrade	NOUN
aiua-6390	125	7	bladder	bladder	NOUN
aiua-6390	125	8	cancer	cancer	NOUN
aiua-6390	125	9	.	.	PUNCT
aiua-6390	126	1	can	can	AUX
aiua-6390	126	2	urol	urol	VERB
aiua-6390	126	3	assoc	assoc	PROPN
aiua-6390	126	4	j.	j.	PROPN
aiua-6390	126	5	2009	2009	NUM
aiua-6390	126	6	;	;	PUNCT
aiua-6390	126	7	3(6	3(6	NUM
aiua-6390	126	8	suppl	suppl	ADJ
aiua-6390	126	9	4):s188s192	4):s188s192	NUM
aiua-6390	126	10	.	.	PROPN
aiua-6390	127	1	7	7	NUM
aiua-6390	127	2	.	.	X
aiua-6390	127	3	brake	brake	PROPN
aiua-6390	127	4	m	m	PROPN
aiua-6390	127	5	,	,	PUNCT
aiua-6390	127	6	loertzer	loertzer	PROPN
aiua-6390	127	7	h	h	NOUN
aiua-6390	127	8	,	,	PUNCT
aiua-6390	127	9	horsch	horsch	ADJ
aiua-6390	127	10	r	r	NOUN
aiua-6390	127	11	,	,	PUNCT
aiua-6390	127	12	keller	keller	PROPN
aiua-6390	127	13	h.	h.	PROPN
aiua-6390	127	14	recurrence	recurrence	PROPN
aiua-6390	127	15	and	and	CCONJ
aiua-6390	127	16	progression	progression	NOUN
aiua-6390	127	17	of	of	ADP
aiua-6390	127	18	stage	stage	NOUN
aiua-6390	127	19	t1	t1	NOUN
aiua-6390	127	20	,	,	PUNCT
aiua-6390	127	21	grade	grade	NOUN
aiua-6390	127	22	3	3	NUM
aiua-6390	127	23	transitional	transitional	ADJ
aiua-6390	127	24	cell	cell	NOUN
aiua-6390	127	25	carcinoma	carcinoma	NOUN
aiua-6390	127	26	of	of	ADP
aiua-6390	127	27	the	the	DET
aiua-6390	127	28	bladder	bladder	NOUN
aiua-6390	127	29	following	follow	VERB
aiua-6390	127	30	intravesical	intravesical	ADJ
aiua-6390	127	31	immunotherapy	immunotherapy	NOUN
aiua-6390	127	32	with	with	ADP
aiua-6390	127	33	bacillus	bacillus	NOUN
aiua-6390	127	34	calmetteguerin	calmetteguerin	NOUN
aiua-6390	127	35	.	.	PUNCT
aiua-6390	128	1	j	j	PROPN
aiua-6390	128	2	urol	urol	PROPN
aiua-6390	128	3	.	.	PROPN
aiua-6390	128	4	2000	2000	NUM
aiua-6390	128	5	;	;	PUNCT
aiua-6390	128	6	163:40	163:40	NUM
aiua-6390	128	7	.	.	NOUN
aiua-6390	128	8	8	8	NUM
aiua-6390	128	9	.	.	PUNCT
aiua-6390	129	1	bianco	bianco	PROPN
aiua-6390	129	2	fj	fj	PROPN
aiua-6390	129	3	jr	jr	PROPN
aiua-6390	129	4	,	,	PUNCT
aiua-6390	129	5	justa	justa	PROPN
aiua-6390	129	6	d	d	PROPN
aiua-6390	129	7	,	,	PUNCT
aiua-6390	129	8	grignon	grignon	PROPN
aiua-6390	129	9	dj	dj	PROPN
aiua-6390	129	10	,	,	PUNCT
aiua-6390	129	11	et	et	PROPN
aiua-6390	129	12	al	al	PROPN
aiua-6390	129	13	.	.	PUNCT
aiua-6390	129	14	management	management	NOUN
aiua-6390	129	15	of	of	ADP
aiua-6390	129	16	clinical	clinical	ADJ
aiua-6390	129	17	t1	t1	NOUN
aiua-6390	129	18	bladder	bladder	NOUN
aiua-6390	129	19	transitional	transitional	ADJ
aiua-6390	129	20	cell	cell	NOUN
aiua-6390	129	21	carcinoma	carcinoma	NOUN
aiua-6390	129	22	by	by	ADP
aiua-6390	129	23	radical	radical	ADJ
aiua-6390	129	24	cystectomy	cystectomy	NOUN
aiua-6390	129	25	.	.	PUNCT
aiua-6390	130	1	urol	urol	PROPN
aiua-6390	130	2	oncol	oncol	PROPN
aiua-6390	130	3	.	.	PUNCT
aiua-6390	131	1	2004	2004	NUM
aiua-6390	131	2	;	;	PUNCT
aiua-6390	131	3	22;290	22;290	NUM
aiua-6390	131	4	.	.	NOUN
aiua-6390	131	5	9	9	X
aiua-6390	131	6	.	.	X
aiua-6390	131	7	smaldone	smaldone	PROPN
aiua-6390	131	8	mc	mc	PROPN
aiua-6390	131	9	,	,	PUNCT
aiua-6390	131	10	jacobs	jacobs	PROPN
aiua-6390	131	11	bl	bl	PROPN
aiua-6390	131	12	,	,	PUNCT
aiua-6390	131	13	smaldone	smaldone	NOUN
aiua-6390	131	14	am	be	AUX
aiua-6390	131	15	,	,	PUNCT
aiua-6390	131	16	hrebinko	hrebinko	PROPN
aiua-6390	131	17	rl	rl	X
aiua-6390	131	18	.	.	PUNCT
aiua-6390	131	19	longterm	longterm	PROPN
aiua-6390	131	20	results	result	NOUN
aiua-6390	131	21	of	of	ADP
aiua-6390	131	22	selective	selective	ADJ
aiua-6390	131	23	partial	partial	ADJ
aiua-6390	131	24	cystectomy	cystectomy	NOUN
aiua-6390	131	25	for	for	ADP
aiua-6390	131	26	invasive	invasive	ADJ
aiua-6390	131	27	urothelial	urothelial	ADJ
aiua-6390	131	28	bladder	bladder	NOUN
aiua-6390	131	29	carcinoma	carcinoma	NOUN
aiua-6390	131	30	.	.	PUNCT
aiua-6390	132	1	urology	urology	NOUN
aiua-6390	132	2	.	.	PUNCT
aiua-6390	132	3	2008	2008	NUM
aiua-6390	132	4	;	;	PUNCT
aiua-6390	132	5	72:613	72:613	NUM
aiua-6390	132	6	-	-	SYM
aiua-6390	132	7	6	6	NUM
aiua-6390	132	8	.	.	NOUN
aiua-6390	132	9	10	10	NUM
aiua-6390	132	10	.	.	PUNCT
aiua-6390	133	1	brausi	brausi	PROPN
aiua-6390	133	2	m	m	PROPN
aiua-6390	133	3	,	,	PUNCT
aiua-6390	133	4	collette	collette	PROPN
aiua-6390	133	5	l	l	PROPN
aiua-6390	133	6	,	,	PUNCT
aiua-6390	133	7	kurth	kurth	PROPN
aiua-6390	133	8	k	k	PROPN
aiua-6390	133	9	,	,	PUNCT
aiua-6390	133	10	et	et	PROPN
aiua-6390	133	11	al	al	PROPN
aiua-6390	133	12	.	.	PUNCT
aiua-6390	133	13	variability	variability	NOUN
aiua-6390	133	14	in	in	ADP
aiua-6390	133	15	the	the	DET
aiua-6390	133	16	recurrence	recurrence	NOUN
aiua-6390	133	17	rate	rate	NOUN
aiua-6390	133	18	at	at	ADP
aiua-6390	133	19	first	first	ADJ
aiua-6390	133	20	follow	follow	VERB
aiua-6390	133	21	-	-	PUNCT
aiua-6390	133	22	up	up	ADP
aiua-6390	133	23	cystoscopy	cystoscopy	NOUN
aiua-6390	133	24	after	after	ADP
aiua-6390	133	25	tur	tur	X
aiua-6390	133	26	in	in	ADP
aiua-6390	133	27	stage	stage	NOUN
aiua-6390	133	28	ta	ta	PROPN
aiua-6390	133	29	-	-	PUNCT
aiua-6390	133	30	t1	t1	NOUN
aiua-6390	133	31	transitional	transitional	ADJ
aiua-6390	133	32	cell	cell	NOUN
aiua-6390	133	33	carcinoma	carcinoma	NOUN
aiua-6390	133	34	of	of	ADP
aiua-6390	133	35	the	the	DET
aiua-6390	133	36	bladder	bladder	NOUN
aiua-6390	133	37	:	:	PUNCT
aiua-6390	133	38	a	a	DET
aiua-6390	133	39	combined	combined	ADJ
aiua-6390	133	40	analysis	analysis	NOUN
aiua-6390	133	41	of	of	ADP
aiua-6390	133	42	seven	seven	NUM
aiua-6390	133	43	eortc	eortc	ADJ
aiua-6390	133	44	studies	study	NOUN
aiua-6390	133	45	.	.	PUNCT
aiua-6390	134	1	eur	eur	PROPN
aiua-6390	134	2	urol	urol	PROPN
aiua-6390	134	3	.	.	PUNCT
aiua-6390	135	1	2002	2002	NUM
aiua-6390	135	2	;	;	PUNCT
aiua-6390	135	3	41:543	41:543	NUM
aiua-6390	135	4	.	.	NOUN
aiua-6390	136	1	11	11	NUM
aiua-6390	136	2	.	.	X
aiua-6390	137	1	babjuk	babjuk	PROPN
aiua-6390	137	2	m	m	PROPN
aiua-6390	137	3	,	,	PUNCT
aiua-6390	137	4	oosterlinck	oosterlinck	PROPN
aiua-6390	137	5	w	w	PROPN
aiua-6390	137	6	,	,	PUNCT
aiua-6390	137	7	sylvester	sylvester	ADJ
aiua-6390	137	8	r	r	NOUN
aiua-6390	137	9	,	,	PUNCT
aiua-6390	137	10	european	european	ADJ
aiua-6390	137	11	association	association	PROPN
aiua-6390	137	12	of	of	ADP
aiua-6390	137	13	urology	urology	NOUN
aiua-6390	137	14	(	(	PUNCT
aiua-6390	137	15	eau	eau	PROPN
aiua-6390	137	16	)	)	PUNCT
aiua-6390	137	17	,	,	PUNCT
aiua-6390	137	18	et	et	PROPN
aiua-6390	137	19	al	al	PROPN
aiua-6390	137	20	.	.	PUNCT
aiua-6390	138	1	eau	eau	PROPN
aiua-6390	138	2	guidelines	guideline	NOUN
aiua-6390	138	3	on	on	ADP
aiua-6390	138	4	non	non	ADJ
aiua-6390	138	5	-	-	ADJ
aiua-6390	138	6	muscle	muscle	ADJ
aiua-6390	138	7	-	-	PUNCT
aiua-6390	138	8	invasive	invasive	ADJ
aiua-6390	138	9	urothelial	urothelial	ADJ
aiua-6390	138	10	carcinoma	carcinoma	NOUN
aiua-6390	138	11	of	of	ADP
aiua-6390	138	12	the	the	DET
aiua-6390	138	13	bladder	bladder	NOUN
aiua-6390	138	14	,	,	PUNCT
aiua-6390	138	15	the	the	DET
aiua-6390	138	16	2011	2011	NUM
aiua-6390	138	17	update	update	NOUN
aiua-6390	138	18	.	.	PUNCT
aiua-6390	139	1	eur	eur	PROPN
aiua-6390	139	2	urol	urol	PROPN
aiua-6390	139	3	.	.	PUNCT
aiua-6390	140	1	2011	2011	NUM
aiua-6390	140	2	;	;	PUNCT
aiua-6390	140	3	59:997	59:997	NUM
aiua-6390	140	4	-	-	SYM
aiua-6390	140	5	1008	1008	NUM
aiua-6390	140	6	.	.	PUNCT
aiua-6390	141	1	12	12	NUM
aiua-6390	141	2	.	.	PUNCT
aiua-6390	142	1	lamm	lamm	PROPN
aiua-6390	142	2	dl	dl	PROPN
aiua-6390	142	3	,	,	PUNCT
aiua-6390	142	4	blumenstein	blumenstein	PROPN
aiua-6390	142	5	ba	ba	PROPN
aiua-6390	142	6	,	,	PUNCT
aiua-6390	142	7	crissman	crissman	NOUN
aiua-6390	142	8	jd	jd	PROPN
aiua-6390	142	9	,	,	PUNCT
aiua-6390	142	10	et	et	PROPN
aiua-6390	142	11	al	al	PROPN
aiua-6390	142	12	.	.	PUNCT
aiua-6390	142	13	maintenance	maintenance	NOUN
aiua-6390	142	14	bacillus	bacillus	NOUN
aiua-6390	142	15	calmette	calmette	NOUN
aiua-6390	142	16	-	-	PUNCT
aiua-6390	142	17	guérin	guérin	PROPN
aiua-6390	142	18	immunotherapy	immunotherapy	NOUN
aiua-6390	142	19	for	for	ADP
aiua-6390	142	20	recurrent	recurrent	NOUN
aiua-6390	142	21	ta	ta	PROPN
aiua-6390	142	22	,	,	PUNCT
aiua-6390	142	23	t1	t1	NOUN
aiua-6390	142	24	and	and	CCONJ
aiua-6390	142	25	carcinoma	carcinoma	NOUN
aiua-6390	142	26	in	in	ADP
aiua-6390	142	27	situ	situ	ADJ
aiua-6390	142	28	transitional	transitional	ADJ
aiua-6390	142	29	cell	cell	NOUN
aiua-6390	142	30	carcinoma	carcinoma	NOUN
aiua-6390	142	31	of	of	ADP
aiua-6390	142	32	the	the	DET
aiua-6390	142	33	bladder	bladder	NOUN
aiua-6390	142	34	:	:	PUNCT
aiua-6390	142	35	a	a	DET
aiua-6390	142	36	ranings	raning	NOUN
aiua-6390	142	37	from	from	ADP
aiua-6390	142	38	second	second	ADJ
aiua-6390	142	39	cturbt	cturbt	NOUN
aiua-6390	142	40	specimens	specimen	NOUN
aiua-6390	142	41	in	in	ADP
aiua-6390	142	42	patients	patient	NOUN
aiua-6390	142	43	with	with	ADP
aiua-6390	142	44	t1	t1	PROPN
aiua-6390	142	45	disease	disease	NOUN
aiua-6390	142	46	.	.	PUNCT
aiua-6390	143	1	they	they	PRON
aiua-6390	143	2	recommended	recommend	VERB
aiua-6390	143	3	that	that	SCONJ
aiua-6390	143	4	patients	patient	NOUN
aiua-6390	143	5	with	with	ADP
aiua-6390	143	6	t0	t0	PROPN
aiua-6390	143	7	upon	upon	SCONJ
aiua-6390	143	8	wlre	wlre	ADJ
aiua-6390	143	9	-	-	PUNCT
aiua-6390	143	10	cturbt	cturbt	NOUN
aiua-6390	143	11	should	should	AUX
aiua-6390	143	12	be	be	AUX
aiua-6390	143	13	considered	consider	VERB
aiua-6390	143	14	for	for	ADP
aiua-6390	143	15	bcg	bcg	NOUN
aiua-6390	143	16	therapy	therapy	NOUN
aiua-6390	143	17	or	or	CCONJ
aiua-6390	143	18	watchful	watchful	ADJ
aiua-6390	143	19	waiting	waiting	NOUN
aiua-6390	143	20	.	.	PUNCT
aiua-6390	144	1	a	a	DET
aiua-6390	144	2	randomized	randomized	ADJ
aiua-6390	144	3	controlled	control	VERB
aiua-6390	144	4	study	study	NOUN
aiua-6390	144	5	is	be	AUX
aiua-6390	144	6	ongoing	ongoing	ADJ
aiua-6390	144	7	comparing	compare	VERB
aiua-6390	144	8	watchful	watchful	ADJ
aiua-6390	144	9	waiting	wait	VERB
aiua-6390	144	10	to	to	ADP
aiua-6390	144	11	bcg	bcg	PROPN
aiua-6390	144	12	therapy	therapy	NOUN
aiua-6390	144	13	in	in	ADP
aiua-6390	144	14	high	high	ADJ
aiua-6390	144	15	-	-	PUNCT
aiua-6390	144	16	grade	grade	NOUN
aiua-6390	144	17	t1	t1	NOUN
aiua-6390	144	18	disease	disease	NOUN
aiua-6390	144	19	with	with	ADP
aiua-6390	144	20	t0	t0	PROPN
aiua-6390	144	21	on	on	ADP
aiua-6390	144	22	wlre	wlre	ADJ
aiua-6390	144	23	-	-	PUNCT
aiua-6390	144	24	cturbt	cturbt	NOUN
aiua-6390	144	25	.	.	PUNCT
aiua-6390	145	1	bcg	bcg	PROPN
aiua-6390	145	2	instillation	instillation	NOUN
aiua-6390	145	3	into	into	ADP
aiua-6390	145	4	bladder	bladder	NOUN
aiua-6390	145	5	is	be	AUX
aiua-6390	145	6	the	the	DET
aiua-6390	145	7	gold	gold	ADJ
aiua-6390	145	8	standard	standard	NOUN
aiua-6390	145	9	for	for	ADP
aiua-6390	145	10	conservative	conservative	ADJ
aiua-6390	145	11	treatment	treatment	NOUN
aiua-6390	145	12	for	for	ADP
aiua-6390	145	13	high	high	ADJ
aiua-6390	145	14	-	-	PUNCT
aiua-6390	145	15	grade	grade	NOUN
aiua-6390	145	16	t1	t1	NOUN
aiua-6390	145	17	disease	disease	NOUN
aiua-6390	145	18	.	.	PUNCT
aiua-6390	146	1	the	the	DET
aiua-6390	146	2	therapeutic	therapeutic	ADJ
aiua-6390	146	3	effect	effect	NOUN
aiua-6390	146	4	of	of	ADP
aiua-6390	146	5	bcg	bcg	PROPN
aiua-6390	146	6	in	in	ADP
aiua-6390	146	7	high	high	ADJ
aiua-6390	146	8	-	-	PUNCT
aiua-6390	146	9	grade	grade	NOUN
aiua-6390	146	10	t1	t1	NOUN
aiua-6390	146	11	has	have	AUX
aiua-6390	146	12	already	already	ADV
aiua-6390	146	13	been	be	AUX
aiua-6390	146	14	established	establish	VERB
aiua-6390	146	15	by	by	ADP
aiua-6390	146	16	several	several	ADJ
aiua-6390	146	17	meta	meta	ADJ
aiua-6390	146	18	-	-	PUNCT
aiua-6390	146	19	analysis	analysis	NOUN
aiua-6390	146	20	studies	study	NOUN
aiua-6390	146	21	(	(	PUNCT
aiua-6390	146	22	31	31	NUM
aiua-6390	146	23	,	,	PUNCT
aiua-6390	146	24	32	32	NUM
aiua-6390	146	25	)	)	PUNCT
aiua-6390	146	26	.	.	PUNCT
aiua-6390	147	1	however	however	ADV
aiua-6390	147	2	,	,	PUNCT
aiua-6390	147	3	we	we	PRON
aiua-6390	147	4	have	have	VERB
aiua-6390	147	5	to	to	PART
aiua-6390	147	6	keep	keep	VERB
aiua-6390	147	7	in	in	ADP
aiua-6390	147	8	mind	mind	NOUN
aiua-6390	147	9	that	that	SCONJ
aiua-6390	147	10	patients	patient	NOUN
aiua-6390	147	11	die	die	VERB
aiua-6390	147	12	upon	upon	SCONJ
aiua-6390	147	13	progression	progression	NOUN
aiua-6390	147	14	to	to	ADP
aiua-6390	147	15	mibc	mibc	PROPN
aiua-6390	147	16	,	,	PUNCT
aiua-6390	147	17	not	not	PART
aiua-6390	147	18	upon	upon	SCONJ
aiua-6390	147	19	recurrence	recurrence	NOUN
aiua-6390	147	20	,	,	PUNCT
aiua-6390	147	21	and	and	CCONJ
aiua-6390	147	22	that	that	SCONJ
aiua-6390	147	23	the	the	DET
aiua-6390	147	24	effectiveness	effectiveness	NOUN
aiua-6390	147	25	of	of	ADP
aiua-6390	147	26	bcg	bcg	PROPN
aiua-6390	147	27	at	at	ADP
aiua-6390	147	28	preventing	prevent	VERB
aiua-6390	147	29	progression	progression	NOUN
aiua-6390	147	30	was	be	AUX
aiua-6390	147	31	not	not	PART
aiua-6390	147	32	as	as	ADV
aiua-6390	147	33	great	great	ADJ
aiua-6390	147	34	as	as	ADP
aiua-6390	147	35	its	its	PRON
aiua-6390	147	36	effectiveness	effectiveness	NOUN
aiua-6390	147	37	at	at	ADP
aiua-6390	147	38	preventing	prevent	VERB
aiua-6390	147	39	recurrence	recurrence	NOUN
aiua-6390	147	40	.	.	PUNCT
aiua-6390	148	1	further	far	ADV
aiua-6390	148	2	,	,	PUNCT
aiua-6390	148	3	residual	residual	ADJ
aiua-6390	148	4	tumor	tumor	NOUN
aiua-6390	148	5	in	in	ADP
aiua-6390	148	6	the	the	DET
aiua-6390	148	7	wlre	wlre	ADJ
aiua-6390	148	8	-	-	PUNCT
aiua-6390	148	9	cturbt	cturbt	NOUN
aiua-6390	148	10	specimen	speciman	NOUN
aiua-6390	148	11	is	be	AUX
aiua-6390	148	12	associated	associate	VERB
aiua-6390	148	13	with	with	ADP
aiua-6390	148	14	poor	poor	ADJ
aiua-6390	148	15	prognosis	prognosis	NOUN
aiua-6390	148	16	.	.	PUNCT
aiua-6390	149	1	in	in	ADP
aiua-6390	149	2	our	our	PRON
aiua-6390	149	3	experience	experience	NOUN
aiua-6390	149	4	,	,	PUNCT
aiua-6390	149	5	we	we	PRON
aiua-6390	149	6	observed	observe	VERB
aiua-6390	149	7	progressions	progression	NOUN
aiua-6390	149	8	in	in	ADP
aiua-6390	149	9	14/92	14/92	NUM
aiua-6390	149	10	patients	patient	NOUN
aiua-6390	149	11	(	(	PUNCT
aiua-6390	149	12	15.2	15.2	NUM
aiua-6390	149	13	%	%	NOUN
aiua-6390	149	14	):	):	PUNCT
aiua-6390	149	15	12	12	NUM
aiua-6390	149	16	from	from	ADP
aiua-6390	149	17	the	the	DET
aiua-6390	149	18	group	group	NOUN
aiua-6390	149	19	with	with	ADP
aiua-6390	149	20	persistent	persistent	ADJ
aiua-6390	149	21	disease	disease	NOUN
aiua-6390	149	22	group	group	NOUN
aiua-6390	149	23	and	and	CCONJ
aiua-6390	149	24	two	two	NUM
aiua-6390	149	25	in	in	ADP
aiua-6390	149	26	t0	t0	PROPN
aiua-6390	149	27	patients	patient	NOUN
aiua-6390	149	28	.	.	PUNCT
aiua-6390	150	1	in	in	ADP
aiua-6390	150	2	the	the	DET
aiua-6390	150	3	persistent	persistent	ADJ
aiua-6390	150	4	disease	disease	NOUN
aiua-6390	150	5	group	group	NOUN
aiua-6390	150	6	,	,	PUNCT
aiua-6390	150	7	we	we	PRON
aiua-6390	150	8	identified	identify	VERB
aiua-6390	150	9	four	four	NUM
aiua-6390	150	10	patients	patient	NOUN
aiua-6390	150	11	with	with	ADP
aiua-6390	150	12	muscle	muscle	NOUN
aiua-6390	150	13	inasive	inasive	ADJ
aiua-6390	150	14	disease	disease	NOUN
aiua-6390	150	15	at	at	ADP
aiua-6390	150	16	wlrecturbt	wlrecturbt	NOUN
aiua-6390	150	17	and	and	CCONJ
aiua-6390	150	18	8	8	NUM
aiua-6390	150	19	more	more	ADJ
aiua-6390	150	20	patients	patient	NOUN
aiua-6390	150	21	during	during	ADP
aiua-6390	150	22	the	the	DET
aiua-6390	150	23	follow	follow	NOUN
aiua-6390	150	24	-	-	PUNCT
aiua-6390	150	25	up	up	NOUN
aiua-6390	150	26	.	.	PUNCT
aiua-6390	151	1	according	accord	VERB
aiua-6390	151	2	to	to	ADP
aiua-6390	151	3	eau	eau	PROPN
aiua-6390	151	4	guidelines	guideline	NOUN
aiua-6390	151	5	(	(	PUNCT
aiua-6390	151	6	11	11	NUM
aiua-6390	151	7	)	)	PUNCT
aiua-6390	151	8	,	,	PUNCT
aiua-6390	151	9	all	all	DET
aiua-6390	151	10	patients	patient	NOUN
aiua-6390	151	11	were	be	AUX
aiua-6390	151	12	submitted	submit	VERB
aiua-6390	151	13	to	to	ADP
aiua-6390	151	14	radical	radical	ADJ
aiua-6390	151	15	cystectomy	cystectomy	NOUN
aiua-6390	151	16	and	and	CCONJ
aiua-6390	151	17	staging	stage	VERB
aiua-6390	151	18	lymphadenectomy	lymphadenectomy	NOUN
aiua-6390	151	19	.	.	PUNCT
aiua-6390	152	1	all	all	DET
aiua-6390	152	2	patients	patient	NOUN
aiua-6390	152	3	who	who	PRON
aiua-6390	152	4	had	have	VERB
aiua-6390	152	5	a	a	DET
aiua-6390	152	6	muscle	muscle	NOUN
aiua-6390	152	7	-	-	PUNCT
aiua-6390	152	8	invasive	invasive	ADJ
aiua-6390	152	9	disease	disease	NOUN
aiua-6390	152	10	,	,	PUNCT
aiua-6390	152	11	confined	confine	VERB
aiua-6390	152	12	within	within	ADP
aiua-6390	152	13	the	the	DET
aiua-6390	152	14	muscle	muscle	NOUN
aiua-6390	152	15	layer	layer	NOUN
aiua-6390	152	16	,	,	PUNCT
aiua-6390	152	17	without	without	ADP
aiua-6390	152	18	extra	extra	ADJ
aiua-6390	152	19	-	-	ADJ
aiua-6390	152	20	parietal	parietal	ADJ
aiua-6390	152	21	extension	extension	NOUN
aiua-6390	152	22	or	or	CCONJ
aiua-6390	152	23	lymphadenopathy	lymphadenopathy	ADJ
aiua-6390	152	24	,	,	PUNCT
aiua-6390	152	25	are	be	AUX
aiua-6390	152	26	today	today	NOUN
aiua-6390	152	27	living	live	VERB
aiua-6390	152	28	(	(	PUNCT
aiua-6390	152	29	ned	ned	PROPN
aiua-6390	152	30	)	)	PUNCT
aiua-6390	152	31	.	.	PUNCT
aiua-6390	153	1	early	early	ADJ
aiua-6390	153	2	cystectomy	cystectomy	NOUN
aiua-6390	153	3	was	be	AUX
aiua-6390	153	4	mandatory	mandatory	ADJ
aiua-6390	153	5	to	to	PART
aiua-6390	153	6	have	have	VERB
aiua-6390	153	7	good	good	ADJ
aiua-6390	153	8	results	result	NOUN
aiua-6390	153	9	.	.	PUNCT
aiua-6390	154	1	cystectomy	cystectomy	NOUN
aiua-6390	154	2	has	have	VERB
aiua-6390	154	3	definite	definite	ADJ
aiua-6390	154	4	advantages	advantage	NOUN
aiua-6390	154	5	for	for	ADP
aiua-6390	154	6	high	high	ADJ
aiua-6390	154	7	-	-	PUNCT
aiua-6390	154	8	grade	grade	NOUN
aiua-6390	154	9	t1	t1	NOUN
aiua-6390	154	10	disease	disease	NOUN
aiua-6390	154	11	.	.	PUNCT
aiua-6390	155	1	in	in	ADP
aiua-6390	155	2	the	the	DET
aiua-6390	155	3	largest	large	ADJ
aiua-6390	155	4	study	study	NOUN
aiua-6390	155	5	so	so	ADV
aiua-6390	155	6	far	far	ADV
aiua-6390	155	7	,	,	PUNCT
aiua-6390	155	8	the	the	DET
aiua-6390	155	9	clinical	clinical	ADJ
aiua-6390	155	10	outcomes	outcome	NOUN
aiua-6390	155	11	of	of	ADP
aiua-6390	155	12	167	167	NUM
aiua-6390	155	13	patients	patient	NOUN
aiua-6390	155	14	with	with	ADP
aiua-6390	155	15	high	high	ADJ
aiua-6390	155	16	-	-	PUNCT
aiua-6390	155	17	grade	grade	NOUN
aiua-6390	155	18	t1	t1	NOUN
aiua-6390	155	19	were	be	AUX
aiua-6390	155	20	reviewed	review	VERB
aiua-6390	155	21	after	after	ADP
aiua-6390	155	22	cystectomy	cystectomy	NOUN
aiua-6390	155	23	(	(	PUNCT
aiua-6390	155	24	33	33	NUM
aiua-6390	155	25	)	)	PUNCT
aiua-6390	155	26	.	.	PUNCT
aiua-6390	156	1	surprisingly	surprisingly	ADV
aiua-6390	156	2	,	,	PUNCT
aiua-6390	156	3	almost	almost	ADV
aiua-6390	156	4	30	30	NUM
aiua-6390	156	5	%	%	NOUN
aiua-6390	156	6	experienced	experience	VERB
aiua-6390	156	7	disease	disease	NOUN
aiua-6390	156	8	recurrence	recurrence	NOUN
aiua-6390	156	9	,	,	PUNCT
aiua-6390	156	10	and	and	CCONJ
aiua-6390	156	11	18.5	18.5	NUM
aiua-6390	156	12	%	%	NOUN
aiua-6390	156	13	died	die	VERB
aiua-6390	156	14	from	from	ADP
aiua-6390	156	15	bladder	bladder	NOUN
aiua-6390	156	16	cancer	cancer	NOUN
aiua-6390	156	17	.	.	PUNCT
aiua-6390	157	1	half	half	NOUN
aiua-6390	157	2	of	of	ADP
aiua-6390	157	3	the	the	DET
aiua-6390	157	4	cases	case	NOUN
aiua-6390	157	5	had	have	VERB
aiua-6390	157	6	disease	disease	NOUN
aiua-6390	157	7	upstaging	upstaging	ADJ
aiua-6390	157	8	,	,	PUNCT
aiua-6390	157	9	and	and	CCONJ
aiua-6390	157	10	27.5	27.5	NUM
aiua-6390	157	11	%	%	NOUN
aiua-6390	157	12	had	have	VERB
aiua-6390	157	13	extravesical	extravesical	ADJ
aiua-6390	157	14	disease	disease	NOUN
aiua-6390	157	15	.	.	PUNCT
aiua-6390	158	1	a	a	PRON
aiua-6390	158	2	greater	great	ADJ
aiua-6390	158	3	than	than	ADP
aiua-6390	158	4	3	3	NUM
aiua-6390	158	5	-	-	PUNCT
aiua-6390	158	6	month	month	NOUN
aiua-6390	158	7	delay	delay	NOUN
aiua-6390	158	8	between	between	ADP
aiua-6390	158	9	cystectomy	cystectomy	NOUN
aiua-6390	158	10	and	and	CCONJ
aiua-6390	158	11	last	last	ADJ
aiua-6390	158	12	wlcturbt	wlcturbt	NOUN
aiua-6390	158	13	showed	show	VERB
aiua-6390	158	14	a	a	DET
aiua-6390	158	15	trend	trend	NOUN
aiua-6390	158	16	toward	toward	ADP
aiua-6390	158	17	upstaging	upstaging	NOUN
aiua-6390	158	18	,	,	PUNCT
aiua-6390	158	19	which	which	PRON
aiua-6390	158	20	means	mean	VERB
aiua-6390	158	21	that	that	SCONJ
aiua-6390	158	22	delaying	delay	VERB
aiua-6390	158	23	cystectomy	cystectomy	NOUN
aiua-6390	158	24	for	for	ADP
aiua-6390	158	25	bcg	bcg	NOUN
aiua-6390	158	26	therapy	therapy	NOUN
aiua-6390	158	27	may	may	AUX
aiua-6390	158	28	worsen	worsen	VERB
aiua-6390	158	29	prognosis	prognosis	NOUN
aiua-6390	158	30	.	.	PUNCT
aiua-6390	159	1	herr	herr	PROPN
aiua-6390	159	2	et	et	PROPN
aiua-6390	159	3	coll	coll	PROPN
aiua-6390	159	4	showed	show	VERB
aiua-6390	159	5	that	that	SCONJ
aiua-6390	159	6	of	of	ADP
aiua-6390	159	7	92	92	NUM
aiua-6390	159	8	patients	patient	NOUN
aiua-6390	159	9	with	with	ADP
aiua-6390	159	10	residual	residual	ADJ
aiua-6390	159	11	t1	t1	NOUN
aiua-6390	159	12	cancer	cancer	NOUN
aiua-6390	159	13	in	in	ADP
aiua-6390	159	14	wlre	wlre	ADJ
aiua-6390	159	15	-	-	PUNCT
aiua-6390	159	16	cturbt	cturbt	NOUN
aiua-6390	159	17	,	,	PUNCT
aiua-6390	159	18	75	75	NUM
aiua-6390	159	19	(	(	PUNCT
aiua-6390	159	20	82	82	NUM
aiua-6390	159	21	%	%	NOUN
aiua-6390	159	22	)	)	PUNCT
aiua-6390	159	23	progressed	progress	VERB
aiua-6390	159	24	to	to	ADP
aiua-6390	159	25	muscle	muscle	NOUN
aiua-6390	159	26	invasion	invasion	NOUN
aiua-6390	159	27	within	within	ADP
aiua-6390	159	28	5	5	NUM
aiua-6390	159	29	years	year	NOUN
aiua-6390	159	30	compared	compare	VERB
aiua-6390	159	31	to	to	ADP
aiua-6390	159	32	49	49	NUM
aiua-6390	159	33	of	of	ADP
aiua-6390	159	34	260	260	NUM
aiua-6390	159	35	(	(	PUNCT
aiua-6390	159	36	19	19	NUM
aiua-6390	159	37	%	%	NOUN
aiua-6390	159	38	)	)	PUNCT
aiua-6390	159	39	who	who	PRON
aiua-6390	159	40	had	have	VERB
aiua-6390	159	41	no	no	DET
aiua-6390	159	42	or	or	CCONJ
aiua-6390	159	43	non	non	ADJ
aiua-6390	159	44	-	-	ADJ
aiua-6390	159	45	t1	t1	ADJ
aiua-6390	159	46	tumor	tumor	NOUN
aiua-6390	159	47	detected	detect	VERB
aiua-6390	159	48	on	on	ADP
aiua-6390	159	49	restaging	restage	VERB
aiua-6390	159	50	cturbt	cturbt	NOUN
aiua-6390	159	51	(	(	PUNCT
aiua-6390	159	52	34	34	NUM
aiua-6390	159	53	)	)	PUNCT
aiua-6390	159	54	.	.	PUNCT
aiua-6390	160	1	a	a	DET
aiua-6390	160	2	similar	similar	ADJ
aiua-6390	160	3	study	study	NOUN
aiua-6390	160	4	reported	report	VERB
aiua-6390	160	5	that	that	SCONJ
aiua-6390	160	6	early	early	ADJ
aiua-6390	160	7	cystectomy	cystectomy	NOUN
aiua-6390	160	8	seems	seem	VERB
aiua-6390	160	9	to	to	PART
aiua-6390	160	10	prolong	prolong	VERB
aiua-6390	160	11	cancer	cancer	NOUN
aiua-6390	160	12	-	-	PUNCT
aiua-6390	160	13	specific	specific	ADJ
aiua-6390	160	14	survival	survival	NOUN
aiua-6390	160	15	compared	compare	VERB
aiua-6390	160	16	to	to	ADP
aiua-6390	160	17	deferred	defer	VERB
aiua-6390	160	18	cystectomy	cystectomy	NOUN
aiua-6390	160	19	in	in	ADP
aiua-6390	160	20	high	high	ADJ
aiua-6390	160	21	-	-	PUNCT
aiua-6390	160	22	risk	risk	NOUN
aiua-6390	160	23	high	high	ADJ
aiua-6390	160	24	-	-	PUNCT
aiua-6390	160	25	grade	grade	NOUN
aiua-6390	160	26	t1	t1	NOUN
aiua-6390	160	27	patients	patient	NOUN
aiua-6390	160	28	(	(	PUNCT
aiua-6390	160	29	35	35	NUM
aiua-6390	160	30	)	)	PUNCT
aiua-6390	160	31	.	.	PUNCT
aiua-6390	161	1	considering	consider	VERB
aiua-6390	161	2	the	the	DET
aiua-6390	161	3	high	high	ADJ
aiua-6390	161	4	risk	risk	NOUN
aiua-6390	161	5	of	of	ADP
aiua-6390	161	6	progression	progression	NOUN
aiua-6390	161	7	and	and	CCONJ
aiua-6390	161	8	cancer	cancer	NOUN
aiua-6390	161	9	death	death	NOUN
aiua-6390	161	10	of	of	ADP
aiua-6390	161	11	high	high	ADJ
aiua-6390	161	12	-	-	PUNCT
aiua-6390	161	13	grade	grade	NOUN
aiua-6390	161	14	t1	t1	NOUN
aiua-6390	161	15	disease	disease	NOUN
aiua-6390	161	16	,	,	PUNCT
aiua-6390	161	17	cystectomy	cystectomy	NOUN
aiua-6390	161	18	would	would	AUX
aiua-6390	161	19	be	be	AUX
aiua-6390	161	20	the	the	DET
aiua-6390	161	21	best	good	ADJ
aiua-6390	161	22	answer	answer	NOUN
aiua-6390	161	23	for	for	ADP
aiua-6390	161	24	treatment	treatment	NOUN
aiua-6390	161	25	.	.	PUNCT
aiua-6390	162	1	however	however	ADV
aiua-6390	162	2	,	,	PUNCT
aiua-6390	162	3	there	there	PRON
aiua-6390	162	4	are	be	VERB
aiua-6390	162	5	disadvantages	disadvantage	NOUN
aiua-6390	162	6	.	.	PUNCT
aiua-6390	163	1	first	first	ADV
aiua-6390	163	2	,	,	PUNCT
aiua-6390	163	3	cystectomy	cystectomy	NOUN
aiua-6390	163	4	may	may	AUX
aiua-6390	163	5	be	be	AUX
aiua-6390	163	6	overtreatment	overtreatment	ADJ
aiua-6390	163	7	for	for	ADP
aiua-6390	163	8	highgrade	highgrade	NOUN
aiua-6390	163	9	t1	t1	NOUN
aiua-6390	163	10	disease	disease	NOUN
aiua-6390	163	11	.	.	PUNCT
aiua-6390	164	1	since	since	SCONJ
aiua-6390	164	2	at	at	ADV
aiua-6390	164	3	least	least	ADV
aiua-6390	164	4	50	50	NUM
aiua-6390	164	5	%	%	NOUN
aiua-6390	164	6	of	of	ADP
aiua-6390	164	7	high	high	ADJ
aiua-6390	164	8	-	-	PUNCT
aiua-6390	164	9	grade	grade	NOUN
aiua-6390	164	10	t1	t1	NOUN
aiua-6390	164	11	patients	patient	NOUN
aiua-6390	164	12	are	be	AUX
aiua-6390	164	13	not	not	PART
aiua-6390	164	14	upstaged	upstaged	ADJ
aiua-6390	164	15	upon	upon	SCONJ
aiua-6390	164	16	cystectomy	cystectomy	NOUN
aiua-6390	164	17	(	(	PUNCT
aiua-6390	164	18	36	36	NUM
aiua-6390	164	19	)	)	PUNCT
aiua-6390	164	20	.	.	PUNCT
aiua-6390	165	1	second	second	ADV
aiua-6390	165	2	,	,	PUNCT
aiua-6390	165	3	cystectomy	cystectomy	NOUN
aiua-6390	165	4	deteriorates	deteriorate	VERB
aiua-6390	165	5	the	the	DET
aiua-6390	165	6	quality	quality	NOUN
aiua-6390	165	7	of	of	ADP
aiua-6390	165	8	life	life	NOUN
aiua-6390	165	9	.	.	PUNCT
aiua-6390	166	1	finally	finally	ADV
aiua-6390	166	2	,	,	PUNCT
aiua-6390	166	3	cystectomy	cystectomy	NOUN
aiua-6390	166	4	is	be	AUX
aiua-6390	166	5	a	a	DET
aiua-6390	166	6	highly	highly	ADV
aiua-6390	166	7	complicated	complicated	ADJ
aiua-6390	166	8	surgery	surgery	NOUN
aiua-6390	166	9	in	in	ADP
aiua-6390	166	10	the	the	DET
aiua-6390	166	11	urological	urological	ADJ
aiua-6390	166	12	field	field	NOUN
aiua-6390	166	13	,	,	PUNCT
aiua-6390	166	14	and	and	CCONJ
aiua-6390	166	15	almost	almost	ADV
aiua-6390	166	16	30%-50	30%-50	NUM
aiua-6390	166	17	%	%	NOUN
aiua-6390	166	18	of	of	ADP
aiua-6390	166	19	patients	patient	NOUN
aiua-6390	166	20	experience	experience	VERB
aiua-6390	166	21	perioperative	perioperative	ADJ
aiua-6390	166	22	or	or	CCONJ
aiua-6390	166	23	long	long	ADJ
aiua-6390	166	24	-	-	PUNCT
aiua-6390	166	25	term	term	NOUN
aiua-6390	166	26	complications	complication	NOUN
aiua-6390	166	27	(	(	PUNCT
aiua-6390	166	28	37	37	NUM
aiua-6390	166	29	)	)	PUNCT
aiua-6390	166	30	.	.	PUNCT
aiua-6390	167	1	in	in	ADP
aiua-6390	167	2	our	our	PRON
aiua-6390	167	3	experience	experience	NOUN
aiua-6390	167	4	,	,	PUNCT
aiua-6390	167	5	the	the	DET
aiua-6390	167	6	most	most	ADV
aiua-6390	167	7	important	important	ADJ
aiua-6390	167	8	predictive	predictive	ADJ
aiua-6390	167	9	prognostic	prognostic	ADJ
aiua-6390	167	10	factor	factor	NOUN
aiua-6390	167	11	–	–	PUNCT
aiua-6390	167	12	in	in	ADP
aiua-6390	167	13	patients	patient	NOUN
aiua-6390	167	14	with	with	ADP
aiua-6390	167	15	pt1hg	pt1hg	PROPN
aiua-6390	167	16	tumours	tumour	NOUN
aiua-6390	167	17	–	–	PUNCT
aiua-6390	167	18	is	be	AUX
aiua-6390	167	19	the	the	DET
aiua-6390	167	20	presence	presence	NOUN
aiua-6390	167	21	of	of	ADP
aiua-6390	167	22	concomitant	concomitant	ADJ
aiua-6390	167	23	cis	cis	NOUN
aiua-6390	167	24	.	.	PUNCT
aiua-6390	168	1	sylvester	sylvest	ADJ
aiua-6390	168	2	et	et	PROPN
aiua-6390	168	3	al	al	PROPN
aiua-6390	168	4	.	.	PROPN
aiua-6390	168	5	observed	observe	VERB
aiua-6390	168	6	in	in	ADP
aiua-6390	168	7	pt1hg	pt1hg	PROPN
aiua-6390	168	8	patients	patient	NOUN
aiua-6390	168	9	without	without	ADP
aiua-6390	168	10	cis	cis	NOUN
aiua-6390	168	11	a	a	DET
aiua-6390	168	12	probability	probability	NOUN
aiua-6390	168	13	of	of	ADP
aiua-6390	168	14	progression	progression	NOUN
aiua-6390	168	15	around	around	ADP
aiua-6390	168	16	10	10	NUM
aiua-6390	168	17	%	%	NOUN
aiua-6390	168	18	at	at	ADP
aiua-6390	168	19	1	1	NUM
aiua-6390	168	20	year	year	NOUN
aiua-6390	168	21	and	and	CCONJ
aiua-6390	168	22	29	29	NUM
aiua-6390	168	23	%	%	NOUN
aiua-6390	168	24	at	at	ADP
aiua-6390	168	25	5	5	NUM
aiua-6390	168	26	years	year	NOUN
aiua-6390	168	27	.	.	PUNCT
aiua-6390	169	1	in	in	ADP
aiua-6390	169	2	pt1hg	pt1hg	PROPN
aiua-6390	169	3	patients	patient	NOUN
aiua-6390	169	4	with	with	ADP
aiua-6390	169	5	cis	cis	NOUN
aiua-6390	169	6	,	,	PUNCT
aiua-6390	169	7	the	the	DET
aiua-6390	169	8	corresponding	corresponding	ADJ
aiua-6390	169	9	features	feature	NOUN
aiua-6390	169	10	are	be	AUX
aiua-6390	169	11	29	29	NUM
aiua-6390	169	12	%	%	NOUN
aiua-6390	169	13	and	and	CCONJ
aiua-6390	169	14	74	74	NUM
aiua-6390	169	15	%	%	NOUN
aiua-6390	169	16	,	,	PUNCT
aiua-6390	169	17	respectively	respectively	ADV
aiua-6390	169	18	(	(	PUNCT
aiua-6390	169	19	3	3	NUM
aiua-6390	169	20	)	)	PUNCT
aiua-6390	169	21	.	.	PUNCT
aiua-6390	170	1	giulianelli_stesura	giulianelli_stesura	NOUN
aiua-6390	170	2	seveso	seveso	NOUN
aiua-6390	170	3	03/01/18	03/01/18	PROPN
aiua-6390	170	4	11:58	11:58	NUM
aiua-6390	170	5	pagina	pagina	NOUN
aiua-6390	170	6	275	275	NUM
aiua-6390	170	7	archivio	archivio	NOUN
aiua-6390	170	8	italiano	italiano	NOUN
aiua-6390	170	9	di	di	X
aiua-6390	170	10	urologia	urologia	PROPN
aiua-6390	170	11	e	e	PROPN
aiua-6390	170	12	andrologia	andrologia	NOUN
aiua-6390	170	13	2017	2017	NUM
aiua-6390	170	14	;	;	PUNCT
aiua-6390	170	15	89	89	NUM
aiua-6390	170	16	,	,	PUNCT
aiua-6390	170	17	4	4	NUM
aiua-6390	170	18	r.	r.	PROPN
aiua-6390	170	19	giulianelli	giulianelli	PROPN
aiua-6390	170	20	,	,	PUNCT
aiua-6390	170	21	b.c	b.c	PROPN
aiua-6390	170	22	.	.	PROPN
aiua-6390	170	23	gentile	gentile	NOUN
aiua-6390	170	24	,	,	PUNCT
aiua-6390	170	25	g.	g.	PROPN
aiua-6390	170	26	mirabile	mirabile	PROPN
aiua-6390	170	27	,	,	PUNCT
aiua-6390	170	28	l.	l.	PROPN
aiua-6390	170	29	albanesi	albanesi	PROPN
aiua-6390	170	30	,	,	PUNCT
aiua-6390	170	31	p.	p.	NOUN
aiua-6390	170	32	tariciotti	tariciotti	PROPN
aiua-6390	170	33	,	,	PUNCT
aiua-6390	170	34	g.	g.	PROPN
aiua-6390	170	35	rizzo	rizzo	PROPN
aiua-6390	170	36	,	,	PUNCT
aiua-6390	170	37	m.	m.	NOUN
aiua-6390	170	38	buscarini	buscarini	PROPN
aiua-6390	170	39	,	,	PUNCT
aiua-6390	170	40	m.	m.	NOUN
aiua-6390	170	41	vermiglio	vermiglio	NOUN
aiua-6390	170	42	276	276	NUM
aiua-6390	170	43	domized	domize	VERB
aiua-6390	170	44	southwest	southwest	ADJ
aiua-6390	170	45	oncology	oncology	NOUN
aiua-6390	170	46	group	group	NOUN
aiua-6390	170	47	study	study	NOUN
aiua-6390	170	48	.	.	PUNCT
aiua-6390	171	1	j	j	PROPN
aiua-6390	171	2	urol	urol	PROPN
aiua-6390	171	3	.	.	PROPN
aiua-6390	171	4	2000	2000	NUM
aiua-6390	171	5	;	;	PUNCT
aiua-6390	171	6	163:11241129	163:11241129	NUM
aiua-6390	171	7	.	.	NOUN
aiua-6390	171	8	13	13	NUM
aiua-6390	171	9	.	.	PUNCT
aiua-6390	172	1	kaplan	kaplan	PROPN
aiua-6390	172	2	el	el	PROPN
aiua-6390	172	3	,	,	PUNCT
aiua-6390	172	4	meier	meier	PROPN
aiua-6390	172	5	p.	p.	PROPN
aiua-6390	172	6	nonparametric	nonparametric	PROPN
aiua-6390	172	7	estimation	estimation	NOUN
aiua-6390	172	8	from	from	ADP
aiua-6390	172	9	incomplete	incomplete	ADJ
aiua-6390	172	10	observations	observation	NOUN
aiua-6390	172	11	.	.	PUNCT
aiua-6390	173	1	j	j	PROPN
aiua-6390	173	2	amer	amer	PROPN
aiua-6390	173	3	statist	statist	PROPN
aiua-6390	173	4	assn	assn	PROPN
aiua-6390	173	5	.	.	PROPN
aiua-6390	173	6	1958	1958	NUM
aiua-6390	173	7	;	;	PUNCT
aiua-6390	173	8	53:457	53:457	NUM
aiua-6390	173	9	-	-	SYM
aiua-6390	173	10	481	481	NUM
aiua-6390	173	11	.	.	PUNCT
aiua-6390	174	1	14	14	NUM
aiua-6390	174	2	.	.	PUNCT
aiua-6390	175	1	harrington	harrington	PROPN
aiua-6390	175	2	d.	d.	PROPN
aiua-6390	175	3	linear	linear	PROPN
aiua-6390	175	4	rank	rank	PROPN
aiua-6390	175	5	tests	test	NOUN
aiua-6390	175	6	in	in	ADP
aiua-6390	175	7	survival	survival	NOUN
aiua-6390	175	8	analysis	analysis	NOUN
aiua-6390	175	9	,	,	PUNCT
aiua-6390	175	10	in	in	ADP
aiua-6390	175	11	encyclopedia	encyclopedia	NOUN
aiua-6390	175	12	of	of	ADP
aiua-6390	175	13	biostatistics	biostatistic	NOUN
aiua-6390	175	14	,	,	PUNCT
aiua-6390	175	15	wiley	wiley	NOUN
aiua-6390	175	16	interscience	interscience	NOUN
aiua-6390	175	17	,	,	PUNCT
aiua-6390	175	18	2005	2005	NUM
aiua-6390	175	19	.	.	PUNCT
aiua-6390	176	1	15	15	NUM
aiua-6390	176	2	.	.	PUNCT
aiua-6390	176	3	pearson	pearson	PROPN
aiua-6390	176	4	k.	k.	PROPN
aiua-6390	177	1	on	on	ADP
aiua-6390	177	2	the	the	DET
aiua-6390	177	3	criterion	criterion	NOUN
aiua-6390	177	4	that	that	SCONJ
aiua-6390	177	5	a	a	DET
aiua-6390	177	6	given	give	VERB
aiua-6390	177	7	system	system	NOUN
aiua-6390	177	8	of	of	ADP
aiua-6390	177	9	deviations	deviation	NOUN
aiua-6390	177	10	from	from	ADP
aiua-6390	177	11	the	the	DET
aiua-6390	177	12	probable	probable	NOUN
aiua-6390	177	13	in	in	ADP
aiua-6390	177	14	the	the	DET
aiua-6390	177	15	case	case	NOUN
aiua-6390	177	16	of	of	ADP
aiua-6390	177	17	a	a	DET
aiua-6390	177	18	correlated	correlate	VERB
aiua-6390	177	19	system	system	NOUN
aiua-6390	177	20	of	of	ADP
aiua-6390	177	21	variables	variable	NOUN
aiua-6390	177	22	is	be	AUX
aiua-6390	177	23	such	such	ADJ
aiua-6390	177	24	that	that	SCONJ
aiua-6390	177	25	it	it	PRON
aiua-6390	177	26	can	can	AUX
aiua-6390	177	27	be	be	AUX
aiua-6390	177	28	reasonably	reasonably	ADV
aiua-6390	177	29	supposed	suppose	VERB
aiua-6390	177	30	to	to	PART
aiua-6390	177	31	have	have	AUX
aiua-6390	177	32	arisen	arise	VERB
aiua-6390	177	33	from	from	ADP
aiua-6390	177	34	random	random	ADJ
aiua-6390	177	35	sampling	sampling	NOUN
aiua-6390	177	36	.	.	PUNCT
aiua-6390	178	1	the	the	DET
aiua-6390	178	2	london	london	PROPN
aiua-6390	178	3	,	,	PUNCT
aiua-6390	178	4	edinburgh	edinburgh	PROPN
aiua-6390	178	5	,	,	PUNCT
aiua-6390	178	6	and	and	CCONJ
aiua-6390	178	7	dublin	dublin	PROPN
aiua-6390	178	8	philosophical	philosophical	PROPN
aiua-6390	178	9	magazine	magazine	NOUN
aiua-6390	178	10	and	and	CCONJ
aiua-6390	178	11	journal	journal	PROPN
aiua-6390	178	12	of	of	ADP
aiua-6390	178	13	science	science	PROPN
aiua-6390	178	14	series	series	PROPN
aiua-6390	178	15	5	5	NUM
aiua-6390	178	16	1900	1900	NUM
aiua-6390	178	17	;	;	PUNCT
aiua-6390	178	18	50:157	50:157	NUM
aiua-6390	178	19	-	-	SYM
aiua-6390	178	20	175	175	NUM
aiua-6390	178	21	.	.	PUNCT
aiua-6390	178	22	16	16	NUM
aiua-6390	178	23	.	.	PUNCT
aiua-6390	179	1	cheng	cheng	PROPN
aiua-6390	179	2	l	l	PROPN
aiua-6390	179	3	,	,	PUNCT
aiua-6390	179	4	montironi	montironi	X
aiua-6390	179	5	r	r	NOUN
aiua-6390	179	6	,	,	PUNCT
aiua-6390	179	7	davidson	davidson	PROPN
aiua-6390	179	8	dd	dd	PROPN
aiua-6390	179	9	,	,	PUNCT
aiua-6390	179	10	lopez	lopez	NOUN
aiua-6390	179	11	-	-	PUNCT
aiua-6390	179	12	beltran	beltran	PROPN
aiua-6390	179	13	a.	a.	NOUN
aiua-6390	179	14	staging	staging	NOUN
aiua-6390	179	15	and	and	CCONJ
aiua-6390	179	16	reporting	reporting	NOUN
aiua-6390	179	17	of	of	ADP
aiua-6390	179	18	urothelial	urothelial	ADJ
aiua-6390	179	19	carcinoma	carcinoma	NOUN
aiua-6390	179	20	of	of	ADP
aiua-6390	179	21	the	the	DET
aiua-6390	179	22	urinary	urinary	ADJ
aiua-6390	179	23	bladder	bladder	NOUN
aiua-6390	179	24	.	.	PUNCT
aiua-6390	180	1	modern	modern	ADJ
aiua-6390	180	2	pathology	pathology	NOUN
aiua-6390	180	3	.	.	PUNCT
aiua-6390	181	1	2009	2009	NUM
aiua-6390	181	2	;	;	PUNCT
aiua-6390	181	3	22	22	NUM
aiua-6390	181	4	:	:	PUNCT
aiua-6390	181	5	s70	s70	NOUN
aiua-6390	181	6	-	-	PUNCT
aiua-6390	181	7	s95	s95	NOUN
aiua-6390	181	8	;	;	PUNCT
aiua-6390	181	9	17	17	NUM
aiua-6390	181	10	.	.	PUNCT
aiua-6390	181	11	ramírez	ramírez	NOUN
aiua-6390	181	12	-	-	PUNCT
aiua-6390	181	13	backhaus	backhaus	NOUN
aiua-6390	181	14	m	m	PROPN
aiua-6390	181	15	,	,	PUNCT
aiua-6390	181	16	dominguez	dominguez	PROPN
aiua-6390	181	17	-	-	PUNCT
aiua-6390	181	18	escrig	escrig	PROPN
aiua-6390	181	19	j	j	PROPN
aiua-6390	181	20	,	,	PUNCT
aiua-6390	181	21	collado	collado	X
aiua-6390	181	22	a	a	X
aiua-6390	181	23	,	,	PUNCT
aiua-6390	181	24	et	et	PROPN
aiua-6390	181	25	al	al	PROPN
aiua-6390	181	26	.	.	PUNCT
aiua-6390	181	27	restaging	restage	VERB
aiua-6390	181	28	transurethral	transurethral	ADJ
aiua-6390	181	29	resection	resection	NOUN
aiua-6390	181	30	of	of	ADP
aiua-6390	181	31	bladder	bladder	NOUN
aiua-6390	181	32	tumor	tumor	NOUN
aiua-6390	181	33	for	for	ADP
aiua-6390	181	34	high	high	ADJ
aiua-6390	181	35	-	-	PUNCT
aiua-6390	181	36	risk	risk	NOUN
aiua-6390	181	37	stage	stage	NOUN
aiua-6390	181	38	ta	ta	X
aiua-6390	181	39	and	and	CCONJ
aiua-6390	181	40	t1	t1	NOUN
aiua-6390	181	41	bladder	bladder	NOUN
aiua-6390	181	42	cancer	cancer	NOUN
aiua-6390	181	43	.	.	PUNCT
aiua-6390	182	1	curr	curr	PROPN
aiua-6390	182	2	urol	urol	PROPN
aiua-6390	182	3	rep	rep	PROPN
aiua-6390	182	4	.	.	PROPN
aiua-6390	182	5	2012	2012	NUM
aiua-6390	182	6	;	;	PUNCT
aiua-6390	182	7	13:109	13:109	NUM
aiua-6390	182	8	-	-	SYM
aiua-6390	182	9	114	114	NUM
aiua-6390	182	10	.	.	PUNCT
aiua-6390	182	11	18	18	NUM
aiua-6390	182	12	.	.	PUNCT
aiua-6390	183	1	shim	shim	NOUN
aiua-6390	183	2	js	js	PROPN
aiua-6390	183	3	,	,	PUNCT
aiua-6390	183	4	choi	choi	NOUN
aiua-6390	183	5	h	h	PROPN
aiua-6390	183	6	,	,	PUNCT
aiua-6390	183	7	noh	noh	PROPN
aiua-6390	183	8	ti	ti	PROPN
aiua-6390	183	9	,	,	PUNCT
aiua-6390	183	10	et	et	PROPN
aiua-6390	183	11	al	al	PROPN
aiua-6390	183	12	.	.	PUNCT
aiua-6390	184	1	the	the	DET
aiua-6390	184	2	clinical	clinical	ADJ
aiua-6390	184	3	significance	significance	NOUN
aiua-6390	184	4	of	of	ADP
aiua-6390	184	5	a	a	DET
aiua-6390	184	6	second	second	ADJ
aiua-6390	184	7	transurethral	transurethral	ADJ
aiua-6390	184	8	resection	resection	NOUN
aiua-6390	184	9	for	for	ADP
aiua-6390	184	10	t1	t1	ADJ
aiua-6390	184	11	high	high	ADJ
aiua-6390	184	12	-	-	PUNCT
aiua-6390	184	13	grade	grade	NOUN
aiua-6390	184	14	bladder	bladder	NOUN
aiua-6390	184	15	cancer	cancer	NOUN
aiua-6390	184	16	:	:	PUNCT
aiua-6390	184	17	results	result	NOUN
aiua-6390	184	18	of	of	ADP
aiua-6390	184	19	a	a	DET
aiua-6390	184	20	prospective	prospective	ADJ
aiua-6390	184	21	study	study	NOUN
aiua-6390	184	22	.	.	PUNCT
aiua-6390	185	1	korean	korean	PROPN
aiua-6390	185	2	j	j	PROPN
aiua-6390	185	3	urol	urol	PROPN
aiua-6390	185	4	.	.	PROPN
aiua-6390	186	1	2015	2015	NUM
aiua-6390	186	2	;	;	PUNCT
aiua-6390	186	3	56:429	56:429	NUM
aiua-6390	186	4	-	-	SYM
aiua-6390	186	5	434	434	NUM
aiua-6390	186	6	.	.	PUNCT
aiua-6390	186	7	19	19	NUM
aiua-6390	186	8	.	.	X
aiua-6390	186	9	jahnson	jahnson	PROPN
aiua-6390	186	10	s	s	PROPN
aiua-6390	186	11	,	,	PUNCT
aiua-6390	186	12	wiklund	wiklund	NOUN
aiua-6390	186	13	f	f	PROPN
aiua-6390	186	14	,	,	PUNCT
aiua-6390	186	15	duchek	duchek	PROPN
aiua-6390	186	16	m	m	PROPN
aiua-6390	186	17	,	,	PUNCT
aiua-6390	186	18	et	et	PROPN
aiua-6390	186	19	al	al	PROPN
aiua-6390	186	20	.	.	PROPN
aiua-6390	186	21	results	result	NOUN
aiua-6390	186	22	of	of	ADP
aiua-6390	186	23	second	second	ADJ
aiua-6390	186	24	-	-	PUNCT
aiua-6390	186	25	look	look	NOUN
aiua-6390	186	26	resection	resection	NOUN
aiua-6390	186	27	after	after	ADP
aiua-6390	186	28	primary	primary	ADJ
aiua-6390	186	29	resection	resection	NOUN
aiua-6390	186	30	of	of	ADP
aiua-6390	186	31	t1	t1	NOUN
aiua-6390	186	32	tumour	tumour	NOUN
aiua-6390	186	33	of	of	ADP
aiua-6390	186	34	the	the	DET
aiua-6390	186	35	urinary	urinary	ADJ
aiua-6390	186	36	bladder	bladder	NOUN
aiua-6390	186	37	.	.	PUNCT
aiua-6390	187	1	scand	scand	PROPN
aiua-6390	187	2	j	j	PROPN
aiua-6390	187	3	urol	urol	PROPN
aiua-6390	187	4	nephrol	nephrol	PROPN
aiua-6390	187	5	.	.	PUNCT
aiua-6390	188	1	2005	2005	NUM
aiua-6390	188	2	;	;	PUNCT
aiua-6390	188	3	39:206	39:206	NUM
aiua-6390	188	4	-	-	SYM
aiua-6390	188	5	210	210	NUM
aiua-6390	188	6	.	.	PUNCT
aiua-6390	189	1	20	20	NUM
aiua-6390	189	2	.	.	X
aiua-6390	190	1	vasdev	vasdev	PROPN
aiua-6390	190	2	n	n	PRON
aiua-6390	190	3	,	,	PUNCT
aiua-6390	190	4	dominguez	dominguez	PROPN
aiua-6390	190	5	-	-	PUNCT
aiua-6390	190	6	escrig	escrig	PROPN
aiua-6390	190	7	j	j	PROPN
aiua-6390	190	8	,	,	PUNCT
aiua-6390	190	9	paez	paez	PROPN
aiua-6390	190	10	e	e	PROPN
aiua-6390	190	11	,	,	PUNCT
aiua-6390	190	12	et	et	PROPN
aiua-6390	190	13	al	al	PROPN
aiua-6390	190	14	.	.	PUNCT
aiua-6390	191	1	the	the	DET
aiua-6390	191	2	impact	impact	NOUN
aiua-6390	191	3	of	of	ADP
aiua-6390	191	4	early	early	ADJ
aiua-6390	191	5	re	re	NOUN
aiua-6390	191	6	-	-	NOUN
aiua-6390	191	7	resection	resection	NOUN
aiua-6390	191	8	in	in	ADP
aiua-6390	191	9	patients	patient	NOUN
aiua-6390	191	10	with	with	ADP
aiua-6390	191	11	pt1	pt1	PROPN
aiua-6390	191	12	high	high	ADJ
aiua-6390	191	13	-	-	PUNCT
aiua-6390	191	14	grade	grade	NOUN
aiua-6390	191	15	non	non	ADJ
aiua-6390	191	16	-	-	ADJ
aiua-6390	191	17	muscle	muscle	ADJ
aiua-6390	191	18	invasive	invasive	ADJ
aiua-6390	191	19	bladder	bladder	NOUN
aiua-6390	191	20	cancer	cancer	NOUN
aiua-6390	191	21	.	.	PUNCT
aiua-6390	192	1	ecancermedicalscience	ecancermedicalscience	NOUN
aiua-6390	192	2	2012	2012	NUM
aiua-6390	192	3	;	;	PUNCT
aiua-6390	192	4	6:269	6:269	NUM
aiua-6390	192	5	.	.	NOUN
aiua-6390	192	6	21	21	NUM
aiua-6390	192	7	.	.	PUNCT
aiua-6390	193	1	kim	kim	PROPN
aiua-6390	193	2	w	w	PROPN
aiua-6390	193	3	,	,	PUNCT
aiua-6390	193	4	song	song	NOUN
aiua-6390	193	5	c	c	NOUN
aiua-6390	193	6	,	,	PUNCT
aiua-6390	193	7	park	park	NOUN
aiua-6390	193	8	s	s	PROPN
aiua-6390	193	9	,	,	PUNCT
aiua-6390	193	10	et	et	PROPN
aiua-6390	193	11	al	al	PROPN
aiua-6390	193	12	.	.	PROPN
aiua-6390	193	13	value	value	NOUN
aiua-6390	193	14	of	of	ADP
aiua-6390	193	15	immediate	immediate	ADJ
aiua-6390	193	16	second	second	ADJ
aiua-6390	193	17	resection	resection	NOUN
aiua-6390	193	18	of	of	ADP
aiua-6390	193	19	the	the	DET
aiua-6390	193	20	tumor	tumor	NOUN
aiua-6390	193	21	bed	bed	NOUN
aiua-6390	193	22	to	to	PART
aiua-6390	193	23	improve	improve	VERB
aiua-6390	193	24	the	the	DET
aiua-6390	193	25	effectiveness	effectiveness	NOUN
aiua-6390	193	26	of	of	ADP
aiua-6390	193	27	transurethral	transurethral	ADJ
aiua-6390	193	28	resection	resection	NOUN
aiua-6390	193	29	of	of	ADP
aiua-6390	193	30	bladder	bladder	NOUN
aiua-6390	193	31	tumor	tumor	NOUN
aiua-6390	193	32	.	.	PUNCT
aiua-6390	194	1	j	j	PROPN
aiua-6390	194	2	endourol	endourol	NOUN
aiua-6390	194	3	.	.	PUNCT
aiua-6390	195	1	2012	2012	NUM
aiua-6390	195	2	;	;	PUNCT
aiua-6390	195	3	26:1059	26:1059	NUM
aiua-6390	195	4	-	-	SYM
aiua-6390	195	5	1064	1064	NUM
aiua-6390	195	6	.	.	PUNCT
aiua-6390	196	1	22	22	NUM
aiua-6390	196	2	.	.	PUNCT
aiua-6390	197	1	dutta	dutta	PROPN
aiua-6390	197	2	sc	sc	PROPN
aiua-6390	197	3	,	,	PUNCT
aiua-6390	197	4	smith	smith	PROPN
aiua-6390	197	5	jr	jr	PROPN
aiua-6390	197	6	ja	ja	PROPN
aiua-6390	197	7	,	,	PUNCT
aiua-6390	197	8	shappell	shappell	PROPN
aiua-6390	197	9	sb	sb	PROPN
aiua-6390	197	10	,	,	PUNCT
aiua-6390	197	11	et	et	PROPN
aiua-6390	197	12	al	al	PROPN
aiua-6390	197	13	.	.	PROPN
aiua-6390	198	1	clinical	clinical	ADJ
aiua-6390	198	2	under	under	ADP
aiua-6390	198	3	staging	staging	NOUN
aiua-6390	198	4	of	of	ADP
aiua-6390	198	5	high	high	ADJ
aiua-6390	198	6	risk	risk	NOUN
aiua-6390	198	7	nonmuscle	nonmuscle	NOUN
aiua-6390	198	8	invasive	invasive	ADJ
aiua-6390	198	9	urothelial	urothelial	ADJ
aiua-6390	198	10	carcinoma	carcinoma	NOUN
aiua-6390	198	11	treated	treat	VERB
aiua-6390	198	12	with	with	ADP
aiua-6390	198	13	radical	radical	ADJ
aiua-6390	198	14	cystectomy	cystectomy	NOUN
aiua-6390	198	15	.	.	PUNCT
aiua-6390	199	1	j	j	PROPN
aiua-6390	199	2	urol	urol	PROPN
aiua-6390	199	3	.	.	PUNCT
aiua-6390	200	1	2004	2004	NUM
aiua-6390	200	2	;	;	PUNCT
aiua-6390	201	1	166:539	166:539	NUM
aiua-6390	201	2	.	.	PUNCT
aiua-6390	202	1	23	23	NUM
aiua-6390	202	2	.	.	PUNCT
aiua-6390	203	1	grimm	grimm	PROPN
aiua-6390	203	2	mo	mo	PROPN
aiua-6390	203	3	,	,	PUNCT
aiua-6390	203	4	steinhoff	steinhoff	ADP
aiua-6390	203	5	c	c	PROPN
aiua-6390	203	6	,	,	PUNCT
aiua-6390	203	7	simon	simon	PROPN
aiua-6390	203	8	x	x	PROPN
aiua-6390	203	9	,	,	PUNCT
aiua-6390	203	10	et	et	PROPN
aiua-6390	203	11	al	al	PROPN
aiua-6390	203	12	.	.	PROPN
aiua-6390	203	13	effect	effect	NOUN
aiua-6390	203	14	of	of	ADP
aiua-6390	203	15	routine	routine	ADJ
aiua-6390	203	16	repeat	repeat	NOUN
aiua-6390	203	17	transurethral	transurethral	ADJ
aiua-6390	203	18	resection	resection	NOUN
aiua-6390	203	19	for	for	ADP
aiua-6390	203	20	superficial	superficial	ADJ
aiua-6390	203	21	bladder	bladder	NOUN
aiua-6390	203	22	cancer	cancer	NOUN
aiua-6390	203	23	a	a	DET
aiua-6390	203	24	long	long	ADJ
aiua-6390	203	25	-	-	PUNCT
aiua-6390	203	26	term	term	NOUN
aiua-6390	203	27	observational	observational	ADJ
aiua-6390	203	28	study	study	NOUN
aiua-6390	203	29	.	.	PUNCT
aiua-6390	204	1	j	j	PROPN
aiua-6390	204	2	urol	urol	PROPN
aiua-6390	204	3	2003	2003	NUM
aiua-6390	204	4	;	;	PUNCT
aiua-6390	204	5	170:433	170:433	NUM
aiua-6390	204	6	.	.	PUNCT
aiua-6390	205	1	24	24	NUM
aiua-6390	205	2	.	.	PUNCT
aiua-6390	205	3	divrik	divrik	PROPN
aiua-6390	205	4	rt	rt	PROPN
aiua-6390	205	5	,	,	PUNCT
aiua-6390	205	6	yldirim	yldirim	PROPN
aiua-6390	205	7	u	u	NOUN
aiua-6390	205	8	,	,	PUNCT
aiua-6390	205	9	zorlu	zorlu	PROPN
aiua-6390	205	10	f	f	PROPN
aiua-6390	205	11	,	,	PUNCT
aiua-6390	205	12	ozen	ozen	PROPN
aiua-6390	205	13	h.	h.	PROPN
aiua-6390	205	14	the	the	DET
aiua-6390	205	15	effect	effect	NOUN
aiua-6390	205	16	of	of	ADP
aiua-6390	205	17	repeat	repeat	NOUN
aiua-6390	205	18	transurethral	transurethral	ADJ
aiua-6390	205	19	resection	resection	NOUN
aiua-6390	205	20	on	on	ADP
aiua-6390	205	21	recurrence	recurrence	NOUN
aiua-6390	205	22	and	and	CCONJ
aiua-6390	205	23	progression	progression	NOUN
aiua-6390	205	24	rates	rate	NOUN
aiua-6390	205	25	in	in	ADP
aiua-6390	205	26	patients	patient	NOUN
aiua-6390	205	27	with	with	ADP
aiua-6390	205	28	t1	t1	PROPN
aiua-6390	205	29	tumours	tumour	NOUN
aiua-6390	205	30	of	of	ADP
aiua-6390	205	31	the	the	DET
aiua-6390	205	32	bladder	bladder	NOUN
aiua-6390	205	33	who	who	PRON
aiua-6390	205	34	received	receive	VERB
aiua-6390	205	35	intravesical	intravesical	ADJ
aiua-6390	205	36	mytomicin	mytomicin	NOUN
aiua-6390	205	37	:	:	PUNCT
aiua-6390	205	38	a	a	DET
aiua-6390	205	39	prospective	prospective	ADJ
aiua-6390	205	40	,	,	PUNCT
aiua-6390	205	41	randomised	randomise	VERB
aiua-6390	205	42	clinical	clinical	ADJ
aiua-6390	205	43	trial	trial	NOUN
aiua-6390	205	44	.	.	PUNCT
aiua-6390	206	1	j	j	PROPN
aiua-6390	206	2	urol	urol	PROPN
aiua-6390	206	3	.	.	PUNCT
aiua-6390	207	1	2006	2006	NUM
aiua-6390	207	2	;	;	PUNCT
aiua-6390	207	3	175:1644	175:1644	NUM
aiua-6390	207	4	.	.	NOUN
aiua-6390	207	5	25	25	NUM
aiua-6390	207	6	.	.	PUNCT
aiua-6390	208	1	klan	klan	PROPN
aiua-6390	208	2	r	r	PROPN
aiua-6390	208	3	,	,	PUNCT
aiua-6390	208	4	loy	loy	PROPN
aiua-6390	208	5	v	v	PROPN
aiua-6390	208	6	,	,	PUNCT
aiua-6390	208	7	huland	huland	PROPN
aiua-6390	208	8	h.	h.	PROPN
aiua-6390	209	1	residual	residual	ADJ
aiua-6390	209	2	tumour	tumour	NOUN
aiua-6390	209	3	discovered	discover	VERB
aiua-6390	209	4	in	in	ADP
aiua-6390	209	5	routine	routine	ADJ
aiua-6390	209	6	second	second	ADJ
aiua-6390	209	7	transurethral	transurethral	ADJ
aiua-6390	209	8	resection	resection	NOUN
aiua-6390	209	9	in	in	ADP
aiua-6390	209	10	patients	patient	NOUN
aiua-6390	209	11	with	with	ADP
aiua-6390	209	12	stage	stage	NOUN
aiua-6390	209	13	t1	t1	NOUN
aiua-6390	209	14	transitional	transitional	ADJ
aiua-6390	209	15	cell	cell	NOUN
aiua-6390	209	16	carcinoma	carcinoma	NOUN
aiua-6390	209	17	of	of	ADP
aiua-6390	209	18	the	the	DET
aiua-6390	209	19	bladder	bladder	NOUN
aiua-6390	209	20	.	.	PUNCT
aiua-6390	210	1	j	j	PROPN
aiua-6390	210	2	urol	urol	PROPN
aiua-6390	210	3	.	.	PUNCT
aiua-6390	210	4	1991	1991	NUM
aiua-6390	210	5	;	;	PUNCT
aiua-6390	210	6	148:316	148:316	X
aiua-6390	210	7	.	.	PROPN
aiua-6390	210	8	26	26	NUM
aiua-6390	210	9	.	.	PUNCT
aiua-6390	211	1	herr	herr	PROPN
aiua-6390	211	2	hw	hw	PROPN
aiua-6390	211	3	.	.	PUNCT
aiua-6390	212	1	the	the	DET
aiua-6390	212	2	value	value	NOUN
aiua-6390	212	3	of	of	ADP
aiua-6390	212	4	a	a	DET
aiua-6390	212	5	second	second	ADJ
aiua-6390	212	6	transurethral	transurethral	ADJ
aiua-6390	212	7	resection	resection	NOUN
aiua-6390	212	8	in	in	ADP
aiua-6390	212	9	evaluating	evaluate	VERB
aiua-6390	212	10	patients	patient	NOUN
aiua-6390	212	11	with	with	ADP
aiua-6390	212	12	bladder	bladder	NOUN
aiua-6390	212	13	tumours	tumour	NOUN
aiua-6390	212	14	.	.	PUNCT
aiua-6390	213	1	j	j	PROPN
aiua-6390	213	2	urol	urol	PROPN
aiua-6390	213	3	.	.	PUNCT
aiua-6390	213	4	1999	1999	NUM
aiua-6390	213	5	;	;	PUNCT
aiua-6390	214	1	162:74	162:74	NUM
aiua-6390	214	2	.	.	PROPN
aiua-6390	214	3	27	27	NUM
aiua-6390	214	4	.	.	PUNCT
aiua-6390	215	1	mesdorf	mesdorf	PROPN
aiua-6390	215	2	a	a	PRON
aiua-6390	215	3	,	,	PUNCT
aiua-6390	215	4	brauers	brauer	NOUN
aiua-6390	215	5	a	a	PRON
aiua-6390	215	6	,	,	PUNCT
aiua-6390	215	7	wolff	wolff	PROPN
aiua-6390	215	8	jm	jm	PROPN
aiua-6390	215	9	,	,	PUNCT
aiua-6390	215	10	et	et	PROPN
aiua-6390	215	11	al	al	PROPN
aiua-6390	215	12	.	.	PUNCT
aiua-6390	216	1	2nd	2nd	PROPN
aiua-6390	216	2	tur	tur	PROPN
aiua-6390	216	3	for	for	ADP
aiua-6390	216	4	superficial	superficial	ADJ
aiua-6390	216	5	bladder	bladder	NOUN
aiua-6390	216	6	cancer	cancer	NOUN
aiua-6390	216	7	,	,	PUNCT
aiua-6390	216	8	a	a	DET
aiua-6390	216	9	must	must	NOUN
aiua-6390	216	10	?	?	PUNCT
aiua-6390	217	1	j	j	PROPN
aiua-6390	217	2	urol	urol	PROPN
aiua-6390	217	3	.	.	PUNCT
aiua-6390	218	1	1998	1998	NUM
aiua-6390	218	2	;	;	PUNCT
aiua-6390	218	3	suppl	suppl	PROPN
aiua-6390	218	4	.	.	PROPN
aiua-6390	218	5	,	,	PUNCT
aiua-6390	218	6	159:143	159:143	NOUN
aiua-6390	218	7	,	,	PUNCT
aiua-6390	218	8	abstract	abstract	ADJ
aiua-6390	218	9	542	542	NUM
aiua-6390	218	10	.	.	PUNCT
aiua-6390	219	1	28	28	NUM
aiua-6390	219	2	.	.	PUNCT
aiua-6390	220	1	schips	schips	PROPN
aiua-6390	220	2	l	l	PROPN
aiua-6390	220	3	,	,	PUNCT
aiua-6390	220	4	augustin	augustin	PROPN
aiua-6390	220	5	h	h	PROPN
aiua-6390	220	6	,	,	PUNCT
aiua-6390	220	7	zigeuner	zigeuner	NOUN
aiua-6390	220	8	re	re	PROPN
aiua-6390	220	9	,	,	PUNCT
aiua-6390	220	10	et	et	PROPN
aiua-6390	220	11	al	al	PROPN
aiua-6390	220	12	.	.	PROPN
aiua-6390	220	13	is	be	AUX
aiua-6390	220	14	repeated	repeat	VERB
aiua-6390	220	15	transurethral	transurethral	ADJ
aiua-6390	220	16	resection	resection	NOUN
aiua-6390	220	17	justified	justify	VERB
aiua-6390	220	18	in	in	ADP
aiua-6390	220	19	patients	patient	NOUN
aiua-6390	220	20	with	with	ADP
aiua-6390	220	21	newly	newly	ADV
aiua-6390	220	22	diagnosed	diagnose	VERB
aiua-6390	220	23	superficial	superficial	ADJ
aiua-6390	220	24	bladder	bladder	NOUN
aiua-6390	220	25	cancer	cancer	NOUN
aiua-6390	220	26	?	?	PUNCT
aiua-6390	221	1	urology	urology	NOUN
aiua-6390	221	2	.	.	PUNCT
aiua-6390	222	1	2002	2002	NUM
aiua-6390	222	2	;	;	PUNCT
aiua-6390	222	3	60:822	60:822	NUM
aiua-6390	222	4	.	.	PUNCT
aiua-6390	223	1	29	29	NUM
aiua-6390	223	2	.	.	PUNCT
aiua-6390	224	1	ojea	ojea	PROPN
aiua-6390	224	2	calvo	calvo	PROPN
aiua-6390	224	3	a	a	PROPN
aiua-6390	224	4	,	,	PUNCT
aiua-6390	224	5	nunuz	nunuz	PROPN
aiua-6390	224	6	lopez	lopez	PROPN
aiua-6390	224	7	a	a	PROPN
aiua-6390	224	8	,	,	PUNCT
aiua-6390	224	9	alonso	alonso	PROPN
aiua-6390	224	10	rodrigo	rodrigo	PROPN
aiua-6390	224	11	a	a	PROPN
aiua-6390	224	12	,	,	PUNCT
aiua-6390	224	13	et	et	PROPN
aiua-6390	224	14	al	al	PROPN
aiua-6390	224	15	.	.	PROPN
aiua-6390	224	16	value	value	NOUN
aiua-6390	224	17	of	of	ADP
aiua-6390	224	18	a	a	DET
aiua-6390	224	19	second	second	ADJ
aiua-6390	224	20	transurethral	transurethral	ADJ
aiua-6390	224	21	resection	resection	NOUN
aiua-6390	224	22	in	in	ADP
aiua-6390	224	23	the	the	DET
aiua-6390	224	24	assesment	assesment	NOUN
aiua-6390	224	25	and	and	CCONJ
aiua-6390	224	26	treatment	treatment	NOUN
aiua-6390	224	27	of	of	ADP
aiua-6390	224	28	patients	patient	NOUN
aiua-6390	224	29	with	with	ADP
aiua-6390	224	30	bladder	bladder	NOUN
aiua-6390	224	31	tumour	tumour	NOUN
aiua-6390	224	32	.	.	PUNCT
aiua-6390	224	33	actas	actas	VERB
aiua-6390	224	34	urol	urol	PROPN
aiua-6390	224	35	esp	esp	PROPN
aiua-6390	224	36	.	.	PUNCT
aiua-6390	225	1	2001	2001	NUM
aiua-6390	225	2	;	;	PUNCT
aiua-6390	225	3	25:182	25:182	NUM
aiua-6390	225	4	.	.	PUNCT
aiua-6390	226	1	30	30	NUM
aiua-6390	226	2	.	.	PUNCT
aiua-6390	227	1	kitamura	kitamura	PROPN
aiua-6390	227	2	h	h	PROPN
aiua-6390	227	3	,	,	PUNCT
aiua-6390	227	4	kakehi	kakehi	PROPN
aiua-6390	227	5	y.	y.	PROPN
aiua-6390	227	6	treatment	treatment	NOUN
aiua-6390	227	7	and	and	CCONJ
aiua-6390	227	8	management	management	NOUN
aiua-6390	227	9	of	of	ADP
aiua-6390	227	10	highgrade	highgrade	NOUN
aiua-6390	227	11	t1	t1	NOUN
aiua-6390	227	12	bladder	bladder	NOUN
aiua-6390	227	13	cancer	cancer	NOUN
aiua-6390	227	14	:	:	PUNCT
aiua-6390	227	15	what	what	PRON
aiua-6390	227	16	should	should	AUX
aiua-6390	227	17	we	we	PRON
aiua-6390	227	18	do	do	VERB
aiua-6390	227	19	after	after	ADP
aiua-6390	227	20	second	second	NOUN
aiua-6390	227	21	tur	tur	INTJ
aiua-6390	227	22	?	?	PUNCT
aiua-6390	228	1	jpn	jpn	PROPN
aiua-6390	228	2	j	j	PROPN
aiua-6390	228	3	clin	clin	PROPN
aiua-6390	228	4	oncol	oncol	PROPN
aiua-6390	228	5	.	.	PUNCT
aiua-6390	229	1	2015	2015	NUM
aiua-6390	229	2	;	;	PUNCT
aiua-6390	229	3	45:315	45:315	PROPN
aiua-6390	229	4	-	-	SYM
aiua-6390	229	5	322	322	NUM
aiua-6390	229	6	..	..	NUM
aiua-6390	229	7	31	31	NUM
aiua-6390	229	8	.	.	PUNCT
aiua-6390	230	1	shelley	shelley	PROPN
aiua-6390	230	2	md	md	PROPN
aiua-6390	230	3	,	,	PUNCT
aiua-6390	230	4	wilt	wilt	PROPN
aiua-6390	230	5	tj	tj	PROPN
aiua-6390	230	6	,	,	PUNCT
aiua-6390	230	7	court	court	PROPN
aiua-6390	230	8	j	j	PROPN
aiua-6390	230	9	,	,	PUNCT
aiua-6390	230	10	et	et	PROPN
aiua-6390	230	11	al	al	PROPN
aiua-6390	230	12	.	.	PROPN
aiua-6390	230	13	intravesical	intravesical	ADJ
aiua-6390	230	14	bacillus	bacillus	NOUN
aiua-6390	230	15	calmette	calmette	NOUN
aiua-6390	230	16	-	-	PUNCT
aiua-6390	230	17	guérin	guérin	PROPN
aiua-6390	230	18	is	be	AUX
aiua-6390	230	19	superior	superior	ADJ
aiua-6390	230	20	to	to	ADP
aiua-6390	230	21	mitomycin	mitomycin	PROPN
aiua-6390	230	22	c	c	PROPN
aiua-6390	230	23	in	in	ADP
aiua-6390	230	24	reducing	reduce	VERB
aiua-6390	230	25	tumour	tumour	NOUN
aiua-6390	230	26	recurrence	recurrence	NOUN
aiua-6390	230	27	in	in	ADP
aiua-6390	230	28	high	high	ADJ
aiua-6390	230	29	-	-	PUNCT
aiua-6390	230	30	risk	risk	NOUN
aiua-6390	230	31	superficial	superficial	ADJ
aiua-6390	230	32	bladder	bladder	NOUN
aiua-6390	230	33	cancer	cancer	NOUN
aiua-6390	230	34	:	:	PUNCT
aiua-6390	230	35	a	a	DET
aiua-6390	230	36	meta	meta	ADJ
aiua-6390	230	37	-	-	PUNCT
aiua-6390	230	38	analysis	analysis	NOUN
aiua-6390	230	39	of	of	ADP
aiua-6390	230	40	randomized	randomized	ADJ
aiua-6390	230	41	trials	trial	NOUN
aiua-6390	230	42	.	.	PUNCT
aiua-6390	231	1	bju	bju	NOUN
aiua-6390	231	2	int	int	PROPN
aiua-6390	231	3	.	.	PUNCT
aiua-6390	232	1	2004	2004	NUM
aiua-6390	232	2	;	;	PUNCT
aiua-6390	232	3	93:485	93:485	NUM
aiua-6390	232	4	-	-	SYM
aiua-6390	232	5	490	490	NUM
aiua-6390	232	6	.	.	NOUN
aiua-6390	232	7	32	32	NUM
aiua-6390	232	8	.	.	PUNCT
aiua-6390	233	1	böhle	böhle	PROPN
aiua-6390	233	2	a	a	PRON
aiua-6390	233	3	,	,	PUNCT
aiua-6390	233	4	bock	bock	NOUN
aiua-6390	233	5	pr	pr	NOUN
aiua-6390	233	6	.	.	PUNCT
aiua-6390	234	1	intravesical	intravesical	ADJ
aiua-6390	234	2	bacille	bacille	PROPN
aiua-6390	234	3	calmette	calmette	PROPN
aiua-6390	234	4	-	-	PUNCT
aiua-6390	234	5	guérin	guérin	PROPN
aiua-6390	234	6	versus	versus	ADP
aiua-6390	234	7	mitomycin	mitomycin	PROPN
aiua-6390	234	8	c	c	PROPN
aiua-6390	234	9	in	in	ADP
aiua-6390	234	10	superficial	superficial	ADJ
aiua-6390	234	11	bladder	bladder	NOUN
aiua-6390	234	12	cancer	cancer	NOUN
aiua-6390	234	13	:	:	PUNCT
aiua-6390	234	14	formal	formal	ADJ
aiua-6390	234	15	meta	meta	ADJ
aiua-6390	234	16	-	-	PUNCT
aiua-6390	234	17	analysis	analysis	NOUN
aiua-6390	234	18	of	of	ADP
aiua-6390	234	19	comparative	comparative	ADJ
aiua-6390	234	20	studies	study	NOUN
aiua-6390	234	21	on	on	ADP
aiua-6390	234	22	tumor	tumor	NOUN
aiua-6390	234	23	progression	progression	NOUN
aiua-6390	234	24	.	.	PUNCT
aiua-6390	235	1	urology	urology	NOUN
aiua-6390	235	2	.	.	PUNCT
aiua-6390	236	1	2004	2004	NUM
aiua-6390	236	2	;	;	PUNCT
aiua-6390	237	1	63:682686	63:682686	X
aiua-6390	237	2	.	.	PROPN
aiua-6390	237	3	33	33	NUM
aiua-6390	237	4	.	.	PUNCT
aiua-6390	238	1	gupta	gupta	PROPN
aiua-6390	238	2	a	a	PRON
aiua-6390	238	3	,	,	PUNCT
aiua-6390	238	4	lotan	lotan	PROPN
aiua-6390	238	5	y	y	PROPN
aiua-6390	238	6	,	,	PUNCT
aiua-6390	238	7	bastian	bastian	PROPN
aiua-6390	238	8	pj	pj	PROPN
aiua-6390	238	9	,	,	PUNCT
aiua-6390	238	10	et	et	PROPN
aiua-6390	238	11	al	al	PROPN
aiua-6390	238	12	.	.	PUNCT
aiua-6390	239	1	outcomes	outcome	NOUN
aiua-6390	239	2	of	of	ADP
aiua-6390	239	3	patients	patient	NOUN
aiua-6390	239	4	with	with	ADP
aiua-6390	239	5	clinical	clinical	ADJ
aiua-6390	239	6	t1	t1	NOUN
aiua-6390	239	7	grade	grade	NOUN
aiua-6390	239	8	3	3	NUM
aiua-6390	239	9	urothelial	urothelial	ADJ
aiua-6390	239	10	cell	cell	NOUN
aiua-6390	239	11	bladder	bladder	NOUN
aiua-6390	239	12	carcinoma	carcinoma	NOUN
aiua-6390	239	13	treated	treat	VERB
aiua-6390	239	14	with	with	ADP
aiua-6390	239	15	radical	radical	ADJ
aiua-6390	239	16	cystectomy	cystectomy	NOUN
aiua-6390	239	17	.	.	PUNCT
aiua-6390	240	1	urology	urology	NOUN
aiua-6390	240	2	2008	2008	NUM
aiua-6390	240	3	;	;	PUNCT
aiua-6390	240	4	71:302	71:302	NUM
aiua-6390	240	5	-	-	SYM
aiua-6390	240	6	307	307	NUM
aiua-6390	240	7	.	.	PUNCT
aiua-6390	241	1	34	34	NUM
aiua-6390	241	2	.	.	PUNCT
aiua-6390	242	1	herr	herr	PROPN
aiua-6390	242	2	hw	hw	PROPN
aiua-6390	242	3	,	,	PUNCT
aiua-6390	242	4	donat	donat	PROPN
aiua-6390	242	5	sm	sm	PROPN
aiua-6390	242	6	,	,	PUNCT
aiua-6390	242	7	dalbagni	dalbagni	PROPN
aiua-6390	242	8	g.	g.	PROPN
aiua-6390	242	9	can	can	AUX
aiua-6390	242	10	restaging	restage	VERB
aiua-6390	242	11	transurethral	transurethral	ADJ
aiua-6390	242	12	resection	resection	NOUN
aiua-6390	242	13	of	of	ADP
aiua-6390	242	14	t1	t1	NOUN
aiua-6390	242	15	bladder	bladder	NOUN
aiua-6390	242	16	cancer	cancer	NOUN
aiua-6390	242	17	select	select	ADJ
aiua-6390	242	18	patients	patient	NOUN
aiua-6390	242	19	for	for	ADP
aiua-6390	242	20	immediate	immediate	ADJ
aiua-6390	242	21	cystectomy	cystectomy	NOUN
aiua-6390	242	22	?	?	PUNCT
aiua-6390	243	1	j	j	PROPN
aiua-6390	243	2	urol	urol	PROPN
aiua-6390	243	3	.	.	PUNCT
aiua-6390	244	1	2007	2007	NUM
aiua-6390	244	2	;	;	PUNCT
aiua-6390	244	3	177:75	177:75	NUM
aiua-6390	244	4	-	-	SYM
aiua-6390	244	5	79	79	NUM
aiua-6390	244	6	.	.	PUNCT
aiua-6390	245	1	35	35	NUM
aiua-6390	245	2	.	.	PUNCT
aiua-6390	246	1	denzinger	denzinger	PROPN
aiua-6390	246	2	s	s	PROPN
aiua-6390	246	3	,	,	PUNCT
aiua-6390	246	4	fritsche	fritsche	PROPN
aiua-6390	246	5	hm	hm	PROPN
aiua-6390	246	6	,	,	PUNCT
aiua-6390	246	7	otto	otto	PROPN
aiua-6390	246	8	w	w	PROPN
aiua-6390	246	9	,	,	PUNCT
aiua-6390	246	10	et	et	PROPN
aiua-6390	246	11	al	al	PROPN
aiua-6390	246	12	.	.	PROPN
aiua-6390	247	1	early	early	ADV
aiua-6390	247	2	versus	versus	ADP
aiua-6390	247	3	deferred	deferred	ADJ
aiua-6390	247	4	cystectomy	cystectomy	NOUN
aiua-6390	247	5	for	for	ADP
aiua-6390	247	6	initial	initial	ADJ
aiua-6390	247	7	high	high	ADJ
aiua-6390	247	8	-	-	PUNCT
aiua-6390	247	9	risk	risk	NOUN
aiua-6390	247	10	pt1g3	pt1g3	NOUN
aiua-6390	247	11	urothelial	urothelial	ADJ
aiua-6390	247	12	carcinoma	carcinoma	NOUN
aiua-6390	247	13	of	of	ADP
aiua-6390	247	14	the	the	DET
aiua-6390	247	15	bladder	bladder	NOUN
aiua-6390	247	16	:	:	PUNCT
aiua-6390	247	17	do	do	AUX
aiua-6390	247	18	risk	risk	NOUN
aiua-6390	247	19	factors	factor	NOUN
aiua-6390	247	20	define	define	VERB
aiua-6390	247	21	feasibility	feasibility	NOUN
aiua-6390	247	22	of	of	ADP
aiua-6390	247	23	bladder	bladder	NOUN
aiua-6390	247	24	-	-	PUNCT
aiua-6390	247	25	sparing	spare	VERB
aiua-6390	247	26	approach	approach	NOUN
aiua-6390	247	27	?	?	PUNCT
aiua-6390	248	1	eur	eur	PROPN
aiua-6390	248	2	urol	urol	PROPN
aiua-6390	248	3	.	.	PUNCT
aiua-6390	248	4	2008	2008	NUM
aiua-6390	248	5	;	;	PUNCT
aiua-6390	248	6	53:146	53:146	NUM
aiua-6390	248	7	-	-	SYM
aiua-6390	248	8	152	152	NUM
aiua-6390	248	9	.	.	PUNCT
aiua-6390	249	1	36	36	NUM
aiua-6390	249	2	.	.	PUNCT
aiua-6390	250	1	lambert	lambert	PROPN
aiua-6390	250	2	eh	eh	PROPN
aiua-6390	250	3	,	,	PUNCT
aiua-6390	250	4	pierorazio	pierorazio	PROPN
aiua-6390	250	5	pm	pm	PROPN
aiua-6390	250	6	,	,	PUNCT
aiua-6390	250	7	olsson	olsson	PROPN
aiua-6390	250	8	ca	can	AUX
aiua-6390	250	9	,	,	PUNCT
aiua-6390	250	10	et	et	PROPN
aiua-6390	250	11	al	al	PROPN
aiua-6390	250	12	.	.	PUNCT
aiua-6390	251	1	the	the	DET
aiua-6390	251	2	increasing	increase	VERB
aiua-6390	251	3	use	use	NOUN
aiua-6390	251	4	of	of	ADP
aiua-6390	251	5	intravesical	intravesical	ADJ
aiua-6390	251	6	therapies	therapy	NOUN
aiua-6390	251	7	for	for	ADP
aiua-6390	251	8	stage	stage	NOUN
aiua-6390	251	9	t1	t1	NOUN
aiua-6390	251	10	bladder	bladder	NOUN
aiua-6390	251	11	cancer	cancer	NOUN
aiua-6390	251	12	coincides	coincide	VERB
aiua-6390	251	13	with	with	ADP
aiua-6390	251	14	decreasing	decrease	VERB
aiua-6390	251	15	survival	survival	NOUN
aiua-6390	251	16	after	after	ADP
aiua-6390	251	17	cystectomy	cystectomy	NOUN
aiua-6390	251	18	.	.	PUNCT
aiua-6390	252	1	bju	bju	NOUN
aiua-6390	252	2	int	int	PROPN
aiua-6390	252	3	.	.	PUNCT
aiua-6390	253	1	2007	2007	NUM
aiua-6390	253	2	;	;	PUNCT
aiua-6390	253	3	100:33	100:33	NUM
aiua-6390	253	4	-	-	SYM
aiua-6390	253	5	36	36	NUM
aiua-6390	253	6	.	.	PUNCT
aiua-6390	254	1	37	37	NUM
aiua-6390	254	2	.	.	PUNCT
aiua-6390	255	1	hautmann	hautmann	PROPN
aiua-6390	255	2	re	re	PROPN
aiua-6390	255	3	,	,	PUNCT
aiua-6390	255	4	abol	abol	NOUN
aiua-6390	255	5	-	-	PUNCT
aiua-6390	255	6	enein	enein	NOUN
aiua-6390	255	7	h	h	NOUN
aiua-6390	255	8	,	,	PUNCT
aiua-6390	255	9	davidsson	davidsson	PROPN
aiua-6390	255	10	t	t	PROPN
aiua-6390	255	11	,	,	PUNCT
aiua-6390	255	12	et	et	PROPN
aiua-6390	255	13	al	al	PROPN
aiua-6390	255	14	.	.	PUNCT
aiua-6390	256	1	icud	icud	PROPN
aiua-6390	256	2	-	-	PUNCT
aiua-6390	256	3	eau	eau	PROPN
aiua-6390	256	4	international	international	ADJ
aiua-6390	256	5	consultation	consultation	NOUN
aiua-6390	256	6	on	on	ADP
aiua-6390	256	7	bladder	bladder	NOUN
aiua-6390	256	8	cancer	cancer	NOUN
aiua-6390	256	9	2012	2012	NUM
aiua-6390	256	10	:	:	PUNCT
aiua-6390	256	11	urinary	urinary	ADJ
aiua-6390	256	12	diversion	diversion	NOUN
aiua-6390	256	13	.	.	PUNCT
aiua-6390	257	1	eur	eur	PROPN
aiua-6390	257	2	urol	urol	PROPN
aiua-6390	257	3	.	.	PUNCT
aiua-6390	258	1	2013	2013	NUM
aiua-6390	258	2	;	;	PUNCT
aiua-6390	258	3	63:67	63:67	NUM
aiua-6390	258	4	-	-	SYM
aiua-6390	258	5	80	80	NUM
aiua-6390	258	6	.	.	PUNCT
aiua-6390	259	1	correspondence	correspondence	NOUN
aiua-6390	259	2	roberto	roberto	PROPN
aiua-6390	259	3	giulianelli	giulianelli	PROPN
aiua-6390	259	4	,	,	PUNCT
aiua-6390	259	5	md	md	PROPN
aiua-6390	259	6	giulianelli0764@gmail.com	giulianelli0764@gmail.com	PROPN
aiua-6390	260	1	barbara	barbara	PROPN
aiua-6390	260	2	cristina	cristina	PROPN
aiua-6390	260	3	gentile	gentile	PROPN
aiua-6390	260	4	,	,	PUNCT
aiua-6390	260	5	md	md	PROPN
aiua-6390	260	6	gabriella	gabriella	PROPN
aiua-6390	260	7	mirabile	mirabile	PROPN
aiua-6390	260	8	,	,	PUNCT
aiua-6390	260	9	md	md	PROPN
aiua-6390	260	10	luca	luca	PROPN
aiua-6390	260	11	albanesi	albanesi	PROPN
aiua-6390	260	12	,	,	PUNCT
aiua-6390	260	13	md	md	PROPN
aiua-6390	260	14	paola	paola	PROPN
aiua-6390	260	15	tariciotti	tariciotti	PROPN
aiua-6390	260	16	,	,	PUNCT
aiua-6390	260	17	md	md	PROPN
aiua-6390	260	18	paola.tariciotti@libero.it	paola.tariciotti@libero.it	PROPN
aiua-6390	260	19	giorgio	giorgio	PROPN
aiua-6390	260	20	rizzo	rizzo	PROPN
aiua-6390	260	21	,	,	PUNCT
aiua-6390	260	22	md	md	PROPN
aiua-6390	260	23	cura	cura	PROPN
aiua-6390	260	24	,	,	PUNCT
aiua-6390	260	25	nuova	nuova	PROPN
aiua-6390	260	26	villa	villa	PROPN
aiua-6390	260	27	claudia	claudia	PROPN
aiua-6390	260	28	clinic	clinic	PROPN
aiua-6390	260	29	,	,	PUNCT
aiua-6390	260	30	rome	rome	PROPN
aiua-6390	260	31	,	,	PUNCT
aiua-6390	260	32	italy	italy	PROPN
aiua-6390	260	33	maurizio	maurizio	PROPN
aiua-6390	260	34	buscarini	buscarini	PROPN
aiua-6390	260	35	,	,	PUNCT
aiua-6390	260	36	md	md	PROPN
aiua-6390	260	37	campus	campus	NOUN
aiua-6390	260	38	biomedico	biomedico	PROPN
aiua-6390	260	39	,	,	PUNCT
aiua-6390	260	40	rome	rome	PROPN
aiua-6390	260	41	,	,	PUNCT
aiua-6390	260	42	italy	italy	PROPN
aiua-6390	260	43	mauro	mauro	PROPN
aiua-6390	260	44	vermiglio	vermiglio	PROPN
aiua-6390	260	45	,	,	PUNCT
aiua-6390	260	46	md	md	PROPN
aiua-6390	260	47	villa	villa	PROPN
aiua-6390	260	48	gioia	gioia	PROPN
aiua-6390	260	49	clinic	clinic	PROPN
aiua-6390	260	50	,	,	PUNCT
aiua-6390	260	51	sora	sora	PROPN
aiua-6390	260	52	(	(	PUNCT
aiua-6390	260	53	fr	fr	PROPN
aiua-6390	260	54	)	)	PUNCT
aiua-6390	260	55	,	,	PUNCT
aiua-6390	260	56	italy	italy	PROPN
aiua-6390	260	57	giulianelli_stesura	giulianelli_stesura	PROPN
aiua-6390	260	58	seveso	seveso	PROPN
aiua-6390	260	59	03/01/18	03/01/18	PROPN
aiua-6390	260	60	11:58	11:58	NUM
aiua-6390	260	61	pagina	pagina	NOUN
aiua-6390	260	62	276	276	NUM